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Isolated enzymes and whole cell biocatalysts can both be applied for the synthesis of 
chiral  hydroxy  compounds.  It  is  hypothesized  that  whole  cells  can  easily  be 
employed  for  such  reactions  using  simple  technology  which  is  robust.  This  is 
because whole cells contain all the necessary enzymes and metabolic pathways for 
cofactor regeneration.  This  also  means  that  the  enzymes  and  their  cofactors  are 
well-protected within their natural cell environment.  In contrast, it is hypothesized 
that  isolated  enzymes  require  complicated  and  expensive  purification  procedures. 
They also require the stoichiometric addition of cofactors (or methods employed for 
their regeneration),  and are susceptible to inactivation since they are isolated from 
their natural cell environment.  The aim of this thesis was to systematically compare 
a  whole  cell  biocatalyst  (Trichosporon  capitatum  (MY1890))  and  an  NADH 
dependent isolated reductase (tetralone reductase) in the synthesis of a chiral alcohol 
(6-bromo-P-tetralol).  The  comparison  was  carried  out  to  ascertain  which  type 
biocatalyst  is  preferred,  and  also  to  establish  whether  the  general  hypotheses  (as 
stated above) are true with respect to each biocatalyst.
Comparison  of the  isolated  enzyme  and  whole  cell  biocatalyst  showed  that  there 
were  significant  differences  with  respect  to  each  of the  systems.  These  included 
differences  in:  the  biocatalytic  purity,  the  reaction  methodology,  the  system 
efficiency,  and  the  effects  on  the  biocatalyst  from  the  addition  of substrate  and 
solvent.  The isolated enzyme methods were much more complicated than the whole 
cell  methods,  from  the  preparation  of  the  isolated  enzyme  through  to  the 
bioreduction.  This was because a novel protein purification process needed to be set 
up and a cofactor regeneration system was required.  However, the isolated enzyme 
system showed higher substrate conversions than the whole cell system.  At 1  g/L, a 
conversion  of  86%  after  420min  was  achieved,  whereas  the  whole  cell  system 
exhibited a conversion of 79% after 450min.  It was hypothesized that the whole cell 
system  suffered  from  lower  conversions  due  to  the  substrate  and  product 
accumulating inside the cell membrane and disrupting cell metabolism.  In the same 
configuration, the whole cell  system also suffered from lower reaction rates which 
were attributed to mass transfer limitations through the cell membrane.  The addition 
of a solvent enhanced whole cell biocatalytic reaction rates, but only at low substrate 
concentrations.  The  isolated  enzyme  system  was  susceptible  to  inactivation,  and 
increased solvent concentrations caused a detrimental affect on the reaction rates and 
conversions.  This was most likely due to the solvent causing an irreversible change 
in  the  active  site  conformation.  The  similarities  and  differences  of employing  an 
NADH  dependent  reductase  and  a  whole  cell  biocatalyst  for the  production  of a 
chiral alcohol are discussed in this thesis.
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15Introduction
1.1  Introduction to Biocatalysis
Isolated enzymes and whole cell microorganisms can both be applied as biocatalysts 
to achieve highly specific and desired conversions under controlled conditions in a 
bioreactor  (Buchholz  et  al.,  2000).  Glucose  isomerase  is  a  good  example  of a 
successfully applied biocatalyst.  This immobilised enzyme isomerises glucose into 
fructose,  and  is  the  biggest  selling  immobilised  enzyme  in  the  world  (Cheetham, 
2000).  Another example of the industrial use of biocatalysts is the manufacture of 
enantiopure  L-amino  acids  through  the  dynamic  resolution  of racemic  A-acetyl 
amino acids by L-acylases (Schmid et al., 2002).  Whole cell biocatalysts can also 
be  employed  to  carry  out  a  series  of reactions  where  the  product  may  be  very 
dissimilar to the starting compound. An example of this is the use of microorganisms 
to produce antibiotics from glucose.  Antibiotics are highly complex molecules and 
require  a number  of enzymatic  steps  from  glucose  to  the  final  product  (Dordick, 
1991).
Enzymes are of particular importance as they display four types of selectivity:
1.  Substrate selectivity
The ability to distinguish and to act upon a subset of compounds within a larger 
group of chemically related compounds.
2.  Chemoselectivity
The ability to react on one type of functional group, leaving other groups alone.
3.  Regioselectivity and diastereoselectivity
The ability to distinguish between identical groups on the same substrate.  The 
regioselectivity of enzymes  even  on complex  molecules,  without  any  need  of 
protecting groups, is a fundamental strength of biocatalysis (Rasor et al., 2001).
16This reduces the number of synthetic steps and thereby cuts occupation time of 
chemical  reactors,  which  is  an  important  factor  of  process  economy  in 
pharmaceutical and chemical production.
4.  Enantioselectivity/stereoselectivity.
The  ability to  produce  optically  active  substances  from pro-chiral  substrates. 
Enzymes  have  gained  most  attention  because  of  their  stereoselectivity, 
especially in the preparation of pharmaceutical compounds. The recent tendency 
to develop single stereoisomer pharmaceuticals instead of racemates has helped 
to establish enzymes as tools in organic synthesis (Rasor et al., 2001)
Another major advantage of biological catalysts is that they can utilise the growing 
resources of biotechnology.  This includes: random or site selective mutagenesis for 
the optimisation of enzymatic properties, transfer of the gene into high productivity 
organisms, and overexpression by incorporation of a promoter gene.  An example of 
where this has occurred is in the Baeyer-Villiger reaction in which a gene expressing 
CHMO from Acinetobacter calcoaceicus NCIB  9871  was cloned into Escherichia 
coli in an L-arabinose inducible vector (Doig et al., 2001).  This was done because 
firstly,  the wild  type  host  was  a class  2  pathogen,  therefore  unattractive  for large 
scale  fermentation.  Secondly,  the  fermentation  protocol  for  Acinetobacter 
calcoaceicus  NCIB  9871  involved  growth  on  a  toxic  carbon  source  which  was 
required for induction.  Finally, Acinetobacter calcoaceicus NCIB  9871  contained 
an  active  lactone  hydrolase  and  therefore  either  purification  of  the  CHMO  or 
selective inhibition of the hydrogenase was required prior to the biotransformation.
Enzymes  can  be  very  efficient  catalysts  on  their  natural  substrates  with  higher 
acceleration  rates  and  lower  mole  ratios  when  compared  to  their  chemical 
counterparts.  Enzymes  are  environmentally  friendly  (they  can  be  completely 
degraded  by  the  environment),  and  they require  mild  reaction  conditions  such  as 
neutral  pHs  (6-8)  and  low  temperatures  (20-40°C)  (Faber,  1997).  These  mild
17reaction conditions minimise the problems associated with harsh chemical reaction 
conditions, such as product degradation and side-reactions, and minimise the amount 
of energy required in the process.  Enzymes are also advantageous because they do 
not need to be used in their natural environment.  For example, two enzymes may be 
isolated  from  two  different  types  of cell  and  put  together  in  a  compatible  new 
reaction  environment.  Sequential  reactions  can  be  performed  in  this  manner  by 
using  multi-enzyme  systems,  thus  simplifying  reaction  processes  (Faber,  1997). 
Similarly,  enzymes  are  not  purely bound  to  their natural  role  and  can  catalyse  a 
variety of substrates including many synthetic substrates which can be used in the 
synthesis of new  and  important pharmacological  compounds.  This,  alongside the 
diverse  biocatalytic  systems  available,  can  give  rise  to  numerous  reaction 
configurations.
1.2  The Disadvantages of Biocatalysts
There are a number of disadvantages  associated with the use of biocatalysts when 
substituted in place of chemical catalysts, these are:
1.  In general, enzymes require mild conditions; this means that the process needs to 
be monitored and controlled within narrow parameters as any slight change in 
pH, temperature, or salt concentration could denature the enzyme (Faber,  1997).
2.  A  large  number  of organic  compounds  which  are  of importance  in  modem 
biotechnology are insoluble in aqueous media (Angelova et al.,  1999).  Solvents 
are required to  dissolve these types of compounds,  or these compounds  are in 
fact  organic  solvents  themselves,  and  biocatalysts  are  often  liable  to  be 
denatured  in  the  presence  of organic  solvents  (Fukui  and  Tanaka,  1985).  A 
compromise  may be made with the  ratio  of solvent to  aqueous phase  and  the 
type of solvent used, although still there may be losses in activity and stability.
183.  The  selectivity  of  enzymes  means  that  they  are  specific  to  one  type  of 
enantiomer,  and  there  is  no  way  of creating  mirror  image  enzymes  (from  D- 
amino  acids).  The  only  way  to  achieve  conversion  to  the  other  enantiomer 
would be to  undergo  a separate screening process  for another enzyme  (Faber, 
1997).
4.  Many enzymatic reactions are prone to substrate or product inhibition; substrate 
inhibition  can  be  overcome  by  the  monitoring  and  controlled  addition  of 
substrate levels.  Product inhibition is more complicated as in situ removal of the 
product needs to be facilitated (Faber, 1997).
1.3  Oxidoreductases
Oxidoreductases  are  the  class  of enzyme  which  catalyse  reduction  and  oxidation 
reactions,  specifically  the  removal  or  addition  of  hydrogen.  Enzymes  can  be 
classified into six groups by the nature of their specificity:
Enzyme Classification
EC1 Oxidoreductases which catalyse redox reactions
EC2 Transferases which catalyse the transfer of a group from one molecule to 
another e.g. acyl or phosphate
EC3 Hydrolases which catalyse hydrolysis reaction e.g. Esterases, lipases and 
amidases
EC4 Lyases catalyses the cleavage of C-C, C-O, and C-N bonds other than by 
hydrolysis or redox reactions. Typically these reactions involve elimination 
of, or addition to double bonds.
EC5 Isomerases catalyse isomerizations such as epimerization and racemization
EC6 Ligases catalyse the intermolecular bond formation coupled with the 
cleavage of ATP or other nucleotide triphosphates
(International Union of  Biochemistry and Molecular Biology,  (IUBMB); 1992)
The oxidoreductases  are  one  of the  most  important classes  of enzyme  and this  is 
seen through the asymmetrisation of a prochiral substrate which leads to an optically 
pure product with  a possible  100% conversion  (Anthonsen,  2000).  Optical  purity
19(chirality) is the property which characterises a pair of enantiomers or molecules that 
are  non-superimposable mirror images  of each other.  Enantiomers have  different 
biological  activities  which  can  often  influence  the  efficacy  or  toxicity  of  a 
compound.  For example,  the i?-enantiomer of penicillamine is toxic whilst the S- 
enantiomer is antiarthritic (Figure  1.1).  The reverse oxidative process is of limited 
use (for example,  alcohol oxidation)  as this generally leads to the destruction of a 
chiral centre.
R-enantiomer  S-enantiomer
n h 2  n h 2
Toxic  Antiarthritic
Figure 1.1 Biological effect o f  penicillamine (adapted  from Faber, 1997).
Industry is finding an ever-increasing need for the production of safe products with 
greater purity and different chiral forms of every new drug have to be synthesised to 
study  their  individual  pharmacological  effects  (FDA’s  Policy  Statement  on  the 
Development of New Stereoisomeric Drugs,  1992).  Chemical catalysts, in general, 
do not possess the specificity required to produce chiral products,  oxidoreductases, 
in contrast, have ability to produce products of high optically purity.  However, the 
disadvantage  of  using  oxidoreductases  for  such  reactions  is  that  these  enzymes 
require the stoichiometric use of cofactors.
201.4  Cofactors for Oxidoreductase Activity
Cofactors  are  a low  molecular weight,  (0.5  -  0.8  kD)  non-protein  species that  are 
essential participants in most isolated  enzyme catalysed reactions  (Chenault et al., 
1988).  Cofactors and coenzymes are distinguished from each other in that a cofactor 
is tightly bound to the enzyme, whereas a coenzyme can dissociate into the medium 
(Faber,  1997).  The most common type of cofactor for the oxidoreductases are the 
nicotinamide  derivatives  (NAD(P)(H));  these  cofactors  are  often  loosely bound to 
the enzyme  and can in many ways be considered  as cosubstrates which donate or 
accept a functional group (i.e. a hydride, or a phosphate) (Adlercreutz,  1996).  Many 
enzymes require coordinated metals such as iron, zinc, magnesium and manganese 
(Faber,  1997)  as  a type of coenzyme.  However,  this in itself does not result in  a 
problem as many enzymes have a high affinity for these metals, and if they do not, 
the cost of supplying a metal rich medium is not significant.
The stability of nicotinamide cofactors is dependent on a variety of situations and 
conditions.  Temperature and pH have the greatest impact on the degradation of both 
NADH and NADPH.  However, the degradation of NADPH was much faster under 
all conditions investigated compared to the degradation of NADH (Wu et al.,  1986). 
One instability in particular is the catalysis arising from exposure to extremes of pH. 
Acidic conditions catalyse the hydration of the reduced cofactors (NAD(P)H) (Wong 
et  al.,  1981),  where  basic  conditions  catalyse  the  hydrolysis  of  the  cofactors 
(NAD(P))(Guilbert  et  al.,  1977).  The  optimal  stability  of NAD(H)  in  aqueous 
solutions  is  hard  to  predict  because  the  destruction  of  the  reduced  cofactor  is 
minimised  by  alkaline  conditions  and  the  destruction  of  the  oxidised  form  is 
minimised by acidic conditions.  In a two-enzyme cofactor regeneration system, the 
cofactor is continuously recycled between its reduced and oxidised forms (Chenault 
and Whitesides,  1987).  Knowledge of activities of the enzymes must be acquired to 
allow  optimisation  of the process.  NAD(H)  is  also  known  to  be  degraded  in  the 
presence  of  phosphates,  and  enzymes  such  as  phosphodiesterases  and 
phosphoesterases are occasionally present as impurities in enzymes (Chenault et al.,
211987).  Reduced  nicotinamide  cofactors  are  particularly  unstable  in  phosphate 
buffers  and  depending  on  the  buffer  or  other  ions  present,  the  half  life  of 
nicotinamide cofactors in solution at pH 7, and 25°C can range from several hours to 
a month. Acetate buffers also produce a similar effect (Wu et al.,  1986; Chenault et 
al, 1987).
In  both  forms  of  nicotinamide  cofactors,  electron  transfer  involves  only  the 
nicotinamide moiety.  Enzymatic reduction of NAD(P) directs hydride attack at the 
C-4 position of the pyridinium ring and forms exclusively the  1,4-dihydropyridine 
product, which is the only enzymatically active form of NAD(P)H (Figure 1.2).  The 
requirement  for the  highly  specific  1,4-  reduction  of the pyridinium ring  severely 
limits the number of strategies practical  for large  scale regeneration  of NAD(P)H 
(Chenault et al.,  1988).
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Figure 1.2 Electron Transfer in NAD(H)
Enzymatic  reduction  of NAD  directs  hydride  attack  at  the  C-4  position  of the 
pyridinium ring and forms exclusively the 1,4-dihydropyridine product,  which is the 
only  enzymatically  active  form  of  NADH.  The  only  difference  between  the 
nicotinamide cofactors NAD and NADP is the 2-phosphate on the adenosine ring.
221.5  Oxidoreductase Isolation and Purification
The oxidoreductase required for a specific bioreduction will be just one of a large 
number of components which make up a whole cell biocatalyst.  To apply isolated 
enzyme catalysis efficiently, methods of purifying the target enzyme from the other 
cell contaminants are required.  These contaminants may include: cell growth debris, 
nucleic acids, endotoxins, small molecules and other cell proteins (Bailey and Ollis, 
1986).  If the  protein  of interest  is  overexpressed  then  it  will  make  up  a  large 
percentage of the total  cell protein,  if not,  then the method of protein purification 
will need to be extremely efficient to gain a protein of high purity and concentration. 
Extraction  of an  active  and  intact  protein  from  a natural  source  may  employ the 
following methods:  homogenisation,  lysis,  extraction,  precipitation,  centrifugation, 
filtration and chromatography (Harris,  1989).  The purification of proteins is usually 
carried  out  by  a  series  of  chromatography  columns  which  separate  the  cell 
components  due  to  the  different  properties  inherent  in  their  structures.  These 
include:  the  number  of ionic  charges  which  are  accessible  on  the  surface  of the 
molecule;  the  hydrophobicity  of  the  molecule  or  functional  groups  within  the 
molecule;  the  presence  of  sites  on  the  molecule  which  can  interact  with  other 
molecules in a bio-specific binding action; the range of chemical conditions in which 
the molecule can stay in solution and maintain biological activity; and the molecular 
weight of the protein (Harris,  1989).  However this mode of separation can end up in 
a circular motion as the properties of the protein of interest may only be ascertained 
after purification of the protein.
1.6  Isolated Oxidoreductase Biocatalysis
In  applied  isolated  oxidoreductase  systems  cofactors  are  used  in  stoichiometric 
quantities  and  these  cofactors  emerge  from  the  enzymatic  reactions  in  an  altered 
form.  It is the high cost of these cofactors which preclude them from being used in 
large-scale  industrial  processes  (Chenault  and  Whitesides,  1987;  Hummel,  1997) 
and  if  oxidoreductases  are  to  be  employed  as  catalysts  for  large-scale  enzyme 
catalysed synthesis of chiral products it will require an efficient procedure for the in
23situ  regeneration  of the  cofactor  (Hummel  and  Kula,  1989;  Hummel  1997).  The 
regeneration  of  cofactors  also  influences  the  position  of the  equilibrium  of the 
reaction,  precludes  the  problem  of product  inhibition,  eliminates  stoichiometric 
quantities, and simplifies reaction work-up (Chenault and Whitesides, 1987).
To be practical a regeneration method must fulfill several requirements:
•  An economical turnover number must be possible.
•  The materials and equipment should be readily available, inexpensive, easily 
manipulated and stable under reaction conditions.
•  The  regeneration  must  also  be  kinetically  and  thermodynamically 
favourable.
•  Compatible with the synthetic reaction system.
(Chenault et al., 1987).
Two definitions concerning the turnover numbers for cofactors are important:
Total  turnover number (TTN)  is the total  number of moles of product  formed per 
mole of cofactor during the course of a complete reaction:
TTN  amount of product formed
amount of cofactor present in reaction
Turnover number (TN) refers to the number of moles of product formed per mole of 
cofactor per unit time, it is measured as a rate and has units of time (s'1 ):
amount of product formed 
amount of cofactor present in reaction x time
Whereas, TTN emphasises the total cost per mole of product formed, TN emphasises 
the  cost  per unit  rate  of product  formation  (Chenault  et al.,  1988).  The turnover
24number required for the reaction depends on several elements, the most important of 
which  is the cost of the process;  the higher the cost of the process the higher the 
turnover number required.  The turnover number also depends on the selling price of 
the  product,  the  higher  the  price  the  lower  the  turnover  number  needed.  Total 
turnover numbers  are generally in the range of 102  -  106 (Kula et al.,  1989).  The 
cofactor regeneration number is important because the cost of cofactor is inversely 
proportional  to  this  number.  There  are  a  number  of methods  which  have  been 
researched to regenerate cofactors, these include; electrochemical methods (Somers 
et al.,  1997; Cantet et al.,  1996; Laval et al.,  1991), chemical methods (Montaine et 
al.,  1987),  and  light  energy methods  (Hatanaka et  al.,  1996;  Karube  et  al.,  1980; 
Miura  et  al.,  1980;  Mandler  et  al.,  1986;  Kirveliene  et  al.,  1993;  Umeda  et  al, 
1993).  All of these methods, however, generally suffer from lack of specificity, low 
specific activity, and low yields.
The most documented and successful method for regenerating cofactors in situ is by 
enzymatic regeneration.  Enzymatic methods to regenerate cofactors can be divided 
into three classes:
1)  The coupled enzyme approach where two different enzymes are used, one is 
the synthetic  enzyme  and requires a substrate,  and the other enzyme is the 
regenerating enzyme which requires a different substrate (the cosubstrate).
2)  The coupled substrate method where this method uses the same approach as 
the first method but the synthetic and regenerating enzymes are the same, yet 
the substrates are different.
3)  The  third  method  is  based  on  the  second  method,  but  the  substrate  of the 
desired product is formed in situ from the precursor; both reactions depend 
on the same cofactor.
25For systems with two different enzymes (the coupled enzyme approach) there is the 
advantage  that  the  rate  of reaction  can  be  controlled  by  changing  the  recycling 
enzyme concentration and the substrate concentration.  Ideally, the recycling enzyme 
reaction would not be the rate limiting step.  Much of the published work on the 
enzymatic  regeneration  of  NAD(H)  uses  formate  dehydrogenase  (FDH)  as  the 
regenerating enzyme.
Synthetic  Enzyme 1   ^  Synthetic
Substrate          Product
NADH NAD
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Figure 1.3 Enzymatic Cofactor Regeneration
NADH  is  used  by  enzyme  1  to  reduce  the  synthetic  substrate  into  the  synthetic 
product.  NADH is oxidised during the reaction into NAD and then is reduced back 
into  NADH  by  the  oxidation  of formate  to  CO2  by  FDH.  The  recycling  can 
performed continuously if enzyme activity is maintained.
FDH catalyses the NAD-dependent oxidation of formic acid to carbon dioxide.  This 
method has the advantage that formate is inexpensive, stable, innocuous to enzymes 
and  strongly reducing.  The by-product,  carbon  dioxide,  is generally innocuous to 
enzymes  and  can  be  easily  removed  from  the  reaction.  The  enzyme  FDH  is 
commercially  available,  readily  immobilised,  and  stable  if protected  from  auto­
oxidation  (Chenault  and  Whitesides,  1987).  However,  FDH  is  an  expensive 
enzyme,  but  this  may be justifiable  if enough  of the product  can  be  formed.  The
26reactions  have  a  generally favourable  equilibrium  strongly shifted towards  carbon 
dioxide  formation.  However,  due  to  the  high  A ^m   value  a  surplus  of formate  is 
required to guarantee a sufficiently high activity even at high conversions (Schutte et 
al.,  1976).  It  has  also  been  suggested that  there  are no  inhibitory effects by high 
formate concentrations (Kragl et al.,  1996).  Formate dehydrogenase has also been 
produced in bulk quantities from Candida boidinii (Weuster-Botz et al.,  1994).  The 
formate/FDH  system  has  been  applied  in  the  continuous  production  of L-amino 
acids (Wichmann et al.,  1981) (Hummel et al.,  1987a, b) and can be employed for 
the commercial preparation of L-tert-leucine (Wandrey and Bossow,  1986).  Large 
scale  applications  of NAD(P)  dependent  oxidoreductases,  and  developments have 
recently been reviewed (Hummel, 1999).
1.7  Continuous Isolated Oxidoreductase Biocatalysis
To enable a two-enzyme cofactor regeneration system to be continuously applied in 
a bioreactor both the enzymes and their respective cofactors must be retained in the 
bioreactor by an effective and economical method (Wichmann and Wandrey,  1981). 
The retention of enzymes is considered less of a problem than the retention of their 
respective  cofactors  as  generally  enzymes  are  >  40kD  and  are  much  larger  than 
cofactors (0.5 - 0.8 kD).  Methods of cofactor regeneration and retention have been 
developed in recent years and to be economical methods must be available to recycle 
the cofactors  102 -  106 times (exact numbers depend on the cost of the cofactor and 
the value of the product) (Chenault et al.,  1988).
Enzyme membrane reactors (EMRs) (Figure  1.4) are devices for performing multi- 
component  enzymatic  catalysis.  In  an  EMR  the  enzymes,  which  are  present  in 
solution,  are  retained  in  a  reaction  vessel  with  continuous  flow  by  means  of an 
ultrafiltration membrane.  This exploits the fact that enzymes are very much larger 
than  the  respective  product  or  substrate  molecules.  This  method  can  provide 
continuous catalysis with good use of the catalyst and an uncoupling of the residence 
periods from the reactants and the catalyst (Kragl et al.,  1993).
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Figure 1.4 Mechanism of the Enzyme Membrane Reactor
An enzyme membrane reactor (EMR) can be employed to maintain enzymes behind a 
membrane  whilst  the product  can  diffuse  through  the  membrane  in  a  continuous 
operation.  The cofactor can be retained behind the membrane by coupling it to a 
water soluble polymer, thus increasing the cofactor size.  Configurations of the EMR 
can  consist  of  using  enforced  flow,  nanofiltration  membranes  and  charged 
membranes.
To  employ  EMRs  for  continuous  cofactor  regeneration  a  high  retention  of  the 
cofactor is  required  and  this  depends  on  (1)  the  average  molecular weight  of the 
cofactor  derivative  and  (2)  the  pore  distribution  determining  the  actual  cutoff 
behaviour  of  a  membrane  (Kula  et  al.,  1987).  One  method  to  sustain  the 
concentration of cofactors behind a membrane is to increase the molecular weight of 
the  cofactor  and  this  has  been  achieved  by  synthesizing  analogues  by  coupling 
cofactors  to  water  soluble  polymers.  NAD(H)  has  been  coupled  to  polyethylene 
glycol  (PEG) (Buckmann et al.,  1981), dextran (Mosbach et al.,  1974) formyl PEI-
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28succinyl, and agarose (Wykes et al.,  1975).  ATP has also been coupled to PEG-N6- 
aminohexyl  (Berke et al.,  1987).  The enlarged cofactors can then be retained with 
the  enzymes  in  an  EMR by means  of an ultrafiltration membrane.  Multi-enzyme 
reaction  systems with simultaneous cofactor regeneration in continuously operated 
membrane  reactors  using  NADH  covalently bound  to  water-soluble polyethylene 
glycol  (PEG)  have  been  shown  to  give  successful  retention  at  bench  scale 
(Wichmann et al.,  1981) and at large-scale (Oshima at al.,  1985).  The performance 
of an enzyme membrane reactor for the production of L-leucine over three months 
with cofactor recycling has also been studied (Kula et al.,  1987).  The system used 
LeuDH as the synthetic enzyme, FDH as the regenerating enzyme and PEG-NADH 
as the cofactor.  A cycle number of 80,000 was obtained for the cofactor.  However, 
no other products have as yet been produced in this manner, and research seems to 
be targeting the use of the native cofactor. One reason for this may be the likely high 
cost  of the  analogue  in  large  scale  synthesis,  and  there  may  also  be  a change  in 
kinetic properties of the cofactor.
Nanofiltration
To maintain the cofactor in its native conformation, which should ensure full kinetic 
activity  of  the  enzyme,  methods  of  retaining  the  cofactor  using  nanofiltration 
membranes have been investigated.  Nanofiltration is a separation process which is 
based  on  the  difference  in  size  and  charge  of the  solutes,  and  depending  on  the 
membrane  material  used  these  contribute  differently  to  the  separation  properties. 
Nanofiltration  membranes,  unlike  conventional  ultrafiltration  membranes,  have 
shown  improved  retention  of cofactors  in  continuous  operations  (Seelbach  et  al., 
1997).  One example of the recent use of nanofiltration membranes is the continuous 
production of L-alanine whereby glucose dehydrogenase (the regenerating enzyme) 
was  co-immobilised  with  alanine  dehydrogenase  in  a  nanofiltration  membrane 
bioreactor.  The  substrate,  pyruvate,  was  supplied  separately  due to  its  instability 
under acidic conditions.  This method for cofactor regeneration and retention proved 
effective,  with  the  NAD  regeneration  number  reaching  20000  (Lin  et  al.,  1997).
29However, there were complications with respect to using a nanofiltration membrane 
in  the  reactor.  Cofactors  were  only partially  retained  in  the  reactors  so  that  an 
external supply of the cofactor was necessary in the continuous operation (Lin et al., 
1997).  Problems  associated  with  nanofiltration  membranes  (0.5-0.7  kD)  include 
retention  issues  in  which  the  nanofiltration  membrane  can  retain  not  only  the 
cofactor but also the product and substrates as well. Flux characterisations are often 
poor and leakage of the cofactor does occur (Nidetzky et al., 1996).
Charged Membranes
To  overcome  the  problems  associated  with  nanofiltration  membranes,  charged 
membranes have been investigated.  Charged membranes work on the principle that 
NAD(H)  is  an  amphoteric molecule which  carries  a negative charge  at pH values 
greater  than  3.  Charged  membranes  can  be  used  instead  of  nanofiltration 
membranes because these membranes have well defined size exclusion.  There are, 
however, a number of problems associated with charged membranes:
1.  NAD+ may not be as well retained as NADH, this is probably attributable to the 
lower net charge of NAD+.  The retention coefficients of NAD+ are in the region 
of 0.65-0.85  (Nidetsky et al.,  1996).  To prevent leakage,  the ratio of NADH 
forming  to  NADH  consuming  activity  should  be  high  enough  to  guarantee  a 
surplus of the reduced cofactor throughout the reaction (Nidetsky et al., 1996).
2.  Strong ionic solutions cause a decrease in the Donnan potential (in strong ionic 
solutions  the  electrostatic  interaction  becomes  weaker  and  therefore  the 
retention coefficients will decrease).  Therefore buffers with a low ionic strength 
(e.g.  triethanolamine,  tris  or 5-10mM phosphate)  should be used to  guarantee 
that the fixed charge density of the membrane is larger than the ionic strength of 
the  solution.  Rough  optimal  conditions  should give the retention  coefficients 
for NAD+ and NADH as 0.85 and 0.99 respectively (Nidetzky et al, 1996).
30Selection of the most suitable reaction conditions will depend upon the activity and 
stability  of  individual  enzymes,  the  overall  thermodynamic  equilibrium  of  the 
coupled reaction,  and the inhibitory effects of the product.  Sulfonated polysulfone 
has  been  used  in  an  ionized  (charged)  membrane  reactor  for  the  retention  of 
NADP(H)  (Kitpreechavanich et al.,  1985).  This system showed good retention of 
NADP(H) yet allowed the product to flow freely through the membrane, however, 
the cofactor was subjected to high levels of degradation.  Another system has used a 
charged membrane  for the retention of NAD(H)  for the  conversion  of fructose to 
mannitol  (Nidetzky  et  al.,  1996).  A  total  turnover  number  between  75000  and 
150000 was achieved with 45 reactor cycles, and it was predicted that with a TTN of
100,000  the total cost of the cofactor would be less than 5% of the total process cost.
Two-phase EMR Systems
Enzyme membrane reactors can also be used to achieve a high turnover number of 
cofactors,  even  when  the  substrates  are  of low  water  solubility.  This  is  made 
feasible  by  the  recycling  of the  water  phase  subsequent  to  the  extraction  of the 
hydrophobic  product.  Although  the  low  solubility  of  the  compounds  could 
potentially  be  overcome  by  the  addition  of  organic  solvents,  dehydrogenases 
normally show increased deactivation rates in the presence of interfaces.  An EMR 
has been set up where a hydrophobic product of the enzyme catalysed process was 
extracted by means of a hydrophobic microfiltration membrane into a hexane cycle 
(Kragl  et  al.,  1996).  This  makes  the  recycling  of the  hydrophilic  cofactor in  the 
NAD+ cycle possible due to the decoupling of the residence times of cofactor and 
substrate.  A TTN of 1350 was reached using FDH and ADH for the production of 
(S)-l-phenyl-2-propanol;  this TTN was 25 times greater in comparison to standard 
techniques used without any cofactor retention (Kragl et al.,  1996).
Dynamic Affinity Reactors
If an enzyme has a high affinity for its cofactor, it is possible to use this as a method 
of cofactor  retention.  However,  a  high  affinity  for  a  cofactor  is  a  very  selected
31property.  Enzymes,  which  are  immobilised  at  high  concentrations,  give  cause  to 
effect high dynamic  affinity.  It is this property which can be used to increase the 
retention of the cofactors in a membrane.  A theoretical study of continuous dynamic 
NAD recycling was investigated in a hollow fiber reactor (Miyawaki et al.,  1982), 
which was later verified experimentally (Miyawaki et al.,  1982).  The method used a 
two  enzyme  system  (ADH  and  Lactate  DH),  and the results  showed  an  adequate 
turnover  of NAD  (6180),  although  the  conversion  was  low  (34.6%).  Alcohol 
dehydrogenase (ADH) has been used as the regenerative and synthetic cofactor in an 
affinity  chromatographic  reactor  (Miyawaki  et  al.,  1991).  The  necessary 
nicotinamide  cofactor  was  regenerated  through  the  conjugated  reaction  of 
propionaldehyde  to  propylalcohol  and  the  oxidation  of  ethanol  to  acetaldehyde. 
Native cofactors have also been recycled and effectively used in a bioreactor with 
immobilised conjugated enzymes through the dynamic  affinity of the immobilised 
enzyme and cofactor (Lin et al.,  1997).  This method, like other methods, requires a 
high concentration of immobilised enzymes to obtain a high enough extent of the 
dynamic  affinity  between  the  immobilised  enzymes  and  the  free  cofactor.  The 
obvious disadvantage of this method for continuous regeneration of cofactors is that 
the  methodology  is  only  applicable  for  enzymes  which  are  immobilised  in  high 
concentrations  and  for  enzymes  with  an  extremely  high  affinity  for  the  cofactor 
(Nidetsky et al., 1996).
1.8  Whole Cell Biocatalysis
Whole  cell  microorganisms  can  be  used  in  instead  of isolated  enzymes  for  the 
bioreduction of substrates (Faber,  1997).  Microorganisms,  in particular yeasts,  are 
made up of a vast number of dehydrogenase enzymes which are able to accept non­
natural  substrates  (Levison,  2001).  These  microorganisms  also  contain  all  the 
necessary  enzymes  and  metabolic  pathways  for cofactor regeneration,  and  can  be 
selected to perform synthetic reactions,  for example the fermentation of glucose to 
ethanol by exploiting the cells metabolism.  In the same way, whole cells can also be
32employed  for the bioreduction  of pharmaceutically important pro-chiral  substrates 
(Figure 1.5).
The  use  of whole  cells  to  reduce  cofactors  is  advantageous  in  that  the  reduction 
reactions take place inside the cells as part of their natural metabolism. This means 
that  the  cofactors  and  enzymes  are  well-protected  within  their  natural  cell 
environment and cheap  carbon  sources can  be used as auxiliary substrates  (Faber, 
1997).  Other  advantages  to  this  method  are  that  the  processes  do  not  introduce 
additional  compounds  into  the  enzymatic  system,  and  therefore  the  downstream 
processing is not affected.  This method is also cheap as the enzyme does not have to 
be isolated and the cofactor does not have to be added stoichiometrically.
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Figure 1.5 Whole Cell Cofactor Regeneration
Whole cells contain multiple enzymes and all the necessary cofactors and pathways 
for  natural  cell  metabolism.  They  can  be  employed for  the  bioreduction  of 
pharmaceutically important pro-chiral substrates by using these naturally occurring 
enzymes inside the cell membrane to complete the reaction.  The converted substrate 
can then be isolated and purified  from the cell debris.
33Baker’s  yeast  (Saccharomyces  cerevisiae)  is  by  far  the  most  widely  used 
microorganism for the asymmetric reduction of ketones (Faber,  1997).  Large-scale 
preparations of chiral alcohols have been completed using baker’s yeast (Kometani 
et al.,  1991,  1993), the method used a  19L bubble column reactor and NADH was 
regenerated from NAD+ through ethanol oxidation.  A scheme was also proposed for 
NAD(P)H  regeneration  coupled  with  the  asymmetric  reduction  of  carbonyl 
compounds  using  ethanol  as  the  energy  source  (Kometani  et  a l,  1994).  The 
regeneration  of  cofactors  can  also  been  achieved  in  immobilised  yeast  cells. 
Immobilisation of cells can promote  stability,  simplify reactor operation,  and ease 
downstream processing (Stevenson et al.,  1993).  Cells of Saccharomyces cerevisiae 
have been immobilised in calcium alginate fibres and used in a reactor as a source of 
ADH for the NAD+ to NADH reaction (Stevenson et al.,  1996).
The  fermentation of Baker’s  yeast  for the production of chiral  alcohols  is  a well- 
established technology;  Baker’s  yeast is  also  an  ideal microorganism  since its use 
does not require sterile fermenters (Faber,  1997).  Baker’s yeast, however, cannot be 
used for the bioreduction of long-chain and bulky ketones as these are not accepted 
by  the  enzyme  (Faber,  1997).  The  ability  of Baker’s  yeast  to  produce  optically 
active  substances  from  pro-chiral  substrates  is  an  advantage;  however,  the 
enantiomer resultant  from  the  reaction  may not  always  be  the  correct  enantiomer 
required for the target molecule.  In practice,  the bioreduction of pharmaceutically 
important  compounds  into  optically pure products  can be  completed  by  screening 
numerous yeasts (from Baker’s yeast to less well-defined soil  microorganisms) for 
their reaction  compatibility.  The  disadvantages  of using  whole  cells  include:  the 
requirement for the use of large volumes, low productivities due to a low synthetic 
compound tolerance,  and side reactions due to uncontrolled cell  metabolism.  The 
use  whole  cell  biocatalysts  also  has  a  big  impact  on  the  amount  of downstream 
processing required,  and if growing  cells  are used process  control  can be  difficult 
(Faber 1997).
341.9  Isolated Oxidoreductases and Whole Cells in Organic Media
Many pharmaceutically  important compounds  are hydrophobic;  these  can include,
steroids, fats, oils, hydrocarbons and precursors of chiral synthons (Carrea,  1988).  It 
is  generally  accepted,  however,  that  enzymes  require  an  aqueous  environment  to 
maintain the active conformations for substrate binding and catalysis (Chen et al., 
1989).  As a result of this conflicting combination there has been interest in finding 
methods of applied catalysis which maintain enzyme activity yet provide adequate 
levels of substrate for an efficient bioconversion; such methods have been reviewed 
(Fukui  et al.,  1985;  Cabral et al.,  1997;  Leon et al.,  1998;  Angelova et al.,  1999; 
Loughlin, 2000).  In cofactor requiring enzyme systems water-organic solvent two- 
phase  systems  (Carrea  et  al.,  1987),  reverse  micelles  (Orlich  et  al.,  1999)  and 
homogenous isotropic microemulsions (Larsson et al., 1990) have all been employed 
to study the effects of organic solvents.
Increasing the solubility of a compound by adding water miscible organic solvents to 
the reaction medium has served to maintain enzyme stability and activity, but only at 
low  concentrations  (Klibanov  et  al,  1979).  Increasing  solvent  concentrations 
progressively gives rise to enzyme inhibition, decreased specificity and denaturation 
(Carrea,  1984), and there are no reports of using water miscible solvents in cofactor 
requiring systems.  One method to overcome the solvent effects on enzymes at high 
concentrations may be to use two-phase systems; these systems contain water and a 
water  immiscible  organic  solvent  (Carrea,  1984),  and  have  been  researched  with 
regard  to  isolated  cofactor  requiring  enzymes  and  whole  cell  cofactor  requiring 
biocatalysts.  The water contains the enzymes or cells and the hydrophilic cofactors, 
and the organic solvent contains the hydrophobic substrates.  On stirring or shaking 
the substrates are transferred from the organic phase to the aqueous phase.  There 
they  undergo  an  enzyme  catalysed  bioconversion  and  the  products  return  to  the 
organic phase.  One of the parameters which influences the reaction effectiveness is 
the rate of transfer of reagents and products between phases; the rate of mass transfer 
can be increased by increasing the mixing, however, a compromise will be made as
35the enzyme will be denatured by the liquid-liquid interfacial contact (Thomas et al., 
1979;  Carrea  et  al.,  1987).  A  number  of  dehydrogenase  enzymes  have  been 
investigated with regard to the effects of water immiscible solvents these include, an 
NAD(P)+  dependent  hydroxysteroid  dehydrogenase,  an  NAD  dependent  alcohol 
dehydrogenase and an NADPH  dependent glutamate dehydrogenase (Carrea et al.,
1987).
Another method  of trying  to  increase enzyme  stability in organic  media  is to use 
reverse micelles.  Reverse micelle systems  are configured  from  an oil  rich micro­
emulsion where the reverse micelles of water are dispersed in the oil (Orlich et al.,
2000).  These types of systems  are capable of solubilising non-polar substrates so 
that  the  reaction  can  occur  at  the  large  internal  interface  between  the  reverse 
micelles and the oil (Figure 1.6).
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Figure 1.6 A Section o f a Reverse Micelle
A  section  of a  reverse  micelle  with  enzyme  cofactor  regeneration  (adapted from 
Orlich et al, 1999).  The aqueous interior of the reverse micelles serves as a host  for 
the water soluble enzymes and cofactors.
36Reverse micelles have been employed in the enzymatic reduction of a poorly water- 
soluble ketone with NADH regeneration (Orlich et al.,  1999). A ternary mixture was 
developed from a surfactant (Marlipal 013/60) an organic solvent (cyclohexane) and 
water.  It was demonstrated that in microemulsions the rate of the reduction of 2- 
heptanone to £-2-heptanol  was  increased up to  12  times compared to the reaction 
rate  in  water.  The  disadvantage  of using  reverse  micelles  for  multi-enzymatic 
cofactor  regeneration  is  that  product  recovery  and  reuse  of  the  enzymes  and 
cofactors is difficult (Orlich et al., 2000).
Oxidoreductase bioreductions have also been performed in homogenous isotrophic 
microemulsions to try to overcome the problems associated with product recovery, 
and enzyme and cofactor recycling.  This is possible by controlling small changes in 
temperature which  shifts the  system  into  the  two phase regions  where  an oil-rich 
phase  containing  the  product  co-exists  with  a  water-rich  phase  containing  the 
surfactant and enzyme.  The oil rich phase may be replaced in continuous operation 
by an oil solution containing new substrate.  The reaction may then be continued and 
the  cofactors  and  enzymes  reused  (Larsson  et  al.,  1990).  Difficulties  in  using 
microemulsions  for cofactor regeneration include maintaining  enzyme activity and 
stability  and  determining  the  optimum  composition  and  temperatures  of  the 
microemulsions
1.10  The Interactions of Organic Solvents with Biocatalysts
Isolated Enzyme Biocatalysts
Enzymes maintain  their  structural  conformation  by the  forces  resulting  from  their 
sequence  of  amino  acids;  in  aqueous  environments  these  forces  (including 
hydrophobic interactions) cause enzymes to  fold into compact structures with non­
polar cores  (Styrer,  1995).  When  the  polarity  of the  surrounding  environment  is 
reduced by adding an organic solvent, the hydrophobic areas in the enzyme disperse 
resulting in an unfolded and inactive enzyme (Fukui,  1985).
37Whole Cell Biocatalysts
Cell membranes consist of lipid bilayers with embedded proteins and are used as a 
barrier to the flow of polar molecules (Styrer L,  1995).  When solvents are added to 
whole cell solutions the solvents tend to have an effect on the cell membranes, there 
are also interactions with the cell due to solvent toxicity on cell physiology and other 
related activities (Angelova,  1999).
Polar head group
Figure 1.7 A Section of a Bilayer Membrane
A section of  a bilayer membrane formed  from phospholipids molecules.
Whole cells do not adequately exhibit the catalytic  activities of many intracellular 
enzymes.  This is likely to be due to the permeability barrier of the cell membrane 
towards the substrates and products (Gowda et al.,  1991).  A number of procedures 
to  permeabilise  cell  membranes  to  enhance  substrate  diffusion  rates  have  been 
reported  for  microbial  organisms  (Gowda  et  al.,  1991;  Liu  et  al.,  1999).  One 
example  is  the  permeabilisation  of  recombinant  Saccharomyces  cerevisae,  these 
cells were permeabilised with alcohol solutions, and results demonstrated that under 
optimum  conditions  the  penneabilised  cells  were  very  effective  as  whole  cell 
biocatalysts (Liu et al.,  1999).  The problems associated with permeabilised cells can 
include a reduction in cell viability and target enzyme leakage (Liu et al., 1999).
The  problems  associated  with  employing  organic  solvents  for  delivery  of  the 
substrate to  the isolated  enzyme and whole cell  systems have not been  overcome.
38Firstly,  there is insufficient information on the physiological response of microbial 
cells  to the presence  of lipophilic  compounds  (Angelova et al.,  1999).  Secondly, 
enzymes are numerous and diverse, and there are no rules concerning the inhibitory 
effects of various solvents on particular biocatalysts, and each solvent must be tested 
individually (Carrea et al., 1987).
1.11  Enzyme Stability and Immobilisation
Methods  such  as  immobilisation  to  retain  enzyme  activity in  organic  media have 
been researched (Fukui et al.,  1985) (Cabral et al.,  1997).  Immobilisation has been 
reported  to  protect  the  enzyme,  bestowing  an  enhanced  stability  against  being 
denatured by organic  solvents  (Fukui  et al.,  1985).  To be  industrially viable,  the 
isolated enzyme stability and activity must be comparable to, or higher than, that of 
the whole cell  enzymes.  Immobilisation of enzymes is one method that has been 
developed to promote stability, but more notably immobilisation of an enzyme can 
be employed to separate the enzyme from the substrate and product in a continuous 
operation.
There are two types of immobilisation methods;  adsorption and covalent linkages. 
Evidence has shown that the adsorption techniques are less valuable.  For instance, a 
comparison was made for the following resins XAD-7, Sepabeads FP-DA, Eupergit 
C,  Celite  547  and  Silica  Gel  60;  the  covalently  linked  enzymes  could  be  washed 
with water to desorb the product with  little loss in  activity, however,  the adsorbed 
enzymes could not be reused and enzyme activity was rapidly lost (Anthonsen et al., 
1999).  Examples  of the  diverse  type  of resins  which  have  been  employed  for 
enzyme  immobilisation  are:  sand  (Brotherton  et  al.,  1976),  CN-Br-activated 
sepharose  (Gorisch  et  al.,  1984;  Schneider-Bemlohr et al.,  1978),  polyacrylamide 
gel  and  glass  balls  (Julliard  et  al.,  1986),  AH-Sepharose-4B,  CH-sepharose  4B, 
DEAE-cellulose or DEAE-sephadex (Kim et al.,  1987) and more recently Eupergit 
C (Brocklebank et al.,  1999; Hublik et al., 2000; D'Annibale et al., 2000).  Much of
39this  research  has  concentrated  on  the  stabilising  effect  it  is  thought  that  these 
matrices bring about as opposed to their separation properties.
Immobilisation  of isolated enzymes can affect the three-dimensional  conformation 
specific to the enzyme;  this has observed through electron paramagnetic resonance 
(EPR)  (Clark  et  al.,  1983)  using  alpha-chymotrypsin  immobilised  on  CNBr- 
activated sepharose 4B.  EPR spectroscopy has also been used (Skerker et al.,  1988) 
to  compare  the  active-site  structural  features  of immobilised Horse  Liver Alcohol 
Dehydrogenase  on  CNBr-Sepharose  and  Octyl-Sepharose  Cl-Br,  both  of  which 
show  slightly different  conformations.  Contrary to  these  results,  however,  great 
similarity  was  shown  in  the  spectroscopic  properties  of soluble  and  immobilised 
horse  liver  ADH  on  CNBr-activated  Sepharose  and  it  was  concluded  that  no 
significant change had taken place during immobilisation (Schneider-Bemlohr et al., 
1978).  Calorimetry  studies  have  also  confirmed  this  idea  (Koch-Schmidt  et  al.,
1977).  Changes  in the  conformational  three-dimensional  shape of some  enzymes 
may be due to a multipoint linkage (Hemaiz et al., 2000).  It has also been suggested 
that additional  multipoint attachment can be used to increase stability (Femandez- 
Lafuente  et  al.,  1999;  Mateo  et  al.,  2000).  Changes  in  enzyme  activity  by 
immobilisation have been reviewed (Clark, 1994).
A  variety  of other  methods  may  be  applied  to  stabilise  enzymes  in  addition  to 
immobilisation.  Free  and  immobilised  Horse  Liver  ADH  (on  CNBr-activated 
sepharose) were both stabilized by the addition of AMP, and both types of enzyme 
were found to have the same stability in the presence of 5mM AMP (Gorisch et al., 
1983).  Lactase  immobilised  onto  controlled porosity  glass  has  also  exhibited  the 
same  stability  as  its  free  form  in  the presence  of ethanol,  acetone,  methanol,  and 
DMSO  (Rogalski  et  al.,  1995).  Enzyme  stability  may  also  be  increased  by  the 
addition of a second protein (thus increasing protein concentration).  The stability of 
a free  enzyme was  increased by adding BSA to the solution,  and was made more
40stable than the immobilised form and the original free enzyme form (Johnson et al.,
1978).
Cross linked enzyme catalysts (CLECs) is a further method by which enzymes can 
be  immobilised.  Small  protein  crystals  are  grown  from  aqueous  solutions,  or 
aqueous solutions containing organic solvents.  These crystals are then cross-linked 
with a bi-functional reagent i.e. glutaraldehyde.  This then enables them to function 
at  elevated  temperatures,  extremes  of  pH,  and  in  harsh  aqueous,  organic  or 
anhydrous media.  Irregular pore  sizes  and  shapes  are  created between  individual 
enzyme  molecules  in  the  underlying  crystal  lattice.  This  restricted  accessibility 
greatly  enhances  the  metal  ion  or  cofactor  retention  characteristics  of CLECs  in 
comparison  to  conventionally  immobilised  enzymes  and  enzymes  in  solution. 
However  this  may  also  mean  that  the  particle  size  is  too  small  to  allow  for 
continuous process, i.e. the retention of products and substrates.  Recent research has 
found that some CLECs will not form unless the respective cofactor is present (Lee 
et al.,  2000).  This  then becomes  a problem  in  the recycling  of the  cofactor,  and 
research must be carried out to see whether it is possible to form a CLEC using a 
two enzyme system.
1.12  Isolated Enzymes versus Whole Cells in Biocatalysis
Isolated  enzymes  and  whole  cells  can  both  be  applied  for  the  bioreductions  of
prochiral substrates.  The methods and controls which ensure that such reactions can 
take  place  with  high  efficiency  and  specificity  in  each  of  them  are,  however, 
considerably different.
1)  Isolation and Purification
Enzymes need to be  isolated and purified  from their host cells and these extra 
steps dramatically increase the process time and costs.  After the isolation and 
purification the enzyme can be used in predefined conditions to carry out highly 
controlled  and  specific  reactions.  In  contrast,  whole  cells  suffer  from  the 
presence  of  multiple  reductases  with  overlapping  substrate  specificities  but
41differing  stereoselectivities  and,  therefore,  when using whole  cells  as  catalysts 
instead of isolated enzymes this can often lead to mixtures of alcohol products 
particularly when whole yeast cells are used for ketone reductions (Stewart et al.,
2001).  This increases the amount of downstream processing which is also made 
difficult due to the large quantities of biomass particularly if the product is stored 
inside the cell.
2)  Cofactors
Microbial cells contain multiple dehydrogenases and all the necessary cofactors 
and metabolic pathways for their regeneration (Chenault and Whitesides,  1987). 
Consequently,  cheap  carbon  sources  can  be  used  as  auxiliary  substrates  for 
asymmetric reduction reactions.  The cofactor is also protected in its natural cell 
environment  (Faber,  1997).  Isolated  enzyme  systems  require  the  addition  of 
stoichiometric  quantities  of cofactor and to be  used  efficiently these  cofactors 
need to be regenerated in situ.
3)  Hydrophobic substrates
The hydrophobicity of many pharmaceutically important substrates and products 
can cause problems for whole cells as there can be difficulties in the transport of 
these compounds in and out of the cells (Angelova,  1999) and in such systems 
the use of isolated enzymes seems attractive.  However, hydrophobic substrates 
also cause problems as the substrate concentrations in aqueous reaction solutions 
are  generally  low  and  the  addition  of  solvents  to  increase  the  substrate 
concentration can cause the isolated enzyme to be denatured.
4)  Single Step/ Multiple Steps
One advantage of the whole cell biocatalyst has over the isolated enzyme, is that, 
a whole series of chemical reactions can effectively be carried out in essentially 
a  single  step  using  cheap  carbon  sources  to  produce  specialty chemicals  from 
amino acids to penicillins.  Such syntheses are known as fermentation processes
42(Faber,  1997).  A  large  number  of bioconversions  often  start  from  relatively 
complex organic molecules and use a single step to convert a synthetic organic 
compound  into  a  desired product.  Such  single  step  bioconversions  can  more 
easily mimicked (than a multiple step reaction) by an isolated enzyme system, by 
isolating  the  enzyme  from  source  and  adding  exogenous  quantities  of  the 
cofactors.
5)  Substrate Inhibition
Whole  cells  and  isolated  enzymes  generally  suffer  similarly  from  substrate 
inhibition.  This  is  exhibited  through  the  enzyme  catalysed  reaction  rate 
diminishing  with  excess  substrate  (Bailey  and  Ollis,  1986)  and  this  enzyme 
behaviour can have important implications in the design of bioreactors.
The decision on whether to employ an isolated enzyme or a whole cell enzyme relies 
upon preliminary analysis of the constraints summarised above, the type of reaction, 
the scale of the reaction and also the potential costs of the process.
1.13  Aim of Thesis
The aim of this thesis is to systematically compare the isolated enzyme and whole 
cell biocatalyst for the bioreduction of a prochiral substrate.  The comparison will be 
used to  determine which  of the  systems  has  the  most potential  for carrying  out  a 
reduction  reaction.  The  model  oxidoreductase  which  will  be  used  for  the 
investigation  is  a NADH-dependent  reductase  from  a  soil  organism  which  is  not 
overexpressed and remains  in  its native microorganism.  This  in  itself reflects the 
ever-increasing need  to  find new  and  valuable methods  and  compounds,  and  is  a 
problem  faced  by  industry  in  the  search  for  new  enzymes  for biocatalysis.  The 
substrate  and  product  which  are  under  investigation  are  novel  compounds  which 
exhibit low aqueous solubility; this low aqueous solubility is an inherent property of 
many  pharmaceutically  important  compounds.  This  limited  knowledge  of  the 
enzyme, the substrate and the product, mirrors the problems in industry of producing
43new  and  invaluable  compounds  via  enzyme  catalysis.  The  comparison  will 
investigate the isolated  enzyme  and the whole cell biocatalyst with respect to:  the 
biocatalyst type,  the  effects  on  the reaction  with respect to biocatalyst purity,  the 
bioreduction methodology including methods of regenerating cofactors, the methods 
of substrate  delivery,  and  the  bioreduction  efficiency.  Lastly  a  comparison  will 
determine  if there  are  any potential  improvements  which  could  be  facilitated  via 
recombinant technology.  The objectives are set out in further detail in Chapter 2.7
1.14  Discussion
Isolated  enzymes  and  whole  cells  can  both  be  employed  as  highly  specific 
biocatalysts for the bioreduction of prochiral substrates.  They are advantageous over 
chemical  catalysts  due  to  their  high  specificity  and  adaptability;  however,  they 
require strict reaction conditions which if not controlled effectively may cause the 
biocatalysts  to  become  denatured.  The  oxidoreductases  are  one  of  the  most 
important types of enzyme as they can reduce prochiral substrates into optically pure 
products  with  high  conversions.  However,  isolated  oxidoreductases  require  the 
stoichiometric use of cofactors which due to their high costs at large scale require 
regenerating.  The regeneration of cofactors can be achieved through a number of 
methods; the most effective method seems to be the addition of a secondary enzyme 
and  secondary  substrate.  There  are  a  number  of documented  secondary  enzyme 
systems,  of which,  the FDH/formate system  appears to be the most viable;  this is 
because the enzyme is highly active,  formate is innocuous to the enzyme,  and the 
product  of the  reaction  is  carbon  dioxide  which  can  be  easily  removed  from  the 
reaction  (Chenault et al.,  1987).  The problems  associated with using this type of 
enzyme  system  in  continuous  operation  are  that the  cofactors  are  often  of similar 
size  to  the  substrates  and  products,  thus  conventional  membranes  cannot  be 
employed to retain enzymes without cofactor leakage.  Enzyme membrane reactors 
(EMRs) have been employed using methods which have either adapted the cofactor 
or adapted  the  membrane to  try to  increase cofactor retention.  Adaptation  of the 
cofactor can cause a change in the kinetic properties of the cofactor and research is
44currently  intent  on  using  the  native  configuration  of the  cofactor.  Methods  to 
continuously recycle cofactors have employed EMRs using nanofiltration or charged 
membranes, but neither type of membrane has demonstrated the required retention to 
ensure economical use of the cofactor.  Retention of the cofactor whilst maintaining 
kinetic activity is a current hurdle in the use of these isolated enzymes at large scale, 
and  therefore  to  use  an  isolated  oxidoreductase  with  cofactor  regeneration  in  a 
bioreactor  means  that  a  novel  approach  is  potentially  required.  The  type  of 
bioreactor  used  for  the  bioreduction  must  ensure  that  the  enzyme  activity  is 
relatively high  and  the  cofactor  is  regenerated  enough  times  to  make  the  system 
economically viable.  If possible the isolated enzyme bioreduction should take place 
in a continuous bioreactor, this would allow a greater efficiency of the enzyme and 
the cofactor,  and would significantly reduce the associated cost of the cofactor (in 
comparison to batch reactors).  If such an isolated enzyme bioreactor system is not 
viable then it may be more appropriate to use a whole cell microorganism which can 
potentially  be  employed  instead  of  an  isolated  enzyme  in  the  bioreduction  of 
synthetic substrates.  Whole cell biocatalysts recycle cofactors as part of their own 
cell metabolism, and therefore the high cost of cofactors will not impact the method 
selected for the bioreduction.  Whole cells, however, contain multiple enzymes and 
this can cause an increase in the competition for the substrate,  and therefore there 
will  also  be  a concurrent  increase  in  the  number of by-products.  The  amount of 
downstream processing will  also be increased (when compared to isolated enzyme 
systems)  due  to  the  increased  number  of by-products,  and  also  because  the  cell 
debris  will  also  need  to  be  removed.  The  selection  of the  type  of  whole  cell 
bioreactor would  generally be the batch  reactor since whole cell  recycling can be 
problematic.  This is because it can be difficult to transport hydrophobic compounds 
in and out of the cells, and thus if the product does not diffuse out of the cell it will 
have to  be  extracted by other means.  This is  generally through the  addition of a 
solvent which can cause detrimental effects to the cells.
45Many  pharmaceutically  important  compounds  are  highly  insoluble  in  aqueous 
environments,  and  thus  methods  to  increase  substrate  concentrations  without 
reducing  biocatalyst  viability  have  been  investigated.  These  have  included  the 
addition  of single-phase  solvents,  two-phase  solvents,  and micro-emulsions.  It is 
generally accepted that:  1) Single phase solvents can be used at low concentrations, 
however,  as  the  solvent  concentration  is  increased  enzyme  activity  is  rapidly 
decreased  (Klibanov  et  al.,  1979).  2)  Two-phase  solvents  retain  greater  enzyme 
activity but by increasing the mixing to increase mass transfer causes an increase in 
the interfacial contact, which also rapidly decreases enzyme activity (Carrea et al.,
1988).  3)  Microemulsions  can  be  used  for  batch  configurations,  however,  the
composition of the microemulsion is difficult to define to ensure enzyme stability 
and activity (Larsson et al.,  1990).  Therefore, the choice of which type of system to 
use will  depend upon the type of biocatalyst employed (isolated enzyme or whole 
cell),  the  respective  activities  and  stabilities,  the  reaction  methodology  including 
cofactor recycling requirements, and the substrate and product hydrophobicity.
Immobilisation  has  been  investigated  to  promote  biocatalyst  stability  in  solvents, 
however there seems to be no common link between the effects of immobilisation 
and  the  stability and  conformation  of the  enzymes.  Immobilisation  has  a  greater 
impact in its ability to facilitate continuously operating bioreactors by separating the 
isolated enzyme from the substrates and products.  This separation ability is true in 
most enzymatic systems, however in an isolated oxidoreductase system the method 
of  cofactor  retention  must  be  considered  separately  if  such  immobilisation 
techniques are to be utilized since the cofactors are often similar in size to synthetic 
substrates and products.
Isolated oxidoreductases have a number of advantages over whole cell biocatalysts 
when  employed  for  the  bioreduction  of pharmaceutically  substrates,  equally,  the 
contrary in  also  true.  Isolated  enzymes  can be  highly  active  and highly  specific, 
however, they require costly isolation and purification techniques.  Isolation of the
46active  enzyme  from  the  cells  also  means  that  the  enzyme  immediately  become 
vulnerable to extrinsic  factors.  Whole cells are less specific, but don’t require the 
stoichiometric  addition  of  cofactors,  however,  the  other  cell  components  are 
contaminants which require removal after the reaction.  The enzymes and cofactors 
used in the whole cell bioreductions are also more protected to extrinsic factors since 
they remain in the cell.  There currently seems to be no direct comparison between 
this type of biocatalyst to determine which type, isolated enzyme or whole cell, has 
the  most  potential  for  large  scale  bioreductions  of  low  soluble  pharmaceutical 
compounds.  The aim of this research is to compare an NADH dependent reductase 
as  an  isolated  enzyme  and  as  a  whole  cell  biocatalyst  for  the  bioreduction  of a 
pharmaceutically important substrate of low aqueous solubility.
1.15  Summary
Isolated  enzymes  and  whole  cell  microorganisms  can  both  be  employed  for  the 
biocatalytic conversion of pharmaceutically important compounds of low solubility. 
The oxidoreductase class of enzyme can be employed for the asymmetric conversion 
of prochiral  substrates  to  optically pure  products;  they  also  have  the  potential  to 
replace chemical  catalysts  (which are,  in  general,  non-specific)  in the synthesis of 
chemical compounds.  In isolated enzyme bioreductions, however,  oxidoreductases 
require the stoichiometric  addition of the  appropriate cofactor,  and because of the 
high  cost  of  these  cofactors  they  need  to  be  regenerated  in  situ.  Whole  cell 
biocatalysts  do not  require the  addition  of a  cofactor regeneration  system  as they 
naturally regenerate cofactors as part of their own cell metabolism.  However,  the 
use of whole cells for such bioreductions is made difficult by the multiple enzymes 
in  the  cells,  and  the  level  of downstream  processing  required.  Many  of the  pre­
cursors  to pharmaceutical  compounds  exhibit  low  solubility  in  aqueous  solutions. 
However, both isolated enzymes and whole cells suffer degradation in low aqueous 
environments.  Therefore,  a compromise may need to be made between method of 
substrate  addition  and  the  biocatalyst  stability.  To  promote  enzyme  stability, 
immobilisation has been used, however, immobilisation has served a greater purpose
47in  separating  the  biocatalyst  from  the  substrates  and  products  in  continuous 
operation.  The  difference  in  employing  isolated oxidoreductases  and  whole  cells 
can be seen through their physical appearance, the operating parameters required for 
each system, and the environments which are required to ensure effective catalysis. 
The  aim  of this  thesis  is  to  compare  an  NADH-dependent  reductase  for  isolated 
enzyme and whole cell  biocatalysis.  In the  following chapter the microorganism, 
enzyme, substrate, and products which will be used in the experiments are described 
in  detail  including  analytical  techniques;  the  objectives  of the  research  are  also 
summarised.
48Background and Experimental Logic
2.1  Introduction to the Model System
The model system used for this research was selected because it replicates many of 
the  characteristics  of  industrially  important  enzymes.  The  active  enzyme  is  a 
reductase  which  carries  out  the  asymmetric  synthesis  of a prochiral  ketone  to  its 
corresponding  (IS)-alcohol  (6-bromo-p-tetralone  to  (*S)-6-bromo-p-tetralol)  and  this 
reaction requires NADH as a cofactor.  There is limited knowledge of the enzyme as 
it  has  not  been  purified,  and  therefore  no  sequencing  or  crystallisation  has  been 
possible.  Stability studies show that the enzyme is unstable, exhibiting a half life of 
7hrs  at  22°C.  The  model  substrate  6-bromo-p-tetralone  and  product  6-bromo-P- 
tetralol  are  both  novel  compounds  which  exhibit  low  solubility  in  aqueous 
environments and 6-bromo-P-tetralone only exhibits a solubility of lOg/L in ethanol. 
Solvents  are  known  to  affect  enzyme  activity  and  consideration  of the  substrate 
addition will be required.  If a process is to be operated with an isolated enzyme, the 
cofactor (NADH) which if not added stoichiometrically will require regenerating in 
situ.  For this research,  FDH has been selected as the regenerating enzyme for the 
isolated enzyme studies.  This is because it has been shown to be highly effective at 
regenerating  NADH  (Chenault  et  al.,  1988)  and  has  undergone  a  number  of 
characterisation studies.  Methods to maximize productivity perhaps by enzyme and 
whole cell regeneration/ recycling will also be analysed.
2.1.1  Inefficiency of the Chemical Catalyst
(»S)-6-bromo-p-tetralol  is  a precursor to the compound MK-0499.  This compound 
was  a  potentially  potent  potassium  channel  blocker,  which  mediated  the  re­
polarization  of  cardiac  tissue  and  was  under  investigation  for  the  treatment  of 
ventricular arrhythmias and the prevention of sudden cardiac death (Tschaen et al.,
1995).  In the synthesis of this drug, the chemical methods for the chiral reduction of
496-bromo-p-tetralone were  inefficient  and microbial  reduction  was  selected  for the 
production of the specific enantiomer (Tschaen et al.,  1995) (Figure 2.1).
6-bromo-P-tetralone  {S)~ 6-bromo-p-tetralol
Figure 2.1 Model Substrate and Product
6-bromo-p-tetralone can be reduced to produce a chiral product.  The figure above 
demonstrates the  (S)-configuration,  the enantiomeric excess is dependent upon  the 
specificity  of the  catalyst.  Chemical  catalysts  are  generally  non-specific  and 
produce  racemic  mixtures;  biological  enzymes  are  highly  specific  and  have  the 
ability to produce substances of  high enantiomeric excess.
2.1.2  Substrate and Product Stability
6-bromo-p-tetralone  and  6-bromo-p-tetralol  (Figure  2.1)  are  used  as  the  model 
substrate and product and were kind gifts from Merck and Co., (Rahway, NJ, USA). 
6-bromo-p-tetralone  and  6-bromo-p-tetralol  are  stable  (>99%)  in  both  water  and 
ethanol for over 12hrs (Thomas, 2000).  6-bromo-p-tetralone and 6-bromo-p-tetralol 
exhibit a solubility of 0.5g/L in water and lOg/L in ethanol (Thomas, 2000).
2.1.3  Media Component Selection
Media components used for the growth of Trichosporon capitatum (MY  1890) have 
previously been evaluated (Reddy et al.,  1996).  Experiments demonstrated that the 
glucose in the growth media most likely promoted another enzyme which converted 
the substrate into the unwanted optical isomer giving only 70% enantiomeric excess. 
Further experiments replaced the glucose with glycerol, thus, causing a change in the
50metabolic pathway and inhibiting the unwanted enzyme.  The optical purity of the 
product after this change in growth media was 99%.
2.1.4  Growth of Trichosporon capitatum (MY 1890)
lml of frozen stock stored at -80°C was used to inoculate 50ml of media in a 200ml
Erlenmeyer™  flask  (30g/L  glycerol,  25g/L  hysoy  peptone,  20g/L  yeast  extract) 
(Sigma, Poole, Dorset, UK).  Cells were grown at 28°C for up to 48hr;  10ml of the 
cells were used to inoculate 500ml of media in a 2L Erlenmeyer™ flask.  The cells 
were  shaken  continuously  at  a  speed  of 200rpm  and  left  to  grow  at  28°C  to  a 
concentration of 18g/L (Figure 2.2).  This protocol was adapted from (Reddy et al.,
1996).
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Figure 2.2 Growth curve of Trichosporon capitatum (MY 1890)
50ml of cells  were grown  at 28()C in a  250ml Erlenmeyer™ flask inoculated with
lml offrozen stock.  10ml of these cells were then used to inoculate 500ml of media. 
The cells were shaken continuously at 200rpm.
512.1.5  Whole Cell Biocatalytic Synthesis of 6-bromo-/3-tetralol
The  whole  cell  biocatalytic  synthesis  of 6-bromo-(3-tetralol  has  previously  been
described  (Reddy  et  al.,  1996).  Gram  quantities  were  produced  through  the 
asymmetric  bioreduction  of  6-bromo-p-tetralone  (dissolved  in  ethanol)  using 
growing cells (Figure 2.3).
NADH  NAD
Tetralone
reductase
6-bromo-P-tetralone  (S)- 6-bromo-p-tetralol
Figure 2.3 Chiral Reduction of 6-bromo-p-tetralone
The  whole  cells  of Trichosporon  capitatum  (MY1890)  can  be  used  to  reduce  6- 
bromo-/3-tetralone to  (S)-6-bromo-/3-tetralol  (99% ee).  NADH is  recycled via  the 
cells metabolic pathway.
2.1.6  Enzymatic Regeneration System
An  oxidoreductase can be  isolated  from  the cells of Trichosporon  capitatum  (MY 
1890), and this enzyme requires NADH as a cofactor (Thomas, 2000).  The enzyme 
(tetralone  reductase)  carries  out  the  bioreduction  of 6-bromo-P-tetralone  to  (£)-6- 
bromo-p-tetralol with high enantiomeric excess (99%) (Thomas 2000).  However, it 
is  unstable  and  has  not  been  fully  purified.  The  enzyme  works  effectively  in  a 
regenerating  system using  formate dehydrogenase as the regenerating enzyme  and 
formate as the cosubstrate (Figure 2.4).
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Figure 2.4 Regenerative Bioreduction
Tetralone reductase isolated from  the cells  of Trichosporon  capitatum  (MY 1890) 
can  be  used  to  reduction  6-bromo-p-tetralone  to  (S)-6-bromo-P~tetralol.  This 
requires  the  addition  of exogenous  quantities  of NADH.  During  the  reduction 
reaction NADH is  oxidized but can  be recycled back into  its reduced form by the 
addition  of a  regenerating  enzyme,  in  this  case formate  dehydrogenase  and  the 
secondary substrate, formate.
2.2  Scale of Experiments
The  scale  of  experiments  is  limited  by  a  number  of  parameters.  Firstly,  the 
quantities available of the model substrate and product are limiting as they are novel 
chemicals  and  can  not  be  purchased.  Nicotinamide  adenine  dinucleotide  (NAD), 
and  its  reduced  form  (NADH),  are  limiting  because  they  are  currently  expensive 
chemicals  to  purchase.  In  addition,  formate  dehydrogenase  is  also  currently  an 
expensive enzyme.  The other important limiting factor is tetralone reductase.  The 
scale of the equipment  limits the production of this novel  enzyme  and only small 
quantities  of the  enzyme  will  be  produced  after  the  purification  steps.  This  is 
because the  enzyme  is not  over-expressed  and  only a small percentage of the cell 
protein is the target enzyme.  Almost all the experiments were carried out at micro­
53litre  scale  in  96-well  flat-bottomed  round  micro-litre  plates  (Nalge  Nunc 
International,  Rochester,  NY,  USA).  Other  experiments  required  larger  volumes 
(ranging up to 10ml) are described in detail in later chapters.
2.3  The Use of Novel Microorganisms for Bioreductions
The bakers’  yeast Saccharomyces cerevisiae was the first eukaryote whose genome
was  entirely  sequenced  and  is  one  of the  favoured  model  organisms  for  basic 
biological  research  (Dujon,  1996).  There  have  been  large  numbers  of  papers 
describing its characteristics and biocatalytic properties under a range of conditions. 
Processes  that  use  novel  microorganisms  suffer  from  the  lack  of  process 
understanding which can only be accumulated through the combination of a number 
of experiments.  Fermentation processes have been characterised to take into account 
temperature,  pH,  dissolved  oxygen,  substrate  feeding  and  mixing,  and therefore  a 
process  which  uses  whole  cells  as  a  biocatalyst  can  be  implemented  with  little 
difficulty using  established  fermentation technology.  This  is  an  advantage whole 
cell biocatalysts have over their isolated enzymes, which require further processing 
for isolation and purification.  There are no set rules for defining methods of enzyme 
purification,  although previously purified  enzymes with  similar characteristics can 
be  used  as  a  guide  for  identifying  appropriate  methods.  One  advantage  of  an 
isolated enzyme process is that it might not require media component optimization 
(Chapter  2.2.3)  as  the  competing  enzyme  may  be  removed  through  the  enzyme 
purification  stages.  The  use  of  a  newly  screened  microorganism  also  has  the 
complication that the active enzyme has not been  isolated and purified this means 
that the crystal  structure of the enzyme is unknown and, the enzyme cannot yet be 
genetically  modified  or  over-expressed.  The  small  quantity  of  enzyme  in  the 
microorganism is probably less than 0.1 % of the total protein in the cell therefore the 
catalytic  activity  of the  enzyme  will  be  low  in  comparison  to  an  over-expressed 
enzyme.
542.4  Oxidoreductases
In fermentations, cells provide all the enzymes necessary for cofactor regeneration, 
whereby  the  cofactors  are  synthesized  and  regenerated  as  part  of  cellular 
metabolism.  In  processes  using  isolated  enzymes  ex  vivo  nicotinamide  cofactors 
must be regenerated explicitly.  In  addition to the system of enzymes used for the 
synthesis, a second reaction system, the regenerative system must be used (Chenault 
and Whitesides,  1986).  This complicates the process engineering, as not only does 
the cofactor need to be added but also a secondary enzyme and substrate.
2.5  Insoluble Substrates and Products
Lipophilic  compounds  are  of  significant  importance  in  modem  biotechnology 
(Angelova  et  al.,  1999).  Steroids,  fats,  oils,  hydrocarbons  and  many  chiral 
precursors are all poorly soluble in aqueous media (Carrea et al.,  1987).  Substrates 
poorly soluble in water present difficulties as the bioconversions must be carried out 
using  large  reaction  volumes  and  consequently  large  amounts  of biocatalyst  and 
cofactors are required (Carrea and Cremonesi,  1987).  The bioavailability of highly 
insoluble  compounds  is  currently  a  problem,  and  organic  solvents  or  surfactants 
have been used mostly as mediators for increasing substrate solubility (Angelova et 
al.,  1999),  although  this  can  have  a  detrimental  effect  on  cell  viability.  In  an 
aqueous medium, the folding of a soluble enzyme protein is driven by the tendency 
of the hydrophobic amino acid residues to be excluded from water so that they are 
buried  in  the  interior  of  the  molecule,  whereas,  the  charged  and  hydrophilic 
molecules  are  on  the  surface  in  contact  with  aqueous  solvent.  When  water  is 
replaced with  an  apolar solvent the interior hydrophobic residues tend to disperse, 
resulting  in  the  reorganization  of the  enzyme  tertiary  structure  (Klyosov  et  al., 
1975).  Therefore,  it  is  likely  that  any  organic  solvent  will  gave  rise  to  enzyme 
inactivation.  Methods to protect the enzyme such as immobilisation may prove to be 
a useful alternative.  In addition, it may be useful to employ another type of medium 
such as an ionic liquid to preserve the enzyme conformation (Lee et al., 2000).
552.6  Objectives
The  aim  of this  thesis  (detailed  in  Chapter  1.13)  is  to  compare  the  biocatalytic 
systems of isolated enzyme and whole cell oxidoreductases for the bioreduction of a 
poorly soluble substrate.  The main objectives of the thesis are as follows:
1)  To investigate the isolation and purification of tetralone reductase from the 
cells of Trichosporon capitatum (MY  1890) using chromatographic methods 
to  purify  the  enzyme,  and  to  characterize  the  isolated  enzyme  to  gain  a 
greater understanding of its instability.
2)  To investigate the immobilization of tetralone reductase, then to develop an 
enzyme  regenerating  system  for  the  bioreduction  of  6-bromo-p-tetralone 
using  FDH  as  the  regenerating  enzyme  and  formate  as  the  regenerating 
substrate.  Finally, to develop a bioreactor configuration for the bioreduction 
with cofactor regeneration.
3)  To  investigate  the  potential  of  the  whole  cell  as  a  biocatalyst  for  the 
bioreduction  of  6-bromo-P-tetralone.  The  whole  cell  system  will  be 
characterised  including  an  investigation  of the  cell  substrate  and  solvent 
tolerance, the potential of cell recycling will also be examined.
4)  To compare the isolated enzyme  system  and the whole cell  system  for the 
bioreduction of 6-bromo-p-tetralone.  This will be done using comparisons of 
productivity  and  conversion,  substrate  and  solvent  tolerance,  and  reaction 
methodologies.  The  potential  of each  system  will  also  be  predicted  for 
genetic modification and overexpression of the enzyme.
562.7  Analytical Techniques
2.7.1  Errors
To  calculate  the  error  in  experimental  results  the  standard  deviation  of triplicate 
results will be used:
Using  the  standard  deviation  should  give  an  accurate  measurement  of  the 
experimental  errors  which  could  result  from  equipment  error,  measurement  of 
materials, timings during kinetic assays and human error.
2.7.2  HPLC
High  performance  liquid  chromatography  (HPLC)  was  used  to  determine  the 
concentrations  of 6-bromo-p-tetralone  and  6-bromo-p-tetralol.  Two  systems were 
used,  a  Gilson  Liquid  Handler  (Gilson,  Middletown,  WI,  USA)  and  a  Dionex 
DX500  chromatography  system  (Camberley,  Surrey,  UK).  Both  methods  used  a 
Zorbax reverse phase RX-C8 25x4.5 column (MacMod analytical, Chadds Ford, PA, 
USA)  with  an  isocratic  elution  at  1.5ml/min  over  lOmin  using  a  mobile phase  of 
50% (v/v) 0.1% phosphoric acid in H2O and 50% (v/v) acetonitrile.  Tetralone and 
tetralol eluted at 4.7 min and 5.6 min respectively.
2.7.3  Spectrophotometric Measurement of  NADH
Reduced  nicotinamide  adenine  dinucleotide  (NADH)  can  be detected  using  a UV 
spectrophotometer  at  340nm.  Enzyme  activity  was  assessed  by  following  the 
reaction at this wavelength.  Tetralone reductase consumes NADH to give NAD, and 
so the decrease in optical  density at 340nm  gives  an  accurate measurement of the 
activity  of tetralone  reductase.  Optical  density  is  related  to  the  concentration  of 
NADH using the following equation:
(  -V
Z  x —  x
V  /
n -1
57A   =   lxsxc 
where:
A  Adsorbance
1   Optical Path length
e  Molar Absorption coefficient (NADH 630 L/mol/mm)
c  Concentration of cofactor
and activity was measured from:
t
where:
U  Activity of enzyme (pmol.mr’.min1 )
Ac  Change in cofactor concentration (pmol.mf1 )
t  time (min)
95% of a 0.5g/L solution of NADH in buffer was added to 5% of a lOg/L tetralone 
in ethanol,  lml of this reaction mixture was added to  lml of protein to be assayed 
and the reaction was followed on the spectrophotometer.
Justification of the Spectrophotometric Assay
The number of moles NADH oxidised in the spectrophotometer should be equal to 
the  number of moles  of 6-bromo-p-tetralone reduced to  6-bromo-p-tetralol  within 
the  limits  of error.  This  statement  is  only  true  if the  only  active  NADH  is  the 
exogenous NADH added to the assay mixture.  This hypothesis was proved correct 
as  the  calculated  number  of  moles  of  6-bromo-p-tetralol  produced  by  the 
spectrophotometer assay was within the standard deviation of the theoretical number 
of moles  of NADH  consumed.  Therefore,  the  spectrophotometer  assay  could  be 
used as an accurate indicator of enzyme activity.
582.7.4  Protein Concentration Assay
Protein  concentration  was  measured  using  an  adapted  Bradford  assay  (Bradford, 
1976).  2.9ml of a 1   part Coomassie brilliant blue G-250 dye (Bio-Rad Laboratories 
Ltd, Hemel Hampstead, Herts, UK) diluted in 4 parts pure water was added to lOOpl 
of protein solution in a 3ml cuvette.  The solutions were left for between 5-30min, 
and then measured at 595nm.  A calibration curve was used to determine the protein 
quantities (Appendix A 1.3).
2.7.5  Micro-Litre NADH A ssay
Round flat bottom 96-well plates (Nalge Nunc International, Rochester, NY, USA) 
were used for many of the screening experiments explained in subsequent chapters. 
The  method  was  the  same  as  for  the  larger  scale  experiment  except  smaller 
quantities were used.  A calibration curve was used to determine the actual quantities 
of NADH rather than the adsorbance equation because the path length was difficult 
to measure (Appendix A1.4).  95% of a 0.5g/L NADH in buffer was added to 5% of 
a lOg/L tetralone in ethanol.  lOOpl of this mixture was added to  lOOpl of tetralone 
reductase solution, and the reaction was followed at 340nm.
2.7.6  Micro-Litre Protein Concentration Assay
The protein content was assayed as described for the 3ml scale (Chapter 2.7.4).  All 
assay components were scaled down to 300pl.
2.7.7  Control Experiments
Control experiments were run alongside enzyme activity experiments.  The control 
assay mix consisted of a 95%  lOmM Tris buffer added to a 5% of a  lOg/L solution 
of  6-bromo-p-tetralone  in  ethanol.  These  solutions  were  prepared  immediately 
before use to avoid precipitation.  The final concentrations in the control assay mix 
were 0.5g/L 6-bromo-p-tetralone and Og/L NADH.  lml of this solution was added 
to  lml  of  the  enzyme  solution.  The  activity  of  the  enzymes  was  followed
59spectrophotometrically at 340nm (as described in section 2.7.3).  For the micro-scale 
assay, the same method was used except lOOpl of reaction mix was added to  lOOpl 
of enzyme solution.
2.8  Summary
In this chapter, the model system was examined with respect to: the media selection 
and  growth  of  the  biocatalyst,  previous  characterisation  studies,  regeneration 
systems,  and  the  application  of  novel  enzymes  and  substrates.  The  analytical 
techniques  used  in  the  experimental  chapters  were  also  described  in  detail.  The 
model  reaction  is the  biocatalytic  reduction  of 6-bromo-p-tetralone to  6-bromo-p- 
tetralol  with  cofactor  regeneration.  The  model  biocatalyst  is  tetralone  reductase 
which requires NADH to complete the bioreduction; NADH can be regenerated as 
part of whole cell metabolism or ex vivo using a secondary isolated enzyme.  The 
product  from  the  bioreduction  is  a  pharmaceutically  important  precursor  which 
cannot  be  prepared  asymmetrically  via  chemical  synthesis.  The  substrate  and 
product  are  novel  compounds  which  are  both  highly  insoluble  in  aqueous 
environments.  The isolated enzyme and whole cell biocatalytic systems both mirror 
a  number  of  issues  associated  with  the  production  of  novel  asymmetric 
intermediates, including low substrate and product solubility, enzyme instability, and 
have potential cofactor and enzyme regeneration issues.  The substrate and product 
can  be  measured  via  HPLC  analysis  and  the  respective  enzyme  activity  can  be 
measured  using  a  kinetic  NADH  spectrophotometer  method.  The  analytical 
methods can be completed at microlitre scale or millilitre scale.
The  objectives  of the  research  are  to  (1)  isolate,  purify  and  stabilise  the  active 
oxidoreductase,  (2)  develop  the  isolated  enzyme  regenerating  system  and  use this 
system  in  a  bioreactor,  (3)  investigate  the  potential  of  the  whole  cell  for  the 
bioreduction, and (4) compare the isolated enzyme system to the whole cell system. 
In the following chapter, the isolation, purification and characterization of tetralone 
reductase will be investigated.
60Isolation, Purification and Characterisation of 
an Oxidoreductase from Trichosporon 
capitatum (MY 1890)
3.1  Introduction
Yeasts are a rich source of proteins, particularly enzymes, and these proteins can be 
isolated and purified for various applications (Levison, 2001).  The purification of a 
novel  protein  from  the  other  cell  proteins  has  a  number of consequences;  firstly, 
competing enzymes and proteolytic enzymes are removed (Harris, 1989).  Secondly, 
more knowledge of the enzyme can be obtained by determining the crystal structure 
and the sequence of genes.  Lastly, after sequencing, the enzyme can be cloned and 
overexpressed into a well-characterised microorganism.  This can make it easier to 
obtain the enzyme at a lower cost.  The sequencing of the genes also gives rise to 
the  potential  for  genetic  modification.  To  effectively purify  an  enzyme,  the  cell 
debris is normally removed and then the isolated enzyme is passed through a number 
of  packed  bed  chromatography  systems.  These  chromatography  systems  may 
involve  ion  exchange,  hydrophobic  interaction,  affinity,  size  exclusion,  thiophilic 
interaction  or  chiral  columns;  or  the  protein  of interest  may  be  purified  through 
precipitation  (for  example  ammonium  sulphate)  or  filtration  devices  (Levison, 
2001).  Precautions must  also be made to minimize proteolysis by the addition of 
protease  inhibitors.  Other  considerations  include  minimizing  the  loss  of activity 
through the adsorption of the enzyme to surfaces, and through instabilities caused by 
high water activities, low enzyme concentrations, oxidizing environments and metal 
ions (Harris,  1989).  It is also important to determine the most favourable operating 
conditions of the reaction components in the bioreactor.  This can be done at small 
scale or microscale using variables such as pH, temperature, alternative solvents, and 
other  specific  additives;  thus,  gathering  essential  information  about  the  type  of 
enzyme, stability properties, and the active site conformation.  The results from the
61characterisation  experiments can then be applied to assess the controls required to 
maintain enzyme activity and stability in a bioreactor.
The  main  objectives  of  this  chapter  are  to  isolate  and  purify  active  tetralone 
reductase from Trichosporon capitatum (MY 1890) (since previous attempts to purify 
tetralone reductase (Thomas, 2000) were ineffective at producing large quantities of 
active  tetralone  reductase).  Tetralone  reductase  is  maintained  inside  the  cell 
membrane; therefore the isolation steps will include a homogenisation step to break 
open the cells and a centrifugation stage to remove the cell debris.  Chromatography 
columns  will  then  be  employed  to  purify  the  active  enzyme  from  the  other  cell 
proteins.  The other objective of this chapter is to characterise tetralone reductase, 
this  is  essential  since  currently  tetralone  reductase  has  a  l A  life  of 7hr  at  22°C 
Characterisation  experiments  are  required  to  define  the  most  effective  operating 
conditions for the  active  enzyme.  Tetralone reductase will be characterised using 
parameters  such  as  temperature,  pH  and  additives.  There  will  also  be  an 
investigation to try to understand the instability of the enzyme and to try to increase 
the stability to enable the enzyme to operate in an environment for much longer than 
7hrs,  thus  increasing  the  value  of the  enzyme  (and potentially decreasing process 
costs).
3.2  Materials and Methods
3.2.1  Isolation of Tetralone Reductase
Cells  of  Trichosporon  capitatum  (MY  1890)  were  washed  by  centrifugation 
(Beckman  Coulter™,  Fullerton,  CA,  USA)  using  a JA-10 rotor at  17000  x  g  and 
resuspended  in  the  same  volume  of  lOmM  Tris  buffer  pH7  containing  protease 
inhibitor  Complete™  (Roche,  Basel,  Switzerland).  The  centrifugation  and 
resuspension was repeated, removing most of the growth media.  The washed cells 
were  homogenised  using  either  a  microfluidizer  M-100EH  (Microfluidics 
Corporation,  Newton,  MA,  USA)  with  3  passes  at  15000psi,  or  an  APV  Lab  60
62homogeniser  (APV  Systems,  Crawley,  W.Sussex)  with  5  passes  at  500bar.  The 
resultant broken cells were centrifuged using a JA-17 at 39000 x g at 4°C for 30min. 
The  active  tetralone  reductase  was  found  in  the  supernatant  (the  pellet  was 
discarded).
3.2.2  Q Sepharose Fast Flow Column Chromatography
The  clarified  homogenate  was  loaded  on  to  an  XK  50  column  (Amersham 
Biosciences,  Inc.,  Piscataway, NJ,  USA)  with  Q  Sepharose fast flow (900ml)  at a 
flow rate of 15ml/min.  500ml of the protein could be applied before breakthrough. 
The column was washed with  lOmM Tris buffer containing protease inhibitor until 
all unbound protein was eluted.  A gradient elution from 0%-100% NaCl lOmM Tris 
buffer containing protease inhibitor at  15ml/min, over a volume of 1500ml, using a 
Biopilot  FPLC  system  (Amersham  Biosciences,  Inc.,  Piscataway,  NJ,  USA)  was 
employed.  12ml fractions were collected in a Pharmacia LKB  FRAC  100 fraction 
collector  (Amersham  Pharmacia  Biotech,  Piscataway,  NJ,  USA).  The  active 
fractions  (62-78)  were pooled  and incubated  at 4°C.  All  of the purification  steps 
were carried out at 4°C.  A second method was also used, employing a step elution 
whereby  every  12min  a  change  in  concentration  of 0M,  0.1M,  0.2M,  0.3M,  and 
0.4M of NaCl was applied.  The column was regenerated by flushing it through with 
0.5  column  volumes  of  1M NaCl,  the  column  was  re-equilibrated  with  1   column 
volume of lOmM Tris buffer pH7.  The isolated enzyme was stored in 20% glycerol 
at -20°C.
3.2.3  Protocol Modification
The  isolation  (Chapter 3.2.1)  and purification  (Chapter 3.2.1)  were  repeated using 
EDTA free Complete™ protease inhibitor instead of Complete™ protease inhibitor, 
and also by using no protease inhibitor.  After the Q Sepharose fast flow column, the 
three types of active tetralone reductase were incubated at 22°C,  1  OOpl samples were
63removed at various time points and assayed for remaining enzyme activity using the 
96-well plate assay.
3. 2.4  Further Purification
A  number  of  purification  resins  were  screened  for  their  affinity  to  tetralone 
reductase.  C l535 Cibacron 3GA-Agarose, R2507 Reactive Blue 4-Agarose, R2632 
Reactive  Blue  72-Agarose,  R2757  Reactive  Brown  10-Agarose,  R2257  Reactive 
Green  5-Agarose,  R2882  Reactive  Green  19-Agarose,  R0503  reactive  Red  120- 
Agarose,  R3757 Reactive Yellow  3-Agarose,  R2382 Reactive Yellow 86-Agarose; 
from a test kit (Sigma, St. Louis, MO, USA).  Amicon Red A and Phenyl Sepharose 
affinity resins were also tested (Sigma,  St. Louis, MO, USA).  Elution buffers used 
were NaCl and NAD(H) (Sigma, St. Louis, MO, USA).
3.2.5  Hydroxyapatite Column Chromatography
100ml of hydroxyapatite HA Ultrogel, (Sigma, St. Louis, MO, USA) was loaded on 
to  an  XK  column  (Amersham  Biosciences,  Inc.,  Piscataway,  NJ,  USA)  and 
equilibrated with H20.  The protein was eluted using a step gradient of 0.1M, 0.2M, 
0.3M  K3PO4.  The  column  was  run  at  3.5ml/min  and  12  x  lmin  fractions  were 
collected.  At the final concentration, samples were collected until all the protein had 
eluted.
3.2.6  Toyopearl Column Chromatography
20ml of Toyopearl  resin was loaded onto an XK column (Amersham Biosciences, 
Inc., Piscataway, NJ, USA).  The column was equilibrated with 1M NH3SO4 (lOmM 
Tris pH7).  Protein was eluted with 6 x  lmin fractions at 0.8M, 0.6M, 0.4M, 0.2M 
and a final 11 samples were collected at 0M of NH3SO4.
643.2.7  SDS-PA GE of the Protein Purification
A  10%  BIS-TRIS  gel  (NOVEX,  San  Diego,  CA,  92121,  USA),  and NuPAGE™ 
running buffer 20X were used to run the samples.  50ml of the running buffer was 
mixed with 950ml of water.  Samples were prepared using  lOpl of enzyme, 65pi of 
H2O  and  25pl  of LDS  4X  (Novex,  CA,  USA).  Bio-Rad  low  molecular  weight 
standards were used to determine the molecular weights.  Samples were run through 
the gel for 40mins.  The gels were stained for 20min with Coomassie Brilliant Blue 
R-250 (Bio-Rad laboratories, Hercules, CA).
3.2.8  pH Profile
10ml  solutions of tetralone reductase were dialysed in tubing of molecular weight 
cut-off of 12,000-14000, 2.4nm pore size (BDH, Poole, Dorset, UK), against  1   litre 
of lOmM Tris buffer at pH values of 5, 6, 7, 8, 9 at 4°C for 12 hours.  The final pH 
of the dialysed  enzymes  was measured to  confirm  dialysis  and the  activity of the 
enzymes was determined using the spectrophotometer assay (Chapter 2.7.3).
3.2.9  Temperature Stability
10ml  solutions  of  tetralone  reductase  purified  using  the  new  protocol,  were 
incubated at 4°C and 22°C.  lOOpl samples were extracted at defined time points and 
used in the 96-well spectrophotometer assay to determine the remaining activity of 
the enzyme.
3.2.10  Activity of Tetralone Reductase with a Number of  Additives
A metal  cation NaCl,  MgCb,  CaCh,  MnCl2,  FeCb,  C0 CI2,  Q 1SO4,  or ZnSC>4 was
dissolved separately in tetralone reductase to a concentration of 5mM and incubated 
at 22°C for 15min, a control was incubated under the same conditions with no metal 
cation addition.  The enzyme was also tested for activity against 5mM phenylglyoxal 
(Sigma,  Poole,  Dorset,  UK),  ImM  p-chloromercuribenzoate  (p-CMB)  (Sigma, 
Poole, Dorset, UK) and ImM EDTA (Sigma, Poole, Dorset, UK).
653.2.11  Inhibition of Tetralone Reductase by NADH
NADH  was dissolved  in  the tetralone reductase  solutions to  the  concentrations of 
0.2g/L,  0.4g/L,  0.6g/L,  0.8g/L,  and  lg/L.  The  activity  was  measured  using  the 
spectrophotometer assay mix (Chapter 2.7.3) with no further addition of NADH.
3.2.12  Solvent Screen for Dissolution of 6-bromo-p-tetralone
lOg/L solutions of 6-bromo-|3-tetralone  in  a number of different types  of solvents
(Sigma,  St Louis, MO, USA) were prepared.  These solutions were used as the 5% 
solvent required in the 96-well plate assay, and assayed for enzyme activity (Chapter
2.7.3).
3.2.13  Solubility of 6-bromo-P-tetralone
6-bromo-p-tetralone  was  assessed  for  visual  solubility  in  ethanol  and 
methoxyethanol.  5mg  samples were added to  lml  of each solvent in a glass vial. 
The solutions were then vortexed to mix.  Additional 5mg samples were added until 
a  tetralone  residue  could  be  seen,  this  was  taken  to  be  the  solubility  point  (+/- 
5mg/ml).
3.2.14  Tetralone Reductase Activity in Ethanol and Methoxyethanol
The percentage of ethanol  and methoxyethanol  in the spectrophotometer assay was
changed  from  0%,  2%,  4.5%,  to 9%  (v/v).  The  solvent was  added to the cuvette 
followed by lml of tetralone reductase and then lml of the spectrophotometer assay. 
The reaction was monitored kinetically using the spectrophotometer assay (Chapter
2.7.3).
3.3  Results
3.3.1  Isolation of Tetralone Reductase
Tetralone reductase was isolated from cells of Trichosporon capitatum (MY  1890) 
(Figure 3.1) by removing the growth media and cell debris.  Centrifugation was used
66to pellet the cells to allow the growth media to be decanted.  Homogenisation was 
used  to  break  open  the  cells  and  release  the  intracellular  protein  of  interest. 
Centrifugation  was  then  used  to pellet  the cell  debris  so  that the protein  solution 
could be decanted.  The clarified homogenate was analysed for kinetic activity.  The 
results show that tetralone reductase has an activity of 23U/g with a total cell protein 
concentration  of  4.4g/L.  The  clarified  homogenate  was  then  applied  to  a 
chromatography  column  (Q  Sepharose  Fast  Flow)  for  purfication  of  tetralone 
reductase from the other bulk intracellular proteins.
3.3.2  Anion Exchange Chromatography
Tetralone reductase was purified to remove the bulk impurities by using the anion 
exchange resin Q-Sepharose Fast Flow (Figure 3.2).  Ion exchange chromatography 
separates molecules based on the number of positive or negative charges accessible 
on their surfaces.  Ion exchange chromatography is widely used in the separation of 
proteins because the relatively mild binding conditions and elution conditions allow 
high  protein  recovery  with  intact  biological  activity.  The  binding  mechanism  is 
based on the  ionic  attraction between  molecules  of opposite  electric  charge.  The 
functional groups of the anion exchange resin have a positive charge which separates 
negatively  charged  molecules.  Ion  exchange  binding  occurs  when  the  salt 
concentration (or ionic strength) of the mobile phase is reduced to the point that the 
ionic  groups  on  the  sample  molecules  begin  to  serve  as  the  counter  ions  for the 
charged  groups  on  the  stationary phase.  Tetralone  reductase  was  applied  to  the 
anion exchange column in 50mM Tris, this allowed the negatively charged surface 
ions  to  bind  to  the positively charged  anion  exchange  resin.  Elution  takes  place 
when  the  ionic  strength  of the  mobile  phase  is  increased;  as  this  happens,  salt 
molecules  displace  the  bound  sample  molecules  back  into  the  mobile  phase. 
Tetralone reductase elutes from the anion exchange resin at a salt concentration of 
0.4M NaCl.  This binding and elution of tetralone reductase onto an anion exchange 
resin  demonstrates  that  tetralone  reductase  has  an  accessible  surface  which  is
67negatively charged.  The kinetic activity of pooled tetralone reductase is 54U/g with 
a total cell protein concentration of 1.1 g/L.
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Figure 3,1 Isolation and Purification Methodology
The cells of Trichosporon capitatum  (MY 1890) were centrifuged and resuspended 
twice  in  the  same  volume  of buffer  to  remove  the  cell  growth  media.  The 
resuspended  cells  were  then  homogenised  to  break  open  the  cells  and  then 
centrifuged to pellet out the cell debris from the protein of interest.  The supernatant 
from this was either stored in 20% glycerol at — 20°C or passed through a Sepharose 
Fast Flow anion exchange column then stored in 20% (v/v) glycerol at — 20°C.
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Figure  3.2  Purification  of Tetralone  Reductase  using  Q  Sepharose  Fast  Flow 
Resin
The elution of the enzyme occurs due to the step change of NaCl over time (__ ) at
15ml/min.  12ml fractions were collected and the active protein (M) eluted between 
the fractions  62  and  78.  The  concentration  of NaCl  is  measured going  into  the 
column.  The activity is measured coming out of the column by assaying each of the 
fractions for kinetic activity.
3.3.3  Protocol Modification
The half-life of tetralone reductase after the isolation and purification from the Fast 
Flow Q Sepharose anion exchange column was 7hr at 22°C (Figure 3.3).  The initial 
procedure  for  the  isolation  used  a  50mM  Tris  buffer  containing  a  cocktail  of 
protease inhibitors (Thomas, 2000), this buffer was used in the resuspension of the 
cell  pellet  after centrifugation,  the buffer was  also  used  as  a mobile phase  in  the 
anion  exchange  chromatography.  The  cocktail  of protease  inhibitors  was  used  to
69prevent unnecessary degradation of the protein of interest via proteolysis.  However, 
upon further investigation it was hypothesized that the cocktail of protease inhibitors 
used was degrading the activity of the protein of interest.  One of the ingredients of 
the protease inhibitor cocktail was ethylenediaminetetraacetic acid (EDTA), a metal 
chelator.  A number of papers document the dehydrogenase requirement for metal 
cations  (Munro  et  al.,  2000),  for  example,  formate  dehydrogensase  contains  zinc 
(Vallee  and  Hoch,  1955),  and  yeast  alcohol  dehydrogenase  (YADH,  EC  1.1.1.1) 
contains  four  or  five  zinc  atoms  (Ganzhom  et  al.,  1987);  and  therefore  the  low 
stability  of  tetralone  reductase  was  most  likely  caused  by  the  EDTA  in  the 
Complete™  protease  inhibitor.  This  experiment  was  carried  out  to  determine 
whether  the  enzyme  activity  was  affected  by  the  current  isolation  buffer.  The 
isolation and purification of tetralone reductase was run again; the isolation buffer 
used was 50mM Tris with (i) EDTA free Complete™ protease inhibitor and (ii) no 
protease  inhibitor.  The  results  demonstrate  that  upon  removal  of  the  protease 
inhibitor  from  the purification  buffer the  half-life  of tetralone  reductase  increases 
from  7hr to  92hr  (Figure  3.4)  at  22°C.  The  addition  of EDTA-free  Complete™ 
protease  inhibitor instead  of the  Complete™  protease  inhibitor also  decreases  the 
initial  activity  of  the  enzyme,  but  the  decrease  is  not  as  apparent  as  when 
Complete™  inhibitor  is  used.  There  is  also  an  initial  sharp  drop  in  tetralone 
reductase activity in the buffer containing  EDTA-free protease inhibitor,  however, 
over the  time  course  tetralone  reductase  activity begins  to parallel  the  activity of 
tetralone reductase in just 50mM Tris buffer.  It is unknown why this is the case, it 
may have been due to another ingredient of the protease inhibitor which may have 
caused a degradation to both tetralone reductase and the proteolytic enzymes,  thus, 
although there was an initial sharp drop in tetralone reductase activity,  the activity 
was  maintained  over time  as  the  inactivated  proteolytic  enzymes  could  not  cause 
further degradation of tetralone reductase.  Tetralone reductase is most stable when 
the Complete™  and EDTA-free Complete™ protease inhibitors are removed  from 
the  buffers.  The  half-life  of  tetralone  reductase  when  employing  Complete™ 
protease  inhibitor  in  the  buffers  is  7hr  at  22°C  and  85hr  when  EDTA-free
70Complete™ is employed.  The half-life of tetralone reductase in a 50mM Tris buffer 
without protease inhibitors is 92hr.  The increase in tetralone reductase stability from 
just under 7hr to 92hr means that tetralone reductase can be used in further reactions 
including immobilisation and applied biocatalysis.
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Figure 3.3 Enzyme Stability
This graph illustrates the stability of tetralone reductase stored at 22( C after elution 
from  the  Q  Sepharose  Fast  Flow  anion  exchange  chromatography  column.  The 
stability  of tetralone  reductase  was  measured  by  assaying for  kinetic  activity  at 
regular  time points.  The  half-life  of tetralone  reductase  is  calculated  using  the 
graph  and drawing a  vertical line  where  the activity has decreased by half.  The 
half-life  of tetralone  reductase  using  the graph  is  7hr at  22()C.  Error bars  were 
calculated as the standard deviations of three separate samples.
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Figure 3.4 Tetralone Reductase Stability Study
Tetralone reductase stability was measured at 22°C after the Q Sepharose Fast Flow 
chromatography  column,  purified  with  no  protease  inhibitor  (U),  EDTA  free 
Complete™ protease inhibitor (0),  and Complete™ protease inhibitor (A).  Error 
bars were calculated as standard deviations of three separate samples.  The graph 
illustrates the increase in stability from a 7hr half-life to a 92hr half-life by removal 
of the protease inhibitor from  the elution  buffer.  The graph  also shows the rapid 
initial decrease in tetralone reductase activity (O),  in the first few hours,  after the 
addition of  EDTA-free Complete™ protease inhibitor.
3.3.4  Affinity Chromatography
The anion exchange chromatography step was used as a capture step to remove the 
bulk contaminants from the tetralone reductase solution.  To further purify tetralone 
reductase a number of affinity resins were screened for tetralone reductase binding
72and elution.  Affinity chromatography is based on bio-specific binding interactions 
between  a  ligand  chemically  bound  to  the  chromatography  packing  and  a  target 
molecule  in  the  sample.  The  forces  involved  in  the  binding  include  ionic  and 
hydrophobic interactions, but also in affinity binding the charged and hydrophobic 
groups  are  arranged  on  the  binding  molecules  (ligands)  in  a  unique  orientation. 
Weaker  forces  such  as  hydrogen  bonding  also  play  an  important  role.  The  two 
ligands fit together like a lock and key, with a high degree of specificity.  Attempts 
were made to further purify tetralone reductase using affinity resins.  Eleven affinity 
resins were screened each exhibiting different reactive sites,  however, none of the 
resins  displayed  any  potential  for  the  ability  to  purify  the  protein  of  interest. 
Tetralone  reductase  either did  not  adhere  to  the  resins  or the protein  adhered but 
could not be eluted by using either NaCl or NAD(H) as the eluant (Table 3.1).
Table 3.1 Affinity Chromatography
Table  3.1  shows  the  affinity  resins  which  were  screened for  the purification  of 
tetralone reductase.  Tetralone reductase either bound to the affinity resin ( f \   but 
could not  be  eluted  with  either NaCl  or NADH in  the  elution  buffer;  or flowed 
through the affinity column without binding (*).
Binding Comments
Cl535 Cibacron 3GA-Agarose X
R2507 Reactive Blue 4-Agarose X
R2632 Reactive Blue 72-Agarose X
R2757 Reactive Brown  10-Agarose X
R2257 Reactive Green 5-Agarose V No elution
R2882 Reactive Green  19-Agarose V No elution
R0503 Reactive Red  120-Agarose Y No elution
R3757 Reactive Yellow 3-Agarose X
R2382 Reactive Yellow 86-Agarose X
Amicon Red A S No elution
Phenyl Sepharose S No elution
733.3.5  Pseudo Affinity Chromatography
A  further protein  purification  stage  was  carried  out  to  increase  the  purity  of the 
enzyme solution.  Hydroxyapatite is a pseudo  affinity resin and works similarly to 
other affinity resins.  The binding properties of tetralone reductase to this resin are 
unknown, however, hydroxyapatite has been previously used to purify enzymes and 
could be used for the purification of tetralone reductase (Figure 3.5).  The enzyme 
was  applied  to  the  column  in  the  same  buffer  as  it  had  left  the  Fast  Flow  Q 
Sepharose  column  (50mM  Tris,  0.4M  NaCl).  This  ability  to  put  the  protein  of 
interest from one column straight onto the next column is extremely useful as there 
is no requirement to add another stage between the columns such as diafiltration to 
ensure the protein is in the correct loading buffer.  This reduced time in processing, 
by  putting  the  enzyme  from  one  column  straight  onto  another  chromatography 
column, means that there is less time for degradation of the enzyme.  The enzyme 
was eluted using a step change of K3PO4,  the results show that tetralone reductase 
elutes  between  the  0.2M-0.3M  step  change.  A  number  of peaks  were  observed 
during the elution of tetralone reductase, these peaks may have been other reductases 
isolated from Trichosporon capitatum (MY  1890).  It would not be uncharacteristic 
of  a  yeast  cell  to  have  a  number  of  reductases  (Levison,  2001)  which  could 
potentially  also  perform  the  bioreduction.  The  main  peak  was  pooled  giving  a 
specific activity of 0.145U/mg and a concentration of 0.63g/L.
3.3.6  Anion Exchange Chromatography
Tetralone reductase after the hydroxyapatite column was still not yet fully purified 
(reference  SDS-PAGE  Figure  3.7),  therefore,  another  purification  stage  was 
required.  Toyopearl  is  an  anion  exchange  resin  where  the  recommended  elution 
buffer is a decreasing ion buffer.  Tetralone reductase was washed off the previous 
column  (hydroxyapatite)  in  0.2-0.3M  K3PO4  and  this  buffer  was  used  to  bind 
tetralone  reductase.  The  column  was  washed  in  purified  water  and  tetralone 
reductase  was  eluted  using  a  decreasing  step  gradient  starting  from  1M NH3SO4. 
Tetralone  reductase  elutes  from  the  column  at  a  0.4M  concentration  of NH3SO4
74(Figure  3.6),  the  pooled  enzyme  has  a  specific  activity  of  0.189U/mg  and  a 
concentration of 0.34g/L.
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Figure 3.5 Hydroxyapatite Chromatography Purification Pro  file
Purification  of  tetralone  reductase  using  a  hydroxyapatite  pseudo-affinity 
chromatography column.  The elution of the enzyme occurs due to the step change of
K3PO4  over  time  (__ ),  elution  of the  active  protein  (M)  occurs  between  the
fractions  48  and  63.  The  concentration  of K3PO4  is  measured  going  into  the 
column.  The amount of tetralone reductase eluted is measured coming out of the 
column by assaying each of the fractions for kinetic activity.
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Figure 3.6 Toyopearl Chromatography Purification Profile
Purification  of tetralone reductase  with  toyopearl  650M resin.  The elution  of the
enzyme occurs due to  the step  change  of NH3SO4 over time  (___ ),  elution  of the
active protein  (M)  occurs between  the fractions  15 and 28.  The concentration  of 
NH3SO4  is  measured going  into  the  column.  The  amount  of tetralone  reductase 
eluted is measured coming out of the column by assaying each of the fractions for 
kinetic activity.
3.3.7  SDS-PAGE
An SDS-PAGE gel was run to determine the purity of the protein of interest (Figure 
3.7).  Samples of the protein solution were run on the gel to show the purification of 
tetralone reductase after each step.  Molecular markers were run each side of the gel
76to indicate the size of the protein molecule.  A band is visible at about 43kDa in the 
protein solution after the Toyopearl resin purification stage, this is consistent with a 
number of dehydrogenases (Munro, 2000).
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Figure 3.7 SDS-PAGE of Tetralone Reductase and Impurities during Purification
This  SDS-PAGE  gel  illustrates  the  purity  of  the  protein  solution  during  the 
purification  of tetralone  reductase.  The  samples  are:  crude  homogenate from 
Trichosporon  capitatum  (MY1890)  after  homogenisation  and  centrifugation,  the 
protein solution after purification through the Q Sepharose  fast flow anion exchange 
chromatography  column,  the  protein  solution  after  purification  through  the 
hydroxyapatite pseudo-affinity  chromatography  column,  and  the protein  solution 
after purification via the toyopearl anion exchange chromatography column.
3.3.8  Purification Table
This table (Table 3.2) displays the results for the three purification steps.  The table 
illustrates  that  as  the  amount  of purification  increases  the  concentration  of the
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77protein decreases.  This is an expected result because as more buffer is applied to the 
system less enzyme is pooled from the fractions.  The specific activity of the enzyme 
increases with each purification step, likewise, this is expected because although the 
sample is becoming more dilute with buffer the sample is of a higher purity.
Table 3.2 Purification Table
This is a summary table of the purification  of tetralone reductase.  The step is the 
chromatography stage,  the  eluant  is  the  buffer which  elutes  the  enzyme from  the 
column, the concentration and specific activity are related to the pooled  fractions.
Step Eluant Concentration
(g/L)
Specific Activity 
(U/g)
1 Homogenate N/A 4.43 23.0
2 Q Sepharose (Fast Flow) NaCl 1.05 54.0
3 Hydroxyapatite (HA Ultrogel) K3PO4 0.63 145.0
4 Toyopearl 650M (phenyl) NH3SO4 0.34 189.0
3.3.9  pH Profile
The  activity  of  tetralone  reductase  at  different  pH  values  was  investigated  to 
determine the optimal pH conditions for the enzyme.  Tetralone reductase exhibits 
highest activity at the slightly acidic conditions of between pH 6.5 and 7 after a 12hr 
dialysis at 4°C (Figure 3.8).  A sharp drop-off in tetralone reductase activity can be 
observed at acidic pH values of less than 6 and at alkali conditions of pH values of 
greater than 7.5.  This gives a relatively small operating range for any biocatalytic 
reactions.
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Figure 3.8 Tetralone Reductase pH Profile
The graph shows the pH profile for tetralone reductase activity after a 12hr dialysis 
at 4°C.  It can be observed that the highest enzyme activity is between pH 6.5 and 
pH 7.0.  The enzyme rapidly loses activity at extremes ofpH; at pH values of  greater 
than 8.5 and lower than 5.0 all tetralone reductase activity is lost.
3.3.10  Temperature Stability
The stability of tetralone reductase purified  from the Q Sepharose Fast Flow anion 
exchange  column  was  investigated  at  temperatures  of 22°C  and  4°C  to  determine 
potential bioreactor operating conditions.  The protein solution was incubated at the 
defined  temperatures  and  assayed  kinetically  for  activity.  Tetralone  reductase 
exhibits good stability at both the temperatures investigated, possessing a half-life of 
130hr at 4°C and a half-life of 92hr at 22°C (Figure 3.9, 3.10).  This means that there 
is a lot of potential to use tetralone reductase in a bioreactor.
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Figure 3.9 Tetralone Reductase Stability at 4°C
This  graph  shows  the  stability  of tetralone  reductase  stability  at  4°C  (M).  The 
stability was measured by assaying for the kinetic activity of tetralone reductase at 
regular time points.  Error  bars  were  calculated as  standard deviations  of three 
sample reactions.  This graph illustrates the high stability of tetralone reductase at 
4°C in a  50mM Tris buffer preparation with  no other additives.  There is a linear 
decrease and a half-life of 13Ohr.
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Figure 3.10 Tetralone Reductase Stability at 22°C
This graph shows the stability of tetralone reductase at 22°C (M).  The stability was 
measured by assaying for the kinetic activity of tetralone reductase at regular time 
points.  Error bars were calculated as standard deviations of three sample reactions. 
This graph illustrates the high stability of tetralone reductase at 22()C in 50mM Tris 
with no other additives.  The half-life is 92hr.
3.3.11  Activity of Tetralone Reductase with a Number of  Additives
Tetralone reductase activity was measured against a number of additives (Table 3.3)
to increase the understanding of the enzyme behaviour.  The metal chelating reagent
EDTA severely decreases tetralone reductase activity; similarly, the heavier cations
also  severely decrease  enzyme  activity.  However,  lighter cations  such  as  sodium
and  calcium  slightly increase tetralone reductase  activity.  It is hypothesized  from
this information that the enzyme has a metal cation in its active site,  however it is
very  likely  that  the  enzyme  has  a  high  enough  affinity  for  the  metal  cation  so
81additional quantities of the cation in the reaction buffers are not required.  Although 
it was determined that the active site of tetralone reductase almost certainly requires 
a metal cation it is unknown which one.  The study into additives also demonstrates 
that,  due the reduction in enzyme activity by the arginine-residue-specific reagent, 
phenylglyoxal,  there  is  an  essential  arginine  residue  in  the  structure  if tetralone 
reductase.  The  combination  of the  sulfhydryl  inhibitor  tested,  p-CMB,  and  the 
inhibition of tetralone reductase by a heavy metal ion such as zinc (the heavy metal 
ions are commonly described as noncompetitive inhibitors which combine reversibly 
with  the  sulfhydryl  (-SH)  group  of  cysteine  residues  (Bailey  and  Ollis,  1986)) 
indicates an essential sulfhydryl group (Ishihara et al., 2000).
Table 3.3 Tetralone Reductase Activity in Additives
This table illustrates the residual activity of tetralone reductase in  the presence of 
additives at 5mM.
Additive Molarity Relative 
Activity (%)
Comment
None 100a
NaCl 5mM 104 Alkali
MgCl2 5mM 108 Alkaline earth metal
CaCl2 5mM 106 Alkaline earth metal
MnCl2 5mM 103
FeCl3 5mM 5.3 Transition metal cation
CoCl2 5mM 34.4 Transition metal cation
Q 1SO4 5mM 47.1 Transition metal cation
ZnSC>4 5mM 13.9 Transition metal cation
Phenylglyoxal 5mM 84 Essential Arginine residue
p-CMB ImM 36 Essential Sulphydryl group
EDTA ImM 56 Metal Chelator
a  The activity in  absence of additive was determined by arbitrarily setting to  100. 
Activity measurements were taken immediately after the additive was added.
823.3.12  Inhibition of Tetralone Reductase by NADH
Tetralone  reductase  requires NADH  as  a  cofactor (Thomas,  2000),  an  experiment 
was executed to determine at which concentrations NADH becomes inhibitory and 
also to find out at which concentration of NADH tetralone reductase has the highest 
activity (Figure 3.11).  Results show that tetralone reductase has the highest activity 
at 0.4g/L of NADH but  loses  all  activity by  lg/L.  These levels of NADH  give a 
good  indication  of the  levels  which  can  be  used  in  a  bioreactor  before  enzyme 
inactivation occurs.  At the low levels of NADH the low enzyme activity is likely to 
be because there is not enough  cofactor to  fill  the available  active sites,  at higher 
levels  of  NADH,  the  reduction  in  enzyme  activity  may  be  attributed  to 
product/substrate inhibition.
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Figure 3.11 The Effect of NADH on Tetralone Reductase Activity
Tetralone  reductase  activity  in  NADH  (M).  The  error  bars  were  calculated  as 
standard  deviations  of  three  reactions.  This  graph  illustrates  how  tetralone
83reductase is affected by the addition of  NADH,  there is a small operating ranging of 
between 0.2 and 0.6mg/ml within which tetralone reductase can operate.
3.3.13  Solvent Screen for the Dissolution o f 6-bromo-p-tetralone
6-bromo-p-tetralone  is  insoluble  in  water  above  0.5g/L.  It  cannot be  added  as  a
solid to the reaction mixture as the rate of dissolution is too slow for an effective 
bioreduction.  Solvents were screened using Log P as a basis for selection to find a 
solvent which could improve the current assay by increasing the substrate solubility 
whilst  maintaining  tetralone  reductase  activity.  The  solvent  selection  was 
determined by assessing the application, the solubility and the enzyme activity.  This 
was completed by dissolving 6-bromo-p-tetralone in the solvents to a concentration 
of 1  Og/L and performing the kinetic assay to determine enzyme activity.  The results 
show  that  (Table  3.4),  in  general,  solvents  with  higher  Log P values  have  a  low 
solubility of 6-bromo-p-tetralone (less than  lOg/L).  The exceptions to this rule are 
toluene  and  a-xylene,  which  have  high  Log  P  values,  but  dissolve  6-bromo-p- 
tetralone to at least  lOg/L, however, tetralone reductase shows little activity in both 
of these solvents.  The low activity exhibited by tetralone reductase in toluene and 
also a-xylene is probably caused by the formation of a two-phase aqueous-organic 
solution with a high partition coefficient, and therefore the rate of mass transfer of 6- 
bromo-p-tetralone from the organic substrate phase into the aqueous enzyme phase 
is likely to be the limiting factor.  To increase the rate of mass transfer of 6-bromo- 
P-tetralone from the solvent into the aqueous phase, mixing could have been applied, 
however, this would also increase the interfacial contact between the enzyme and the 
solvent which,  in turn, would most likely reduce the activity of the  enzyme.  The 
activity of tetralone reductase in toluene and a-xylene is approximately five times 
less than  the  activity of tetralone  reductase  in  ethanol.  Thus,  if a  scaled reaction 
took 5hr to complete using ethanol as the solvent to solubilise 6-bromo-p-tetralone, 
it is likely that it would take 25hr to complete using either toluene or a-xylene as the 
solvent (using the assumption that mass transfer in not increased,  for example, via
84mixing).  In general, solvents with low Log P values dissolve 6 -bromo-p-tetralone to 
concentrations  of  lOg/L  or higher.  Tetralone  reductase  activity tends  to  increase 
with  solvents  of decreasing  Log P values  (Figure  3.12).  The  two  ketones  which 
were analysed, 4-methyl-2-pentanone and 3-pentanone both display high activity on 
the spectrophotometer assay.  However, on analysis of the HPLC chromatograms it 
is possible  to  see  that that 4-methyl-2-pentanone  and  3-pentanone  are themselves 
reduced not 6-bromo-p-tetralone, demonstrating that tetralone reductase has a higher 
affinity for the straight chain ketones than 6-bromo-P-tetralone.  It is not unusual for 
dehydrogenases to have multiple substrate specificity (Faber  1997) and open chain 
methyl- and ethyl ketones are readily reduced by dehydrogenases such as ADH from 
Thermoanaerobium  brockii  (TBADH)  (Faber  1997),  however,  more  complicated 
structures are not.  The ketones screened were derivatives of pentanone,  a straight 
chain  ketone  and,  although  this  reduction  of the  ketones  was  not  useful  for  the 
application  of a  solvent  to  dissolve  6-bromo-p-tetralone,  it  does  demonstrate  the 
catalytic power of tetralone reductase.  Amines cannot be used as they react into an 
unknown black solution.  Ethanol  and methoxyethanol were found to be the most 
compatible solvents as they retain a higher level of tetralone reductase activity than 
the other compatible solvents.
3.3.14  Solubility of 6-bronto-(3-tetralone
Ethanol  has previously been  used to  solubilise  6-bromo-p-tetralone  for the kinetic 
assay to  determine enzyme  activity,  however,  ethanol  only solubilises  6-bromo-p- 
tetralone  to  a  concentration  of  lOg/L.  In  the  previous  screening  experiment, 
tetralone  reductase  had  shown  comparable  activity  in  methanol,  acetonitrile  and 
methoxyethanol,  and therefore  6-bromo-p-tetralone was examined for its solubility 
in these solvents.  The results show that at 22°C 6-bromo-p-tetralone has a solubility 
of 0.5g/L in H20,  lOg/L in ethanol,  30g/L in  methanol,  120g/L in acetonitrile and 
250g/L in methoxyethanol (Table 3.5).  A comparison of the solubilities against the 
Log  P values  shows  that  the  solubility  of  6-bromo-p-tetralone  is  not  completely
85dependant on the Log P values.  Methanol has the lowest Log P value of-0.76 and 
6-bromo-p-tetralone  is  soluble  in  methanol  to  a  concentration  of  30g/L,  yet 
methoxyethanol has a Log P value of -0.50 and a solubility of 6-bromo-p-tetralone 
of 250g/L.  This may mean that the solubility of 6-bromo-p-tetralone in a solvent 
may  be  dependent  on  other  criteria  such  as  the  structure  of  the  solvent. 
Methoxyethanol  was  selected  as  the  solvent  to  be  used  in  further  experiments 
because  it  dissolves  6-bromo-P-tetralone  to  a  solubility  of 250g/L,  a  factor  a  25 
times more than ethanol.
Table 3.4 The Effects of Solvents on Tetralone Reductase Activity
Solvent Initial Activity (U/mg) Comments
4-methyl-2- 
pentanone
0.23 The high activity displayed was not  1  
concurrent with the HPLC assay
3-Pentanone 0.18
Solvent Initial Activity (U/mg) Comments Log P values
2,2,4-
trimethylpentane
0.08 Partially Soluble No data
1,2-Propandiol 0.09 Partially Soluble No data
n-Dodecane 0.06 Partially Soluble No data
n-Tetradecane 0.06 Partially Soluble No data
Ethylene Glycol 0.17 Partially Soluble No data
1  -octanol 0.04 Partially Soluble 2.72
Cyclohexane 0.09 Partially Soluble 3.4
Hexanes 0.09 Partially Soluble 3.9
n-heptane 0.08 Partially Soluble 4.66
Solvent Initial Activity (U/mg) Comments Log P values  |
Ethanolamine -0.04 Reacted to give a 
black solution
No data
Solvent Initial Activity (U/mg) Comments Log P values
N,N-Diethyl
Formamide
0.04 None No data
Pyridine 0.03 None 0.65
Toluene 0.05 None 2.69
a-xylene 0.05 None 3.12
2-propanol 0.10 None 0.05
Ethyl Acetate 0.11 None 0.73
N,N -  Dimethyl 
Formamide
0.11 None -0.87
86Solvent Initial Activity (U/mg) Comments Log P values
Dichloromethane 0.15 None 1.25
DMSO 0.18 None -1.35
Methanol 0.19 None -0.76
Acetonitrile 0.19 None -0.3
2-Methoxyethanol 0.20 None -0.50
Ethanol 0.21 None -0.32
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Figure 3.12 The Effect of Log P on Tetralone Reductase Activity
This graph illustrates the decrease in enzyme activity with increasing Log P values 
(The logarithm of the partition coefficient of a given  compound in  the standard n- 
octanol/water two-phase system).  (The solvents which did not dissolve 6-bromo-fi- 
tetralone fully to lOg/L are not illustrated on this graph).
87Table 3.5 6-bromo-p-tetralone Solubility
Solubility of  6 -bromo-P-tetralone in 100% solvent at 22°C.
Solvent Solubility (g/L) Log P
Water 0.5
Ethanol 10 -0.32
Methanol 30 -0.76
Acetonitrile 120 -0.30
Methoxyethanol 250 -0.50
3.3.15  Activity of Tetralone Reductase in Ethanol and Methoxyethanol
The  activity  of  tetralone  reductase  in  ethanol  was  compared  to  the  activity  of
tetralone reductase in methoxyethanol at different solvent concentrations.  This was 
investigated  to  determine  whether  the  type  of  solvent  at  different  solvent 
concentrations  would  have  an  effect  on  tetralone  reductase  activity  (Figure  3.13). 
The  experiments  were  carried  out  using  the kinetic  enzyme  assay  and the results 
show that there is no significant difference observed in the activity of the enzyme in 
either of the  solvents  up to  9%  (v/v).  Tetralone reductase activity decreases with 
both  increasing  ethanol  and  methoxyethanol  concentrations,  at  9%  (v/v)  tetralone 
reductase  activity is  75% of the  original  enzyme  activity.  The  incompatibility of 
enzymes in solvents has been reviewed in Chapter 1.10 and  1.11.  This reduction in 
activity is likely to be due to the solvent  interfering with the essential  water layer 
surrounding the enzyme (Leon et al.,  1998).  Ethanol and methoxyethanol both have 
the same detrimental effect on the enzyme activity, it also seems that the availability 
of the substrate to the enzyme is sufficient in both ethanol and methoxyethanol  for 
the reactions to be similar.  This, however, may be due to the low concentration of 
enzyme in the reaction, a higher concentration of enzyme in the reaction may change 
the  reaction  rates.  Methoxyethanol  will  be  used  in  further  experiments,  this  is 
because  although  tetralone  reductase  shows  comparable  activity  in  ethanol  the 
solubility  of  6-bromo-p-tetralone  in  methoxyethanol  is  25  times  greater.  Thus, 
inactivation  of tetralone  reductase  can  be  minimized  by  reducing  the  amount  of 
solvent required for the addition of the substrate.100
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Figure  3.13  Effect  of  Ethanol  and  Methoxyethanol  on  Tetralone  Reductase 
Activity
Tetralone reductase activity retained in ethanol (M) and methoxyethanol (#).  Error 
bars were calculated as standard deviations of three samples.
3.4  Discussion
Enzymes isolated from their native cell  environments immediately become subject 
to many inactivating conditions.  The active site of an enzyme is very reactive and is 
therefore susceptible to inactivation by a number of denaturants.  Extremes of pH, 
temperature,  and  organic  solvents  are  examples  of  denaturants,  and  careful 
consideration of the host buffer is essential to minimize loss of activity and stability 
of the required enzyme (Harris,  1986).  In the purification of tetralone reductase,  a 
pre-defined method was employed in which the host buffer had not been optimized, 
in  this  instance,  the  stability of tetralone reductase  was  measured  as  7hr  at  22°C.
89The stability of tetralone reductase was increased to 92hr at 22°C by optimising the 
host  buffer.  One  method  to  find  the  optimal  host  buffer  conditions  for  enzyme 
activity and  stability  is  to  employ  an  iterative procedure,  where the results  of the 
previous  experiment  are  used  to  optimise  the  next  set  of experiments.  A  non­
complex buffer of mid-range pH and low molarity would be used initially to perform 
activity and stability experiments, analysis of these results would either demonstrate 
(a)  the  enzyme  was  stable  enough  for  its  application  (b)  the  host buffer requires 
further optimisation.  The  flow  sheet  (Figure  3.14)  demonstrates that purification, 
optimisation, and characterisation, of an enzyme is a continuous circuit,  in that,  as 
the  enzyme  is  stabilized  further  characterisation  experiments  can  be  carried  out 
which in turn may be used to stabilize the enzyme, this can then also be applied to 
optimise the host buffers.
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Figure 3.14 Proposed Procedure for Enzyme Purification
A simple buffer of low molarity would be employed  for the purification.  Activity and 
stability studies can then be employed (e.g pH range,  additives,  and temperature) to
90optimise  the  host  buffer.  A  number of iterations  of the first  three stages  can  be 
performed until a stable enzyme is established.  The more iterations of the first part 
(shaded  in  grey)  the  more  stable  the  enzyme  should  be for  the purification  and 
ultimately should remain  stable for further  use.  The  stable  enzyme  can  then  be 
characterised which may lead to further optimisation, or the characterisation results 
could be used to optimise the reaction.
In the purification of tetralone reductase it became evident through characterization 
studies  that  the host buffer had not been  optimised.  If the  host buffer had been 
optimised initially using simple non-complex buffers (low molarity, mid-range pH, 
no  additives)  and  then  appropriate  additives  added  after  an  iterative  cycle  of 
optimisation (instead of before) this would most likely have removed the problem 
encountered of low stability (7hr half-life).  A learning point from the purification 
and stability studies of tetralone reductase is that enzymes may not need complex 
environments to be stable, and the purification/isolation should be studied using non­
complex  buffers  before  any  modification  to  the  buffers  are  employed. 
Characterisation of an enzyme should be one of the last stages after the host buffer 
and purification optimisation.  Characterisation studies are employed to understand 
more  about  the  enzyme  structure  and  its  attributes.  In  the  case  of  tetralone 
reductase, it is unlikely that the enzyme was pure enough for either crystallization or 
gene sequencing.  Crystallisation could have determined which of the metal cations 
tetralone reductase has in its structure, however, a high purity protein preparation is 
one of the most important factors for growing diffraction quality crystals (Wood and 
Coker, 2001) and tetralone reductase after the 3rd chromatography column may not 
have been pure enough.  The function of the metal cation could range from simple 
biological  roles  to  DNA  base  selective  recognition  (Kimura  &  Kituta,  2000). 
Characterisation of tetralone reductase also demonstrated that it requires NADH as a 
cofactor;  however,  tetralone  reductase  is  also  inhibited  at  high  concentrations  of 
NADH.  Initially, it was presumed that the reason cofactors need to be recycled was 
due to their high  cost  (Chenault et al.,  1986);  however,  the inhibition of tetralone
91reductase  at  low  levels  of NADH  suggests  that  it  is  more  important  to  recycle 
cofactors to prevent enzyme inactivation than it is to maintain a low cost process.  If 
the cofactor is not recycled then it would need to be controlled and monitored in the 
reaction.  However, as the cofactor is not used up in the reaction and just altered into 
its oxidised form, this would cause a build up of the oxidised form and may cause 
enzyme  inhibition  via  the  oxidised  cofactor.  A  cofactor  regeneration  system, 
therefore,  has  a  number  of  positive  attributes  over  the  stoichiometric  use  of 
cofactors:
•  Removes  the  problems  of  inhibition  by  the  cofactor  by  ensuring  that  only 
quantities of cofactor which maintain enzyme activity are employed.
•  Reduces cost through regeneration of the cofactor (Chenault et al., 1987, 1988).
•  More  easily  controlled  reactors,  as  cofactor  levels  will  not  need  monitoring 
throughout  the  reaction.  The  reaction  can  be  monitored  via  analysis  of the 
substrate and/ or product.
The delivery of cofactors to the reaction mix is not seen to be a problem due to their 
high  solubility  in  aqueous  solutions.  In  contrast,  the  delivery  of the  substrate, 
particularly for substrates which exhibit a low solubility in aqueous environments, is 
currently a limiting  factor in the  efficient use  of isolated  oxidoreductases.  In the 
bioreduction of 6-bromo-p-tetralone, the substrate is added to the reaction dissolved 
in a solvent;  this method of substrate delivery is effective,  in  that,  if the substrate 
was added as a solid to the aqueous enzyme phase the rate of dissolution would be 
very slow and the biocatalytic reaction times would be extensive.  Selection of an 
effective  method  of  substrate  delivery  to  the  reaction  solution  is  critical  in  the 
maintenance  of the  enzyme  activity  and  stability.  Log P values  have  previously 
been described as the main criterion for selecting solvents for biocatalysis (Laane et 
al.,  1986).  However,  subsequent  to  these  findings,  there have been papers  which 
suggest that Log P values alone are not an appropriate guide for selecting solvents, 
and  there  are  a number  of other parameters  which  need  to  be  considered  for the 
choice of solvent particularly for NAD(P)(H) requiring enzymes (Filho et al., 2003),
92this suggestion is also consistent with the results from this chapter.  It might be more 
appropriate to consider the functionality of the solvent alongside the Log P values. 
The solvents tested for tetralone reductase compatibility were screened on a variety 
of Log P values, this gave an initial method for selection, the results show that, in 
general, the more negative the Log P value the higher the enzyme activity.  This is 
likely to be associated with the amount of substrate available to the enzyme, this is 
because as the Log P value is increased the partition of the solvent from the aqueous 
solution  is  also  increased,  thus,  decreasing  the  availability of the  substrate to  the 
enzyme. Tetralone reductase exhibits high activity in solvents which have negative 
Log P values, thus, confirming that a higher log P value decreases the availability of 
the  substrate  to  the  enzyme.  Retention  of  enzyme  activity  is  of  paramount 
importance in obtaining a functional enzyme for biocatalytic reactions.  It has been 
reported  that  activity  retention  increases  with  increasing  Log  P  values  in  a 
sigmoidal-shaped  correlation  (Laane  et  al.,  1986)  (Figure  3.15).  This  theory 
contrasts the method by which the solvent selection can be made, for example,  for 
good  substrate-enzyme  interaction,  a  solvent with  a  low  Log P value is  required; 
however, for high activity retention,  a solvent with a high Log P value, is essential 
(Figure 3.15).
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Figure 3.15 Activity Retention and Specific Activity versus Log P
Enzyme activity retention increases with increasing Log P values and it is possible
to plot retention of enzyme activity against Log P using a sigmoidal-shaped graph. 
This graph is adapted  from Laane et al.,  1986, where a number of enzymatic systems
93were found  to  have  similar  correlations.  Tetralone  reductase  specific  activity 
decreases with increasing Log P values, figure adapted  from Figure 3.12.
Results also demonstrate that the solubility of 6 -bromo-p-tetralone is not completely 
dependent  on  Log  P values,  on  analysis  of 6-bromo-p-tetralone  solubility  it  was 
found to have a solubility of 250g/L in methoxyethanol (Log P = -0.50) compared to 
lOg/L in ethanol (Log P = -0.32).  However, in methanol, which has a Log P value 
of  -0.76,  the  solubility  of  6-bromo-P-tetralone  is  only  30g/L.  This  result  is 
consistent with the theory that the choice of solvent for cofactor requiring enzymes 
should be made on the combination of a number of parameters:
•  Log P.
•  Chemical name (e.g.  alcohol,  amine) - The chemical name is useful when 
selecting a system for substrate delivery as the choice may be incompatible 
with  the  substrate,  product,  or  even  the  enzyme.  For  example,  in  the 
bioreduction  of  6-bromo-tetralone,  the  amines  reacted  into  an  unknown 
compound (detected via a colour change), and the ketones reacted with the 
enzyme and were reduced to their respective alcohols.
•  Molecular properties (e.g. presence of heteroatoms and residues, molecular 
geometry,  electronic  density  distribution  and  frontier  orbitals,  surface 
tension and solvation energy  (Filho et al., 2003)
•  Solubility  of the  substrate  as  it  is  necessary  to  ensure  that  there  is  an 
adequate amount of substrate available for a reaction.
The selected method of substrate delivery for a biocatalytic reaction must ensure a 
high enzyme activity and significant retention of that activity over the course of the 
reaction(s); it must also ensure a good turnover of substrate to product.
943.5  Summary
Tetralone reductase can be isolated from the cells of Trichosporon capitatum (MY 
1890)  by  centrifugation  and  homogenisation,  and  purified  through  Q  Sepharose, 
Hydroxyapatite,  and  Toyopearl  chromatography  columns  respectively.  Affinity 
resins were examined for further purification of tetralone reductase but were found 
to  be  ineffective  due  to  tetralone  reductase  either binding  to  the  chromatography 
resin but not eluting, or not binding at all.  The purification protocol was refined and 
the enzyme stability was increased from just under 7hr to over 92hr at 22°C.  An 
SDS-PAGE gel of the purification stages illustrates a protein band at approximately 
43kDa.  Characterisation of tetralone reductase revealed that the enzyme’s active site 
requires  a  metal  cation,  however  it  was  concluded  that  the  enzyme  has  a  high 
enough affinity for the metal cation that additional quantities are not required in the 
process  buffers.  Inhibition  of tetralone  reductase  by  phenylglyoxal  indicates  an 
essential  arginine  residue;  and  the  combination  of  the  inhibition  of  tetralone 
reductase by the sulfhydryl inhibitor tested, p-CMB, and a heavy metal ion (such as 
zinc)  indicates  an  essential  sulfhydryl  group  (Ishihara  et  al.,  2000).  Tetralone 
reductase  activity  is  also  decreased  by NADH,  and  therefore  it  may be  easier to 
maintain the enzyme activity by using NADH in a regeneration system.  Tetralone 
activity was also screened against a number of solvents with varying Log P values, 
the  results  demonstrated  that  tetralone  reductase  exhibits  its  highest  activity  in 
ethanol  and methoxyethanol,  however,  6-bromo-[3-tetralone has  a higher solubility 
in  methoxyethanol  than  ethanol  and  was  selected  as  the  solvent  to  improve  the 
current assay.  In the following chapter, methods to immobilise tetralone reductase 
will  be  analysed  to  enable  the  separation  of the  substrates  and products  from  the 
enzymes  in  a continuous bioreactor.  Immobilisation  could  also promote tetralone 
reductase  stability  in  a  solvent.  Bioreactor  conformations  and  reaction
methodologies  for  the  regeneration  and  retention  of  the  cofactor  will  also  be 
examined.
95An Alternative Bioreactor Configuration for an 
Isolated Oxidoreductase
4.1  Introduction
Isolated  oxidoreductases  have  found  difficulty  in  being  applied  industrially;  one 
reason for this is because these enzymes require efficient steps for the regeneration 
and  retention  of their  expensive  cofactors  (Chenault  et  al.,  1987,  1988)  and  the 
process problems  related to  the  regeneration  of these  cofactors  at  industrial  scale 
have  not  yet  been  overcome,  although  there  have  been  a  number  of  recent 
developments  (Huisman  et al.,  2002)  (van  der Donk  et al.,  2003)  (Kroutil  et al., 
2004).  The  application  of isolated  oxidoreductases  requires  consideration  of the 
regeneration of the cofactor and reuse of the enzyme, the retention of the enzyme 
and cofactor,  and the separation of the substrate, by-products and products (which 
often  have  similar  molecular  size  to  the  cofactor  and  cannot  be  separated  by 
conventional  fdtration processes)  (Hummel et al.,  1989).  There are also problems 
which are generic for many enzymes; for example, maintenance of enzyme activity 
and  stability,  substrate  and  product  inhibition,  and  methods  of  delivering  the 
substrate into the reaction solution.
A great deal of the research that has been carried out with respect to continuously 
operating bioreactors for the application of oxidoreductases has concentrated on the 
use of the enzyme membrane reactor (EMR).  By employing a reactor containing a 
membrane the enzymes can be retained behind the membrane whilst the product can 
diffuse out (Kragl  et al.,  1993).  Cofactors can be retained alongside the enzymes 
through a number of methods (these were reviewed in Chapter 1).  However, there 
are  no  enzyme  membrane  reactors  which  have,  as  yet,  been  applied  at  industrial 
scale.  The  main  problem  associated  with  the  EMR  is  the  membrane  which  can 
cause problems due to protein  fouling (Huisman et al.,  2000).  There may also be 
potential retention and  separation difficulties  (Buckmann et al.,  1981).  Therefore,
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reactor.  A number of batch reactor systems have been developed for the reduction 
of poorly soluble ketones with cofactor regeneration via a secondary enzyme system. 
Reverse  micelles  have  been  employed  for  the  reduction  of 2-heptanone  to  S-2- 
heptanol where cofactor regeneration was performed by FDH and formate.  It was 
found  that  the  reaction  rate  was  increased  up  to  12  times  compared  to  in  water 
(Orlich et al.,  1999).  It was also suggested that in order to separate and reuse the 
enzyme and the cofactor, an ultrafiltration system might be employed (Schomacker 
et al.,  1997).  Two-phase systems have also been employed in cofactor regeneration 
reactions (Carrea et al.,  1988;  Loughlin, 2000).  A recent example of a two-phase 
cofactor  recycling  system  with  a  ketone  as  the  substrate  is  the  preparative 
asymmetric reduction of /?-chloroacetophenone (Groger et al.,  2004).  In this work 
(Groger et al., 2004), aqueous 5mM /?-chloroacetophenone was reduced by (S)-ADH 
from  Rhodococcus  erythropolis  over-expressed  in E.coli  to  its  respective  product 
with 97% conversion after a reaction time of 21 hours.  The cofactor recycling was 
carried out using  FDH  in a batch reactor at 30°C.  The main problem with the p- 
chloroacetophenone bioreduction was the low ketone concentration leading to non- 
satisfactory productivities  (Groger  et  al.,  2004).  The  addition  of solvent  in  this 
system (Groger et al., 2004) permitted an increase of the substrate concentration in 
the reaction.  This increase in solvent concentration was concurrent with a decrease 
in conversion.  A lOmM substrate conversion using a water/«-heptane 4:1  (biphasic) 
reaction system gave a conversion of 69%.  This work using /?-chloroacetophenone 
with cofactor recycling is similar to the model system in which 6-bromo-p-tetralone 
also exhibits low aqueous solubility (0.5g/L, 2mM) and tetralone reductase exhibits 
decreased  activity  when  exposed  to  a  solvent.  One  difference  of  the  p- 
chloroacetophenone  system  is  that  the  synthetic  enzyme  was  over-expressed  and 
cloned in to E.coli; whereas, in the model system the synthetic enzyme is not over­
expressed and is native to Trichosporon capitatum (MY 1890).
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not necessarily to increase stability, but to optimise productivity by using this as a 
method to reuse/regenerate the enzyme.  Immobilisation has the potential to result in 
an industrially efficient process with a stable, recoverable enzyme.  Immobilising the 
enzyme to a solid phase also means that the downstream purification of the enzyme 
from the product will not be required.  The choice of which bioreactor to employ, 
whether it  is  continuous  or batch,  biphasic,  single phase  or reverse  micelles,  and 
whether  immobilised  or  free  enzymes  are  used  will  ultimately  depend  upon  the 
requirements for the reaction and the constraints of the process.
The main objective of this chapter is to develop a reactor system for the enzymatic 
bioreduction of 6-bromo-P-tetralone.  The enzyme system will require the addition 
of a secondary enzyme and cofactor to allow cofactor regeneration.  If a continuous 
system is employed, it will also require a method of separating the cofactor and the 
enzyme from the product.  Tetralone reductase was previously isolated, purified and 
characterised (Chapter 3).  The results from Chapter 3 show that tetralone reductase 
is a stable enzyme and can potentially be employed for the bioreduction with high 
activity.  To examine the potential for tetralone reductase to be applied in a reactor 
the  following  factors  will  be  investigated:  enzyme  immobilisation  to  enable 
separation  of the  enzyme  from  the products,  characterization  of the  enzyme with 
respect  to  substrate  and  solvent  tolerance,  and  characterisation  of  the  reaction 
components.  Lastly,  a potential bioreactor configuration will be recommended for 
the  regeneration  and  recycling  of  the  synthetic  and  regenerative  enzymes  and 
cofactors.
4.2  Materials and Methods
4.2.1  Production of Tetralone Reductase
Tetralone  reductase  was  isolated  from  Trichosporon  capitatum  (MY  1890)  as 
previously explained (Chapter 3).
984.2.2  Immobilisation of Tetralone Reductase
lg of dry Eupergit C® (Rohm GmbH, Darmstadt, Germany) beads were mixed with 
5ml of enzyme solution in  1M potassium phosphate buffer pH 7.5  and left at room 
temperature for 72hr (as described in the manufacturer’s literature).
4.2.3  Resin Screen for NADH Adsorbance
3ml  of a 0.5g/L NAD(H)  solution  dissolved  in  water was  added  to  0.2g  of resin 
(XAD  4,  XAD  7HP,  Dowex  Optipore  285,  XAD  1180,  XAD  2000,  L323,  XAD 
2010,  or  L493)  (Supelco,  Poole,  Dorset,  UK).  The  solutions  were  shaken 
continuously for 30min  at  22°C  and  then  filtered using  Puradisc™  syringe  filters 
(Whatman  pic,  Maidstone,  Kent,  UK).  The  remaining  NADH  was  assayed  by 
spectrophotometer at 340nm (Chapter 2.7.3).
4.2.4  Resin Screen for Protein Adsorbance
lg of the XAD resins (XAD 4, XAD 7HP, Dowex Optipore 285, XAD  1180, XAD 
2000, L323, XAD 2010, or L493) (Supelco, Poole, Dorset, UK) was added to 3ml of 
a 0.6g/L tetralone reductase solution.  After 30min of continuous shaking at 22°C, 
the samples were filtered using Puradisc™ syringe filters to remove the XAD.  The 
filtered  samples  were  then  assayed  for  total  protein  using  the  Bradford 
spectrophotometer assay (Chapter 2.7.5).
4.2.5  Adsorbance of 6-bromo-/3-tetralol on XAD L-323
5  x  10ml  solutions  of  H2O  containing  1  OOjul  of  a  lOOg/L  6-bromo-p-tetralone 
solution in methoxyethanol  (final  concentration  lg/L),  were added to,  0.05g,  O.lg, 
0.2g,  0.4g,  0.6g  of XAD  L-323.  The  samples  were  left  continuously shaking  for 
30mins.  Samples  were  filtered  using  Puradisc™  syringe  filters  and  assayed  by 
HPLC (Chapter 2.7.2) for 6-bromo-p-tetralol.
994.2.6  Adsorbance of 6-bronto-/3-tetralone on XAD L-323
5  x  10ml  solutions  of H20   containing  lOOpl  of  a  lOOg/L  6-bromo-p-tetralol  in 
methoxyethanol  (final concentration  lg/L),  were  added to,  0.05g,  O.lg,  0.2g,  0.4g, 
0.6g of L-323.  The samples were left continuously shaking  for 30mins.  Samples 
were filtered using Puradisc™ syringe filters and assayed by HPLC (Chapter 2.7.2) 
for 6-bromo-(3-tetralone.
4.2.7  Effect o f  Solvent Type on Rate o f  Enzyme Reaction
2  x  9ml  solutions  of tetralone  reductase  solution  were  added  to  4.5mg  formate, 
1.43mg NAD,  and  lOmg FDH.  The reaction was started by the addition of either 
lml  of a  lOg/L  6-bromo-p-tetralone  in  ethanol  solution,  or  lOOpl  of a  lOOg/L  6- 
bromo-p-tetralone in methoxyethanol solution.  The reaction was run for just under 
4hr and samples were taken and assayed by HPLC (Chapter 2.7.2) for 6-bromo-p- 
tetralone and 6-bromo-P-tetralol at various time points.
4.2.8  Effect o f the Substrate Concentration on the Enzyme Activity
6  x  10ml  solutions  of tetralone  reductase  solution  were  added  to  1.43mg  NAD,
4.5mg  formate  and  lOmg  FDH.  The  reactions  were  initiated  by  the  addition  of 
tetralone dissolved  in  methoxyethanol.  The  starting concentrations of 6-bromo-p- 
tetralone  in  the  reaction  mixtures  were,  0.5g/L,  lg/L,  1.5g/L,  2g/L,  2.5g/L,  3g/L. 
(The volume of methoxyethanol was kept constant and the substrate concentration 
was changed).  The reaction was run for 7hr and samples were taken and assayed by 
HPLC  (Chapter  2.7.2)  for  6-bromo-P-tetralone  and  6-bromo-p-tetralol  at  various 
time points.
4.2.9  Effect o f  Solvent Volume on the Enzyme Activity
5  x  10ml tetralone reductase solutions were added to  1.43mg NAD, 4.5mg formate 
and lOmg FDH.  The reactions were initiated by the addition of 6-bromo-p-tetralone 
dissolved  in  methoxyethanol.  The  volumes  of solvent  used  were  1%,  2%,  3.9%,
1007.4%,  10.7% (v/v).  (The  6-bromo-P-tetralone concentration was kept constant and 
the volume of the solvent was changed).  The reaction was run for 7hr and samples 
were  taken  and  assayed  by HPLC  (Chapter 2.7.2)  for  6-bromo-p-tetralone  and  6- 
bromo-P-tetralol at defined time points.
4.2.10  Effect of  Formate on the Enzyme Activity
Formate was added to the spectrophotometric assay to give the final concentrations 
of Og/L,  0.5g/L,  lg/L, 2g/L, 4g/L,  5g/L in the final reaction mixture.  The reaction 
was initiated by adding  1ml of the assay mix to  1ml of the enzyme and monitored 
over time using the spectrophotometer assay (Chapter 2.7.3).
4.2.11  Effect of  FDH on the Rate of  Enzyme Reaction
A reaction mixture of 0.45g/L formate, 2.7ml tetralone reductase, 0.14g/L NAD, and 
300pl of 1  Og/L 6-bromo-p-tetralone in ethanol was used with varying concentrations 
of  FDH  (6 g/L,  12g/L  and  18g/L).  Samples  were  mixed  using  aspiration  and 
dispersion through a pipette tip. Samples of 200pl were taken and diluted with 800pl 
ethanol  and  assayed  via  HPLC  (Chapter  2.7.2)  for  6-bromo-p-tetralone  and  6- 
bromo-p-tetralol.
4.2.12  Effect of  NAD on the Rate of  Enzyme Reaction
A reaction mixture of 0.45g/L of formate,  2.6g/L  FDH,  2.7ml  tetralone reductase, 
and  300pl  of  a  lOg/L  6-bromo-P-tetralone  in  ethanol  was  used  with  varying 
concentrations  of NAD.  NAD  concentrations were  0.14g/L,  0.28g/L and 0.56g/L 
which  gave  TTNs  of  20,  10  and  5  respectively.  Solutions  were  mixed  using 
aspiration  and dispersion  through  a pipette tip.  Samples of 200pl  were taken  and 
diluted with 800pl ethanol and these were assayed via HPLC (Chapter 2.7.2) for 6- 
bromo-p-tetralone and 6-bromo-p-tetralol.
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Samples  were  set  up  as  before,  but  keeping  the  NAD  concentration  constant  at
0.14g/L.  Tetralone  reductase  was  diluted  to  75%  and  50%  of  its  original 
concentration (0.780g/L).  Solutions were mixed through aspiration and dispersion 
through a pipette tip.  Samples of 200pl were taken and diluted with 800pl ethanol 
and these were  assayed via HPLC  (Chapter 2.7.2)  for  6-bromo-p-tetralone  and  6- 
bromo-p-tetralol.
4.2.14  Regenerative Bioconversion
8mg formate,  0.43mg NAD,  8mg FDH were dissolved into the tetralone reductase 
solution  (2970pl,  2850pl  and  2700pl).  The  reactions  were  initiated  through  the 
addition  of a  lOOg/L  6-bromo-p-tetralone  solution in 30pl,  1  50j l x 1   and 300pl,  final 
concentrations  lg/L 5g/L and  lOg/L respectively.  (Formate was added in excess). 
The reactions were monitored over time by HPLC  (Chapter 2.7.2)  for  6-bromo-p- 
tetralone and 6-bromo-p-tetralol.
4.2.15  Scaled Bioreactor (10ml) Pass 1
10ml  of tetralone  reductase  was  added  to  1.43mg  NAD,  20mg  FDH,  4.5mg  of 
formate.  The reaction was initiated with  lOOpl of a  lOOg/L 6-bromo-p-tetralone in 
methoxyethanol (final reaction concentration  lg/L) solution.  To assay the reaction 
mix,  2 0 0pi samples were taken (a total of 1ml of the reaction mixture was removed 
for assaying).  0.5g of XAD L-323 was added to the reaction components facilitating 
in situ product removal.  The reaction components were then filtered using a syringe 
filter, into a new sterile Sterilin™ reaction vessel (Bibby Sterilin Ltd,  Stone,  Staffs, 
UK).  A  sample  of the  filtered  mix  was  assayed  to  check  that  the  product  and 
remaining  substrates  had  been  removed.  The  reaction  was  run  for  4hr  and  the 
samples were taken and assayed by HPLC (Chapter 2.7.2) for 6-bromo-P-tetralone 
and 6-bromo-p-tetralol at defined time points.
1024.2.16  Scaled Bioreactor (1 Oml) Pass 2
lml (in total) of tetralone reductase was removed in the assaying of the first reaction. 
An extra  lml  of tetralone reductase was added to the filtered reaction components 
with 4mg formate, 2mg FDH and 0.143mg NAD.  The reaction was initiated again 
with  lOOpl of a  lOOg/L 6-bromo-f3-tetralone in methoxyethanol.  The reaction was 
run  for 7hr and  samples were taken and  assayed by HPLC  (Chapter 2.7.2)  for  6- 
bromo-(3-tetralone and 6-bromo-p-tetralol at defined time points.
4.3  Results
4.3.1  Immobilisation of Tetralone Reductase
The  immobilisation  of tetralone  reductase  on  to  Eupergit  C®  was proposed  as  a 
method  to  separate  the  substrates  and  products  from  the  enzymes  in  continuous 
operation.  However, on assaying for enzyme activity it was found that 6-bromo-p- 
tetralone and 6-bromo-p-tetralol had adsorbed on to Eupergit C®, and therefore the 
requirement to separate the substrate and product from the immobilized enzyme (for 
a continuously operating bioreactor) could not be met.  Another issue regarding the 
use of Eupergit C® was that the manufacturer’s protocol required an ionic solution 
for  the  immobilisation  procedure.  The  recommended  buffer  was  phosphate, 
however, NADH (Wu et al.,  1986) and tetralone reductase (Thomas, 2000) are both 
deactivated in high molarity phosphate buffers.  The adsorbance property exhibited 
by the substrate and product,  and the high ionic buffer required for immobilisation 
precluded  the  use  of Eupergit  C®  as  an  immobilisation  resin.  It  was  therefore 
decided that the most effective way of applying tetralone reductase in a biocatalytic 
process would be to use the enzyme in its free state and in batch operation, however, 
an  alternative  methodology  for  enzyme  and  cofactor  regeneration  and  retention 
would be required.  The unexpected binding of 6-bromo-p-tetralone and 6-bromo-P- 
tetralol to Eupergit C® was proposed as a method which could be used for cofactor 
recycling; by employing Eupergit C® to  adsorb the product instead of the enzyme 
via  in  situ  product  adsorption  the  enzymes  and  cofactors  could  be  separated  and 
reused  in  a  multiple  batch  configuration.  A  cofactor-requiring  enzyme  reactor
103system  which  employs  a  solid  phase  component  to  capture  the  product  (and 
remaining substrate) from the reaction system negates the requirement to ensure the 
expensive cofactors are maintained inside the reactor system via other methods such 
as cofactor immobilisation (Wichmann et al.,  1981) or via the employment of less 
conventional membranes; for example, charged membranes (Nidetsky et al.,  1996). 
The theoretical  movement of the reaction components through  a reactor if:  (i) the 
enzymes  are  immobilized,  and  if  (ii)  the  product  is  immobilized,  is  shown  in 
Schemes 4.1  and 4.2 respectively.
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Scheme 4.1
In  this scheme,  the  enzymes  are  immobilised on  a support and the substrates and 
cofactors are reacted in either continuous or batch operation  (A).  The output from 
the reaction  would be a  mix of the product and cofactor (B).  The cofactor would 
need to be separated from  the product  (C)  before it could be recycled in a further 
reaction with the immobilised enzyme (D).
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In  this scheme,  the  enzymes  are  used  in  their free form  in  a  batch  reactor  the 
substrates and cofactor are then  added to the reaction  (A).  Upon completion of 
the reaction  (B)  the product may be separated from  the reaction mixture via the 
addition  of a  solid phase  component  to  which  it  adsorbs  (C)  the  enzymes  and 
cofactors can then be recycled  for  further reactions (D).
4.3.2  Resin Screen for NAD(H) and Tetralone Reductase Adsorbance
Eupergit C® is an  expensive resin  and although the cost may not be significant at
small  scale  it  would  be  a  concern  at  large  scale.  XAD  resins  were  screened  to 
determine  if an  inexpensive  polymeric  resin  could  be  used  as  a  replacement  for 
Eupergit  C®  for  this  in  situ  product  adsorption  and  removal.  The  parameters 
analysed  were:  (1)  the  ability of the  resin  to  reject  the  cofactors  and  hydrophilic 
enzymes;  and  (2)  the  ability  of the  resin  to  retain  the  hydrophobic  substrate  and 
product.  The resins screened were XAD-4, XAD 7HP, Dowex Optipore 285, XAD 
1180, XAD 2000, L323, XAD 2010 and L-493 (Figure 4.1).  NADH is a component 
of the enzyme reaction  which  requires recycling  and  should  not bind  to the resin. 
The results demonstrate that Dowex  Optipore 285  shows significant adsorbance of 
NADH,  the other resins which  adsorbed  NADH  were XAD  1180 which  adsorbed 
about  40%,  XAD  200  which  adsorbed  about  30%  and  XAD  4  which  adsorbed 
approximately  15%.  The difference in the binding capacities of the cofactor to the
105resin is likely due to the different properties exhibited by the resins; any amount of 
binding of NADH onto the resins would decrease the value of the reaction as more 
cofactor would have to be added to the reaction mix.  The resins most successful at 
rejecting NADH are XAD 7HP, L-323, XAD 2010 and L-493.  The resins were also 
screened for their ability to adsorb tetralone reductase (Figure 4.2).
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Figure 4.1 Resin Screen for NADH Adsorption
0.2g of resin was added to 3ml of a 0.5mg/mI NADH solution in water and left for 
30min  at  22°C.  Error  bars  were  calculated  as  standard  deviations  of three 
adsorptions.  The higher the residual NADH in the solution,  the more potential the 
resin has to be used in a bioreactor as a method of in situ product removal.  XAD 
7HP,  L 323,  XAD 2010 and L493  all show potential.  Dowex  Optipore  (DO)  285 
shows least potential (Reference Section 4.2.3 for methodology).
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Figure 4.2 Resin Screen for Protein Adsorption
0.2g of resin was added to 3ml of a 0.6g/L tetralone reductase solution and left for 
30min  at  22°C.  Error  bars  were  calculated as  standard deviations  of the  three 
adsorptions.  The higher the residual protein in the solution the more potential the 
resin has to be used in a bioreactor as a method of in situ product removal.  None of 
the  resins  demonstrate  high  enzyme  binding  (Reference  Section  4.2.4  for 
methodology).
To  reuse  tetralone  reductase  in  a  bioreactor,  the  enzyme  must  not  adhere  to  the 
selected resin.  Adsorbance of the enzyme to a resin will decrease the separation and 
may  also  reduce  the  efficacy  of the  enzyme.  The  results  from  the  experiments
107demonstrate that minimal adsorbance of the enzyme is observed on all of the resins 
tested.  The two most effective resins for the least adsorption of tetralone reductase 
are XAD 4 and L-323.  These two resins maintained nearly 100% of the enzyme in 
solution.  However,  XAD  4  exhibited  a  15%  adsorbance  of NADH  (seen  in  the 
previous step Figure 4.1), of all the resins screened XAD  L-323  appears to be the 
most  effective  resin  for  this  process.  This  shows  that  an  inexpensive  resin  can 
potentially  be  employed  for  replacement  of Eupergit  C®;  this  is  only  true  if 6- 
bromo-P-tetralone and 6-bromo-P-tetralol adhere to XAD L-323.  This is examined 
in Section 4.3.3.
4.3.3  Adsorbance of 6-bromo-p-tetralone and 6-bromo-p-tetralol on XAD L-323
To employ XAD L-323  for in situ product adsorption in a bioreactor the resin must
adsorb  6-bromo-p-tetralone and  6-bromo-p-tetralol.  This would allow the enzyme 
and  cofactor  to  be  separated  from  the  product  and  unconverted  substrate.  The 
following experiment was carried out to determine how easily the substrate and the 
product  adsorbed  on  to  XAD  L-323.  The  results  show  that  6-bromo-p-tetralone 
easily adsorbs onto the XAD resin L-323  (Figure 4.3).  A mass of 0.1 g of the resin 
adsorbs  the  lOmg  of  6-bromo-p-tetralone  in  the  solution.  6-bromo-p-tetralol 
exhibits a lower binding capacity on to the XAD resin L-323  (Figure 4.4) than  6- 
bromo-p-tetralone.  This may be explained as it is less hydrophobic that 6-bromo-p- 
tetralone, and thus, has a tendency to remain in the aqueous phase.  A mass of 0.2g 
of the resin adsorbs the  1  Omg of 6-bromo-p-tetralol in the solution.  This shows that 
XAD L-323  can potentially be used in the adsorption of the substrate and product. 
This mass of resin will be used comparatively in subsequent experiments as this will 
ensure that all of the product and unconverted substrate have the potential to adhere 
to the resin.  It will also ensure that the resin is used in the most efficient quantities.
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Figure 4.3 The Adsorbance of Substrate and Product on XAD L323
This graph  illustrates  the  adsorbance  of 6-bromo-f-tetralol  (R)  and  6-bromo-f3- 
tetralone  (* )  on  to  XAD  L-323.  The  components  were firstly  solubilised  in 
methoxyethanol before diluted using water to lg/L.  The resin was then incubated in 
10ml  of the  substrate  and  product  solutions  at  22°C for  30min.  The  graph 
demonstrates that both 6-bromo-f-tetralone and 6-bromo-j3-tetralol adsorb onto the 
selected resin,  however,  the amount adsorbed per gram  of resin  is  higher for the 
substrate  than  for  the  product.  (Reference  Sections  4.2.5  and  4.2.6  for 
methodologies).
4.3.4  Effect of Type of Solvent on Rate of  Reaction
A major constraint for developing a bioreactor configuration for the reduction of 6- 
bromo-P-tetralone  is  because  6-bromo-p-tetralone  is  a  solid  (with  a  low  aqueous 
solubility)  it needs  to be  solubilised  in  a  secondary medium.  To  facilitate in situ
109product  adsorption  via  a  polymeric  resin  it  was  deemed  necessary  to  maintain  a 
single-phase solution.  This was because  6-bromo-p-tetralol needs to have a higher 
affinity for the polymeric resin than for a secondary phase hydrophobic  solvent or 
the  resin  will  become  redundant  as  a  two-phase  system  would  likely  elute  the 
product  from  the  resin  into  the  secondary phase.  A  water  miscible  solvent  will 
affect  the  enzyme  conformation  (Adlercreutz,  1988),  and  therefore  the  enzyme 
activity.  However, by decreasing the volume of the solvent required by selecting a 
solvent which has a high solubility of the substrate will most likely ensure that the 
enzyme activity is maintained at the highest levels feasible.  This  experiment was 
carried  out  to  determine  whether  a  miscible  solvent  can  be  used  to  solubilise  6- 
bromo-p-tetralone, which in turn, can be applied in the bioreduction of 6-bromo-p- 
tetralone.  The experiment was also carried out to determine if a solvent which has a 
low solubility of the substrate can be substituted with a solvent which has a higher 
solubility of the substrate.  Solvents were previously screened in Chapter 3.3.13 and 
the results demonstrated that ethanol  and methoxyethanol were the solvents which 
maintained  most  of the  activity  of tetralone  reductase  in  a  single  phase  system. 
Comparatively,  both  these  solvents  also  retained  the  same  amount  of  enzyme 
activity  (Figure  3.13).  However,  ethanol  dissolves  6-bromo-p-tetralone  to  a 
concentration of 1  Og/L yet methoxyethanol dissolves 6-bromo-p-tetralone to a much 
higher concentration of 250g/L.  In this experiment,  a bioreduction was run where 
ethanol  was  employed  at  higher  volumes  than  methyoxyethanol  but  with  similar 
substrate  concentrations.  The  results  (Figure  4.4)  show  that  the  rate  of reaction 
significantly increases when methoxyethanol is used.  Not only is the initial rate of 
reaction  increased  by  decreasing  the  volume  of  solvent,  the  reaction  is  also 
completed two hours faster in a time of approximately 3hrs.  The yields, however, 
after 4hr are relatively similar.  This reduction in initial reaction rates is most likely 
caused  by  an  increase  in  the  solution polarity  surrounding the  enzyme;  this  most 
likely  disrupts  the  enzyme’s  tertiary  structure  and  active  site  conformation. 
Analytical techniques such as circular dichroism (CD) could be used to analyze the 
affects of the enzyme conformation in different solvent solutions.  In Figure 4.4 a
110reduction in solvent shows an increase in the enzyme reaction rates, however there 
may  also  be  other  parameters  which  affect  the  reaction  rates.  For  example,  the 
amount of substrate may affect the enzyme kinetics, this is investigated in Chapter 
4.3.5.
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Figure 4.4 The Effects of the Type of Solvent on the Bioreduction
Bioconversion profiles for reactions using,  lml of  a lOmg/ml 6-bromo-f-tetralone in 
ethanol as the solvent (TJ) with respective product (M); and methoxyethanol,  lOOpl 
of a  lOOmg/ml  6-bromo-p-tetralone  in  methoxyethanol  as  the  solvent  (O)  with 
respective product (0).  Reactions were carried out in a volume of 10ml.  The graph 
demonstrates that the bioconversion depends on the volume of solvent added to the 
reaction mixture.  The addition of a  10-fold decrease in solvent whilst maintaining 
substrate  concentration  can  significantly  increase  the  reaction  rates.  (Reference 
Section 4.2.7  for methodology).
IllThese  results  indicate that  a miscible  solvent  can be  used  in  the  isolated  enzyme 
bioreduction  of 6-bromo-p-tetralone.  It  also  demonstrates  that  a  solvent  with  a 
higher solubility of the substrate should be employed for the bioreduction since there 
is  less  of  an  effect  on  tetralone  reductase.  Because  of  these  findings,  it  is 
methoxyethanol  (and not ethanol) will be used in subsequent enzyme regeneration 
reactions.
4.3.5  Effect of  Substrate Concentration on Tetralone Reductase Activity
The  change  in  initial  substrate  concentration  was  investigated  to  determine  the
effects on the activity of the isolated enzyme.  This experiment was carried out using
the  single  enzyme  cofactor  requiring  system,  where  NADH  was  added
stoichiometrically (not recycled).  The results (Figure 4.5) show that the initial rate
of reaction increases rapidly up to an initial substrate concentration of approximately
lg/L;  this  is  most  likely  the  point  at  which  the  enzyme  becomes  saturated  with
substrate.  It was expected that the initial enzyme activity would only increase up to
0.5g/L,  since  this  is  the  solubility of 6-bromo-P-tetralone  in  water.  However,  6-
bromo-P-tetralone  was  solubilised  in  methoxyethanol  first  and  this  could  have
increased the solubility of the substrate in the whole solution.  The solubility of the
substrate in different ratios of methoxyethanol  and water should be investigated to
confirm this hypothesis.  The point  at which the reaction  rates  level  out (lg/L)  is
most likely representative of the enzyme becoming the rate limiting factor.  At this
point it is hypothesized that the transfer of the product from the active site and the
transfer of further substrate to the  active site become the rate-limiting steps.  This
hypothesis could be tested by adding more enzyme to the reaction; an increase in the
amount of enzyme would increase the ratio of enzyme to substrate, thus most likely
increasing the point at which the initial reaction rate levels.  If the point at which the
reaction levels out did not increase then it would  likely mean that there is another
component which limits the reaction.  One potential component could the required
cofactor  (NADH),  where  there  could  potentially  be  less  units  of cofactor  in  the
reaction solution than required by the enzyme;  this could be tested by adding more
112cofactor to the reaction.  It is unlikely that the amount of cofactor added is causing 
the leveling out of reaction rates since this amount was calculated with respect to the 
amount  of substrate  in the reaction.  It  is  more probable  that there  is not enough 
enzyme  (since  only  small  quantities  are  isolated  and  purified  from  the  cell). 
Hypotheses for the rate limiting factors  are discussed,  including the effects of the 
amount of tetralone reductase on the bioreduction, in further detail in Section 4.3.7.
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Figure 4.5 The Effects of  Initial Substrate Concentration on Bio  catalytic Activity
100/ul  of methoxyethanol  was  used  to  dissolve  6-bromo-/3-tetralone  in  10ml  of 
reaction mixture.  The vertical dotted line (—)  illustrates the point at which water 
would become saturated with substrate.  The graph shows an initial increase in the 
rate of reaction before the rate of reaction levels out.  This is most likely the point at 
which  tetralone reductase becomes saturated with  6-bromo-p-tetralone.  This is at 
approximately  lg/L  (where  the  initial  activity  no  longer  increases).  (Reference 
Section 4.2.8  for methodology) (See Appendix Bl. 1 for raw data).
1134.3.6  Effect of  Solvent Volume on Tetralone Reductase Activity
The amount of solvent in the reaction mix in this system is related to the amount of
product  required.  This  is  because  as  more  substrate  is  added  more  solvent  is
required to solubilise the substrate.  In this experiment, the effects of solvent volume
on tetralone reductase activity were investigated.  This could determine the amount
of solvent which could be added to the reaction before tetralone reductase becomes
denatured.  The  results  from  the  experiment  show  that  the  initial  reaction  rates
significantly  decrease  when  methoxyethanol  is  added  to  the  reaction  mix  (Figure
4.6).  A solvent concentration of 6% (v/v) decreases the initial enzyme activity by
approximately  50%  when  compared  to  the  enzyme  activity  at  a  solvent
concentration of 1%  (v/v).  The  final  conversions  are less  affected by the  solvent
volume  at the  substrate  concentration  used  (Figure 4.7),  there  is however a small
decrease and it is likely that if more solvent was added then this would have a more
adverse effect.  The high substrate conversions which were maintained even at high
solvent concentrations may be attributed to the fact that low substrate concentrations
were employed.  Solvent concentrations of up to  11 % show no significant decrease
in  final  conversion,  however,  at  the  same  solvent concentrations  the  activities  are
reduced to very low levels.  This observed reduction in activity is likely to be due to
the solvent interfering with the essential water layer surrounding the enzyme (Leon
et al.,  1998).  The disturbance in the water layer most likely causes the enzyme’s
conformation  to  become perturbed  and therefore  it is  difficult for the  substrate to
bind into the ‘lock and key’ complex in the active site of the enzyme.  The change in
the solution polarity may also cause the weak attractive forces which can help create
the complex to become unstable.  If there is a level of disturbance of the ‘lock and
key’ mechanism at higher solvent concentrations, this will likely cause a decrease in
the  reaction  rates,  since  the  reaction  may  take  longer  to  complete.  This  may,
however,  not  cause  a  decrease  in  the  conversion  (just  longer  for  the  reaction  to
complete).  If an even higher solvent concentration was employed, this would likely
cause an even greater change in the enzyme’s active site and it would be even more
likely  that  the  substrate  would  not  bind,  consequently  lowering  the  conversions
114further.  These results indicate that miscible solvents can be used in the bioreduction 
of  6-bromo-P-tetralone,  however  to  maximise  enzyme  activity  the  solvent 
concentration should not be used above 10% (v/v) in bioreactor experiments.
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Figure 4.6 The Effects of  Initial Solvent Concentration on Bio  catalytic Activity
Initial substrate concentration was 0.5mg/ml.  This graph illustrates how the initial 
enzyme activity is affected by the volume of  solvent in the reaction solution.  There is 
an  initial  increase  in  the  activity  up  to  approximately  2%  (v/v)  before  a  linear 
decrease can be observed.  The initial enzyme activity is minor at about 11% solvent 
(v/v).  0% solvent (v/v) was not measured as 6-bromo-f3-tetralone is highly insoluble 
in aqueous solutions.  ((Reference Section  4.2.9 for methodology).  (See Appendix 
B1.2 for raw data).
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Figure 4.7 The Effects of  Methoxyethanol Concentration on the Conversion
These  results  come  from  the  methodology  used  in  Figure  4.6.  The  results 
demonstrate  that  although  the  initial  enzyme  activity  was  highly  affected  by  an 
increase in solvent volume (Figure 4.6),  the conversions of the substrate were much 
less affected.  There is a small decrease in the final product concentration and this 
becomes  more  pronounced  as  the  amount  of solvent  is  increased.  (Reference 
Section 4.2.9  for methodology).  (See Appendix B1.2 for raw data).
4.3.7  Determining the Rate-Limiting Component
In the two enzyme cofactor regenerating system there are a number of components 
which  could  affect  the  rate  of the  synthetic  reaction  these  are:  formate,  formate 
dehydrogenase, NAD(H) and tetralone reductase.  The following experiments were 
carried out to determine which of the components used in the bioreduction was the 
rate-limiting  factor.  Firstly,  tetralone  reductase  was  examined  for  activity  at 
concentrations of formate which would be  available in the bioreactor.  The results 
show  that  at  the  formate  concentrations  investigated  the  enzyme  activity  is  not
116affected (Figure 4.8).  This means that formate can be employed effectively as the 
regenerating  substrate without  affecting  tetralone  reductase  activity,  it  also means 
that it is not the rate-limiting factor in the reaction.  This result,  in which formate 
was determined to be innocuous to tetralone reductase, is consistent with the results 
from a review paper (Chenault and Whitesides,  1987) (see Chapter 1.7).  Secondly, 
FDH which is a highly stable, purified enzyme purchased in lyophilized form was 
examined to show whether it was the rate-limiting component.  The results show that 
increasing the concentration of FDH does not affect the rate of the reaction (Figure 
4.9).  This was expected  as the enzyme is well  characterised  and highly stable in 
comparison  to  tetralone  reductase.  Thirdly,  the  initial  NAD  concentration  in  the 
reaction  mixture  was  increased  to  examine  whether  NAD  was  the  limiting 
component.  NAD was added to the reaction mix instead of NADH for two reasons. 
Firstly, NAD is more stable in a number of reported environments than NADH (Wu 
et al.,  1986;  Chenault et al.,  1987).  Secondly,  the addition of NAD demonstrates 
that  cofactor  regeneration  occurred  in  the  reaction,  and  is  not  just  used 
stoichiometrically.  An  increase  in  initial  NAD  concentration  would  ultimately 
decrease the TTN, and the lower the TTN the higher the process costs (Chenault and 
Whitesides,  1987).  Results  show  that  the  enzyme  activity  does  not  change  with 
varying NAD concentrations and NAD is therefore not the rate-limiting component 
(Figure  4.10).  Lastly,  tetralone  reductase  was  employed  at  three  different 
concentrations of 0.4g/L,  0.6g/L and 0.8g/L to determine if it was the rate limiting 
component.  The  results  demonstrate  that  as  tetralone  reductase  concentration  is 
increased the rate  of reaction  also  increases  (Figure 4.11).  The results  show that 
under  the  current  operating  parameters,  tetralone  reductase  is  the  rate-limiting 
component in the regenerative bioconversion.  It is also very probable that the rate- 
limiting  step  is  the conversion  of 6-bromo-p-tetralone to  6-bromo-p-tetralol.  The 
most logical reason that tetralone reductase is limiting, is that it is highly diluted and 
not fully purified, unlike FDH which is an over-expressed enzyme and is in a highly 
pure form.  This means, however, that the TTN of NAD to NADH is not accurate as 
tetralone reductase is probably over saturated by the cofactor (there are more units of
117NAD than units of enzyme).  The addition of higher concentrations of NAD does not 
increase the initial  rate of reaction and indicates that FDH  and tetralone reductase 
were already saturated with NAD(H).  Reducing the quantity of NAD to the minimal 
amount would  significantly increase the TTN  whilst keeping the reaction rate the 
same.  Calculating  the  most  efficient  TTN  could  also  give  an  indication  of how 
much active enzyme is in the sample.  As the enzyme activity was not affected by 
the addition of excess NAD over-saturation would only be of concern at large scale 
where its cost would be more prominent.  If tetralone reductase was over-expressed 
the reaction could be significantly enhanced with faster reaction rates and increased 
TTNs.  The reaction would also be more likely to be limited by the transfer of the 
cofactor from one enzyme to the other, rather than the low concentration of tetralone 
reductase in the reaction solution.
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Figure 4.8 The Effects of Formate on Enzyme Activity
This graph illustrates how the amount of  formate (the regenerative substrate) affects 
the  activity  of tetralone  reductase  (the  synthetic  enzyme).  The  experiment  was
118completed  at formate  levels  consistent  with,  and  higher  than,  the  regenerative 
bioconversions  levels.  The  results  demonstrate  that formate  does  not  affect  the 
enzyme activity at the levels tested.  The error bars on the graph are calculated  from 
the standard deviations of three separate experiments.  (Reference Section 4.2.10 for 
methodology).
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Figure 4.9 The Effects of FDH on Enzyme Activity
Bioconversion profile for reactions with  6 mg FDH (M),  12mg FDH (0),and 18mg 
FDH (A).  This graph illustrates how the amount of  FDH (the regenerative enzyme) 
affects  the  bioconversion  of  6 -bromo-p-tetralone  to  6 -bromo-p-tetralol.  The 
experiment  was  completed  at  FDH  levels  consistent  with,  and  higher  than,  the 
regenerative  bioconversions  levels.  The  results  demonstrate  that  FDH does  not 
affect  the  bioconversion  at  the  levels  which  will  be  employed  in  the  bioreactor. 
(Reference Section 4.2.11 for methodology).
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Figure 4.10 The Effects of NAD on Enzyme Activity
Bioconversion profile for reactions with  a  TTN of NAD of 20 ( M ) ,  10 (0 ), and 5 
(A).  This graph  illustrates how the amount of NAD (the oxidized form of NADH) 
affects  the  bioconversion  of  6 -bromo-(d-tetralone  to  6 -bromo-p-tetralol.  The 
experiment  was  completed  at  NAD  levels  consistent  with,  and  higher  than,  the 
regenerative  bioconversions  levels.  The  results  demonstrate  that  NAD  does  not 
affect  the  bioconversion  at  the  levels  which  will  be  employed  in  the  bioreactor. 
(Reference Section 4.2.12 for methodology).
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Figure 4.11 The Effects of Tetralone Reductase on the Rate of  Reaction
Bioconversion profile for reduction of  6 -bromo-p-tetralone with the concentration of 
tetralone reductase at 0.8g/L ( M ) , 0.6g/L (0 ), 0.4g/L  (A).  This graph  illustrates 
how the concentration of tetralone reductase affects rate of  production of 6 -bromo- 
ft-tetralol.  The  experiment  was  completed  at  enzyme  levels  consistent  with  the 
regenerative bioconversions levels.  The results demonstrate that the concentration 
of tetralone reductase considerably affects the rate of reaction and will be the rate- 
limiting component in the bioreactor.  (Reference Section 4.2.13 for methodology).
1214.3.8  Two Enzyme Cofactor-Requiring Bioreduction
In the model system there are two cofactor dependent enzymes and two substrates 
and their respective products, in addition to this a solvent is added and the quantity 
of solvent is dependent on the substrate concentration.  The cofactors are constantly 
in  a  cycle  of reduction  (NADH)  and  oxidation  (NAD)  and  equilibrium  of these 
cofactors is unknown.  However, if two boundaries are drawn between the reaction 
components (Figure 4.12), and it is assumed that:  (i) the components in boundary 2 
(which recycles NAD  to  NADH)  are  in  excess;  (ii)  the  availability  of NADH  to 
tetralone reductase is such that it does not affect tetralone reductase activity yet it is 
not the rate limiting component; (iii) the components in boundary 2 do not affect the 
components  in  boundary  1;  the  reaction  profile  should  be  similar  to  the  single 
substrate and enzyme profile.
Boundary 1
Tetralone Reductase
NADH
Boundary 2
NAD
V   COo « Formate Dehydrogenase  Formate
Figure 4.12 Boundary Interface to Determine Kinetics
If the components  of the  two  enzyme  cofactor-requiring system  may be separated 
into two distinct boundaries, adding excess of the components in boundary 2 into the 
reaction will mean that the reaction should  follow the single substrate profile.
122However,  this  does  not  take  into  consideration  the  decrease  in  activity  due  to 
increasing  the  solvent  quantity  with  increasing  substrate  concentration  and  since 
there  is  an  effect  on  enzyme  activity  with  increasing  solvent  concentration  the 
reaction parameters will only be similar for reactions which use the same volume of 
solvent.  This  experiment  was  carried  out  to  determine  whether  an  efficient 
bioconversion  could  be  achieved  using  low  volumes  of methoxyethanol  but  high 
concentrations  of 6-bromo-p-tetralone.  The  regenerating  enzyme  and  cosubstrate 
were both added to the reaction mixture in excess.  6-bromo-p-tetralone was added 
to the reaction mix  at  lg/L  (highest  initial  enzyme reaction rate  determined  from 
Figure 4.5), 5g/L and lOg/L.  Results show that the recycling enzyme system works 
effectively  (Figure  4.13).  However,  the  effects  of  inhibition  by  the  synthetic 
substrate  and  solvent  when  these  initial  concentrations  are  increased  are  evident. 
For example, the rate of reaction when an initial substrate concentration of 5g/L is 
used is approximately half of the reaction rate compared to when an initial substrate 
concentration of 1  g/L is used, the final conversions, however, are similar.  When the 
initial  substrate  concentration  is  lOg/L,  the  initial  rate  of reaction  is  half of the 
reaction rate when  5g/L is used,  and the  final  conversion is less than half.  These 
results  show  that  an  efficient  bioconversion  can  be  achieved  at  low  substrate 
concentrations.  Using  the  initial  substrate  concentration  of  lg/L  gives  a  high 
conversion  and  a  high  initial  activity  for  the  enzyme.  It  is  this  initial  substrate 
concentration (lg/L) which will be employed in subsequent bioreactor experiments 
to  prove  the  theory  that  product  can  be  removed  in  situ  whilst  maintaining  the 
enzyme and cofactor in a bioreactor for recycling.
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Figure 4.13 Regenerative Bioconversion
Bioconversion  profile  of  6-bromo-/3-tetralone  to  6-bromo-j3-tetralol  using 
methoxyethanol as  the solvent with  an  initial substrate concentration  of lg/L  (M), 
5g/L  (0 ) , and lOg/L  (A ).  In  this experiment NADH was regenerated by formate 
dehydrogenase using formate as  the regenerative substrate.  The graph  illustrates 
the change in the rate of reaction when different substrate concentrations are used. 
At lg/L the conversion is significantly faster than when the substrate concentration 
is  5g/L,  the  conversions,  however,  are  not  too  dissimilar  at  approximately  80%. 
When a substrate concentration of lOg/L is employed there is a low rate of reaction 
and  only  a  conversion  of approximately  30%.  (Reference  Section  4.2.14 for 
methodology).
1244.3.9  Scaled Bioreactor
The following experiments were carried out to prove that a bioreactor configuration 
can  be  established  where  there  is  in  situ  removal  of 6-bromo-p-tetralone  and  6- 
bromo-(3-tetralol  and  subsequent  cofactor  and  enzyme  recycling  and regeneration. 
The  enzyme  was  used  in  its  free  state,  the  regenerating  enzyme  was  formate 
dehydrogenase,  the  solvent  used  to  dissolve  6-bromo-p-tetralone  was 
methoxyethanol, and the resin which was used for in situ product removal was XAD 
L-323.  The bioreactor was run at  10ml scale (this is an increase by a factor of 10). 
The method used a batch reactor in which all the reaction components were added 
simultaneously (Figure 4.14).  The reaction was allowed to continue until there was 
a leveling off in the amount of product produced this takes approximately 4hr.  The 
product and unconverted substrate were then removed from the reaction mix by the 
addition of the XAD resin L-323.  The reaction mixture was filtered and the product 
eluted  using  ethanol.  Tetralone  reductase  was  the  limiting  factor  (this  was 
determined previously,  Figure  4.11),  therefore,  the  amount  of NAD  added  to  the 
reaction was in excess.  If NAD was the limiting factor the cofactor would have been 
recycled  14  times,  but  theoretically  a  much  higher  number  was  achieved  by  the 
enzyme.  The results show that this method can be used for the bioreduction of 6- 
bromo-(3-tetralone to 6-bromo-p-tetralol, and the enzymes and cofactors can also be 
reused (Figure 4.15).  In the second pass, the same quantity of substrate was added 
to the reaction mixture  (the product  and unconverted  substrate was removed from 
pass  1   by in situ product adsorption and removal).  Compensation was made for the 
loss of cofactors and enzymes during the assay process.  It is evident from the results 
that the enzyme  and cofactors  can be  used  in multiple passes  (Figure 4.16).  The 
second pass follows a similar reaction profile to the first pass.  Complete conversion 
was not met in either case, with the second pass showing lower conversion than the 
first pass.  This could be because the scale of the experiments was small and protein 
could adhere to surfaces such as the reaction vessel or pipette tips.  Compensation 
was also not made for the loss of reaction components in the dead space of the XAD 
resin in the initial pass  and also  losses  in the  filtering process.  The results show,
125under the operating system used, that the enzyme was stable enough in its free form 
to perform a multiple batch reaction; the batch reactor configuration employed also 
indicates  that  there  was  successful  recycling  of the  enzymes  and  regeneration  of 
NADH.
1.  Addition o f enzym es and substrates
2. Vessel  shaken  on an orbital shaker 
until reaction complete.
6.  Enzymes 
and cofactors 
are recycled
3.  Adsorption resin 
added to the 
reaction mixture.
4.  Mixture is filtered to remove the 
adsorption resin.
5.  The product is 
desorbed from  resin 
with a solvent.
Figure 4.14 Reaction Methodology
Reaction  methodology for the  batch production  of 6-bromo-/3-tetralol with  in situ 
product removal.  The enzymes, substrates,  and cofactors are added to the reaction 
vessel and mixed until the reaction reaches completion.  The polymeric resin is then 
added to the vessel and the product and unconverted substrate adhere to the resin. 
The resin  is  then filtered and the product is desorbed from  the resin  by a solvent. 
The enzymes and cofactors are then recycled and used in another reaction.
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Figure 4.15 Regenerative Bioreduction Pass 1
This  graph  illustrates  the  bioconversion  of 6-bromo-f3-tetralone  to  6 -bromo-f- 
tetralol with NADH regeneration via the oxidation of  formate to carbon dioxide by 
formate  dehydrogenase  and NAD.  The  concentration  of 6-bromo-j3-tetralone  is 
lg/L,  and  tetralone  reductase  and NAD(H)  are  recycled  after  4hr  using  in  situ 
product  removal.  The  reaction  was  completed  in  batch  operation  with  all 
components in  the same reaction  vessel.  The results demonstrate that an effective 
free  enzyme  bioconversion  with  cofactor  regeneration  can  be  applied for  the 
reduction of 6 -bromo-(3-tetralone.  After 4hrs the product and remaining substrate 
were removed using the previously screened XAD resin L-323,  thus, separating the 
enzymes  and  cofactors from  the product  and  remaining  substrates.  (Reference 
Section 4.2.15 for methodology).
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Figure 4.16 Regenerative Bioconversion Pass 2
This  graph  illustrates  the  bioconversion  of 6-bromo-(3-tetralone  to  6-bromo-(3- 
tetralol with NADH regeneration for the second batch.  The product and remaining 
substrate  are  separated from  the  enzymes  and  cofactors  which  have  already 
completed a first  batch  reaction.  A further quantity  of substrate  is added to  the 
reaction  mixture for the second pass.  This graph  shows  that an  isolated enzyme 
cofactor regenerating system can be used in a multiple pass system and the isolation 
of the product  and substrate  via  a polymeric  resin  can  be  used as  a  separation 
method.  (Reference Section 4.2.16 for methodology).
1284.4  Discussion
Continuously  operating  bioreactors  for  large-scale  isolated  oxidoreductase 
bioreductions with  cofactor regeneration  requires  biotechnology which can ensure 
the reuse of the enzyme and the cofactor.  The difficulty posed is two-fold, firstly, 
the stability of oxidoreductases at high substrate and product concentrations is low. 
Secondly, the substrates and products are often relatively similar in size to cofactors 
and thus separation through conventional membranes is not an option (Wichman and 
Wandrey,  1981).  The investigation into the tetralone reductase system, a cofactor- 
requiring  system,  in  a  continuously  operating  bioreactor  produced  a  number  of 
issues.  One of these issues was that during the immobilisation of tetralone reductase 
onto  Eupergit  C®  it  was  found  that  both  the  substrate  and  the  product  had  also 
adsorbed to the support.  This meant that the enzyme could not be separated from the 
substrate and product via conventional separation methods.  The hydrophobic nature 
of the  substrate  and  product,  and  the  hydrophilic  nature  of the  enzymes  was  the 
foundation for the design of a novel bioreactor configuration, where the product and 
unconverted substrate were removed from the reaction via an adsorbent resin.  This 
design exploits product (and unconverted substrate) immobilisation methods rather 
than enzyme immobilisation methods.  It is this type of bioreactor design which was 
deemed most  appropriate  for the bioreduction of 6-bromo-p-tetralone by tetralone 
reductase  with  cofactor  regeneration  via  the  enzymatic  oxidation  of  formate  by 
formate dehydrogenase.  This method of product removal, and cofactor and enzyme 
reuse, was proved for a number of batches,  where, the cofactors and free enzymes 
upon completion of the bioreduction were available to be used in further reactions. 
The  principles  of  this  type  of  bioreactor  configuration  were  proven  at  scale; 
however,  in  the  tetralone  reductase  case,  the  low potency of the  enzyme  was  the 
limiting component in the reaction.  The low potency of tetralone reductase meant 
that  the  bioreduction  of 6-bromo-P-tetralone  to  6-bromo-p-tetralone  was  the  rate- 
limiting  step.  The bioreactor system  may have been  improved by increasing the 
amount of tetralone reductase available;  increasing the enzyme concentration could 
potentially  be  achieved  through  over-expression  of  the  enzyme  into  a
129microorganism.  This would most likely increase the  efficiency of the purification 
and  thus  produce  greater  amounts  of  tetralone  reductase.  A  higher  tetralone 
reductase  concentration  in  the  reaction  would  mean  that  the  bioreduction  of 6- 
bromo-(3-tetralone would not necessarily be the rate-limiting step.
A  large-scale  generic  method  for  the  application  of  this  type  of  two  enzyme 
cofactor-requiring system has been configured (Figure 4.17).
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Figure 4.17 Theoretical Design of a Bioreactor with in situ Product Removal
The bioreactor configuration shows the reaction vessel which would contain all the 
substrate,  enzymes,  and cofactors;  after the reaction  had reached final conversion 
the reaction mix would pass though a polymeric resin column where the product and
130remaining  substrate  would  adhere  to  the  column.  The  remaining  enzymes  and 
cofactors  would pass  though  the  column  into  the  reaction  mixture  where  the 
quantities could be topped up by exogenous amounts.  The product adsorbed onto 
the resin could be eluted by a solvent wash and collected in an appropriate vessel.
This would work by adding the substrates,  enzymes and cofactors together into the 
bioreactor  to  carry  out  the  asymmetric  synthesis.  After  the  reaction  reached 
completion, the reaction mixture would then be passed down a column of XAD L- 
323 resin where the product would bind and the enzymes and cofactors would be 
recycled back into the reactor where more substrate could be added.  More enzyme 
and cofactor could also be added along with the substrate to top-up the volume as 
there may be  losses  in  the  XAD  column.  The product would be eluted  from the 
XAD resin using a solvent, in this case, ethanol.  Using ethanol as an eluant would 
give a final product concentration of lOg/L.  A higher product concentration could 
be achieved by using a solvent with a higher solubility of 6-bromo-P-tetralol.  The 
batch reactor configuration established for the regenerative bioreduction of 6-bromo- 
p-tetralone  is  convenient  for  use  in  the  laboratory-scale  but  it  has  a  number  of 
disadvantages.  Firstly,  the physical  separation  of the  components  in the  reaction 
solution  requires  an  additional  step.  This  extra  step  in  the  model  system  is  the 
addition of the polymeric resin for the adsorption of the product, and is required for 
successful recycling the cofactor and enzymes from one batch to the next.  Secondly, 
there  is  inhibition  of  tetralone  reductase  by  NADH  but  the  effects  of  this  are 
removed by using a cofactor regeneration system.  Thirdly, processing of 6-bromo- 
p-tetralone  and  6-bromo-p-tetralol  requires  high  dilutions  and thus  larger reaction 
volumes due to their low aqueous solubility.
Improvements  to  the  current  system  would  include  increasing  tetralone  reductase 
concentration  and  thus  reducing  the  reactor  volumes.  This  could  be  achieved 
through  over-expression  of  the  enzyme  into  a  microorganism.  Currently,  the 
enzyme concentration in Trichosporon capitatum (MY 1890) is assumed to be in the
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number of consequences.  It would potentially increase enzyme stability (Johnson et 
ciL,  1978),  the  purification  stages  may  be  easier  and  the  reaction  rates  would 
potentially increase.
The reaction configuration discussed previously is not limited to  free two-enzyme 
systems with cofactor regeneration.  For example,  in the model system if both the 
enzymes (FDH and tetralone reductase) could be immobilized using a resin which 6- 
bromo-P-tetralone and 6-bromo-p-tetralol did not adhere onto, the same bioreactor 
methodology could still be used (Figure 4.18).
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Figure 4.18 Theoretical Method  for the Use of Resins in Continuous Operation.
The synthetic and regenerative enzymes are immobilized onto a resin in a column, 
the substrate  is passed through  the  enzyme  column  and converted,  the product is 
then passed through  an  adsorption  column  along with  the cofactors.  The product 
binds  to  the  adsorption  resin  but  the  cofactors pass  through  the  column  and are 
recycled back into the enzyme column with more substrate.  The columns could be 
duplicated,  thus allowing the adsorption  onto one column  whilst the elution of the 
product from the other column was occurring.
The  immobilized  enzymes  could  be  retained  in  a  column  where  the  cofactor and 
other reaction components could be passed through the immobilized enzyme column
132where the reaction would take place.  The reacted components would then be passed 
through  an  XAD  column  where  the  product  (and  unconverted  substrate  would 
adsorb),  recycled  cofactors,  and  new  substrate  would  be  recycled  back  into  the 
immobilized enzyme bioreactor column in continuous operation
Solid phase components applied for in situ product adsorption have the potential to 
be used  in a number of other biocatalytic  systems  (not just for cofactor requiring 
enzyme applications) including:
1.  Whole cell biocatalysis, where the product can be removed from the reaction 
solution onto a resin, however, there may be difficulties in using whole cell 
microorganisms  in  such  applications  as  there  could  be  the  difficulty  in 
separating the biomass from the resins.
2.  Solid  phases  could  also  be  useful  in  systems  where  there  is  difficulty  in 
immobilizing the enzyme,  such as in the tetralone reductase case,  where it 
was proposed that instead of immobilizing tetralone reductase to separate it 
from the substrate and products, the product should be immobilized instead.
3.  The application of a solid phase resin may be useful in biocatalytic systems 
which  have  compounds  which  exhibit  low  solubility  in  aqueous 
environments.  Instead of using a solvent, the substrate could be pre-bound 
onto the resin and then added to the reaction solution.  This removes the need 
for adding a third component such as a solvent to increase the solubility of 
the substrate.
4.  There may also be the need to control the amount of substrate and product 
delivered if the  components  are  toxic  to  the biocatalyst,  and this  could be 
achieved using the substrate adsorbed to a solid phase.
A common problem of many oxidoreductase processes is the substrate and product 
toxicity to the cell.  Methods to deliver substrates via an adsorption resin to control 
the addition of the substrate and also to use the same resin to capture the product are
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reduction of a methyl benzyl ketone via Baker’s yeast (Anderson et al.,  1995).  The 
substrate was  adsorbed  onto XAD  7  and added to the reaction mix.  The substrate 
diffused into the solution, was reduced by the microorganism, and then re-adsorbed 
back onto the resin.  The adsorbent resin, XAD 7, has also been used to reduce the 
toxicity of a substrate and its respective product to a microorganism in a whole cell 
stereoselective ketone reduction (Vicenzi et al.,  1999).  In this system, XAD 7 was 
used  as  a  method  of  substrate  delivery  and  product  removal.  3,4-methylene- 
dioxyphenyl  acetone  was  reduced  to  the  corresponding  £-3,4-methyl  ene- 
dioxyphenyl isopropanol in greater than 95% isolated yield and 99.9% enantiomeric 
excess.  The supply of the substrate and the removal of the product via a polymeric 
hydrophobic resin allowed the reaction concentration to be increased from 6g/L to 
40g/L, with an overall productivity of 75g/L/day.  This method of substrate delivery 
and  product  removal  has  also  been  described  for  the  Baeyer-Villiger  oxidation, 
where  the  yield  was  increased  from  lg/L  to  20g/L  (Simpson  et  al.,  2001).  The 
Baeyer-Villiger  oxidation  has  also  been  applied  in  a bubble  column  reactor with 
substrate  delivery  and  product  adsorption  using  a polymeric  resin  (Hilker  et  al., 
2004).  The results gave similar productivities to previous experiments by the same 
group.  More  recently,  resins  have  been  applied  in  immobilised  enzyme  systems 
where the substrate was  delivered using Amberlite (IRA 400) resin  (Rojanarata et 
al.,  2004).  The  methods,  which  had  not  been  optimised,  improved  the  product 
concentration by 4-fold.  Enhanced enantioselectivity,  chemoselectivity and space­
time yields for biotransformations of a,(3-unsaturated carbonyl compounds through 
the use of absorbing  resins  have  also been reported  (D’Arrigo  et al.,  1997,  1998) 
(Nakamura et al.,  2002)  (Houng  and  Liau,  2003).  In  cases  as just  described,  the 
properties of the  substrate  and  the product must be such that the  substrate can be 
easily desorbed from the adsorbent resin and the product easily adsorbed back onto 
the  resin.  The  limitations  of  this  method  would  depend  upon  the  affinity  the 
substrate and product have for the resin.  This theory has recently been confirmed 
(Straathof,  2003)  where  it  is  suggested  that  the  charge  and  the  solubility  of the
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usefulness/limitations of adsorption resins for substrate delivery and removal.
The  employment  of solid phase  resins  in biocatalytic  reactions  has  served to:  (1) 
control the movement of substrates and products, and (2) enhance enantioselectivity. 
The discovery of resins for these applications is in its infancy and may have wide- 
ranging  possibilities  in  biocatalytic  reactions  for  whole  cell  biocatalysts, 
immobilised  enzymes,  and  free  enzymes.  A  solid  phase  method  of  substrate 
delivery and product removal removes the requirement for the addition of solvents in 
these reactions  and,  thereby,  removing  any compromise between  enzyme  stability 
and  solvent  type  and  volume.  If 6-bromo-P-tetralone  could  be  delivered  to  the 
aqueous  enzyme  solution  and  6-bromo-p-tetralol  extracted  from  the  aqueous 
solution by the use of adsorbent resins, this would potentially have a great impact on 
the  reaction  efficiency.  The  removal  of  solvent  completely  from  the  reaction 
solution would serve to maintain enzyme activity;  delivery of the substrate via the 
use of an adsorbent resin would control the amount of substrate in the reaction at any 
one time and limit substrate inhibition.  Removal of the product by selecting a resin 
with  a  high  affinity  for  the  product  would  ensure  that  there  is  limited  product 
inhibition.  However, 6-bromo-p-tetralol has a higher solubility in aqueous solutions 
than  6-bromo-P-tetralone,  and  therefore  the  resin  selected  to  deliver the  substrate 
may not be appropriate to remove the product  from the  aqueous  solution.  In this 
case it may be appropriate to use two types of resin, where one which exhibits a high 
affinity  for  6-bromo-p-tetralone  is  used  to  deliver  the  substrate,  and  one,  which 
exhibits  a  high  affinity  for  6-bromo-p-tetralol  is  used  to  extract  the  product.  A 
method  which  uses  two  different  resins  for  the  substrate  delivery  and  product 
removal would still be applicable to cofactor requiring enzymes.  It may, however, 
be necessary to screen the adsorbent resins, in particular, the resin which is used for 
the  adsorbance  of  the  lower  solubility  compound  for  the  adsorbance  of  the 
hydrophilic cofactors and enzymes to ensure that the cofactors and enzymes do not 
adsorb.  If either the cofactor or the enzyme adsorbed onto the resin then it would be
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reaction due to the high cost of cofactors would not be efficient.
4.5  Summary
Tetralone  reductase  can  be  used  as  a  free  enzyme  in  a  low  solvent  single  phase 
system  for  the  bioreduction  of  6-bromo-P-tetralone  to  6-bromo-P-tetralol,  with 
cofactor  regeneration.  The  immobilisation  of  tetralone  reductase  onto  a  solid 
support to facilitate a continuously operating bioreactor was not possible due to the 
subsequent  adherence  of  6-bromo-p-tetralone  and  6-bromo-p-tetralol  to  the 
immobilisation  support  (Eupergit  C™).  This  adsorbance  phenomenon  was 
employed  instead  to  promote  in  situ  removal  of  the  product  and  unconverted 
substrate.  An  alternative  bioreactor  configuration  was  established  for  the 
bioreduction  of  6-bromo-p-tetralone  by  tetralone  reductase.  In  the  bioreactor 
configuration,  the  reaction  components  were  added  together  in  batch,  and  the 
regeneration of NAD(H) was completed by the addition of formate dehydrogenase 
(FDH) and formate.  The bioreduction was monitored and after the reaction showed 
completion, XAD L-323 was added to the reaction mixture and the product adsorbed 
from the reaction mix  onto the resin.  The resin was  filtered  and the product was 
eluted from the XAD resin in a highly pure form using a solvent.  The remaining 
components  (tetralone  reductase,  FDH  and NAD(H))  were  recycled back  into the 
reactor, where more substrates were added and the reaction continued.  This method 
was successful for at least two reaction passes.  It is possible that the system could 
be improved further by the application of resins to introduce the substrate as well as 
separate the enzyme from the product.
In the  following chapter,  the  whole cell  biocatalyst,  Trichosporon  capitatum  (MY 
1890), will be characterised with respect to the substrate delivery, solvent tolerance, 
and  the  process  requirements;  this  will  then  allow  a  comparison  of the  isolated 
enzyme and whole cell biocatalysts systems.
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the Whole Cells of Trichosporon capitatum 
(MY 1890)
5.1  Introduction
The  vast  majority  of  enantioselective  bioreductions  for  the  synthesis  of  chiral 
alcohols  are  conducted  using  intact  whole  cells  (Straathof et  al.,  2002).  This  is 
because  firstly,  the fermentation technology is  available and  already in place,  and 
secondly, no external cofactor regeneration is required as the regeneration is carried 
out as part of the cells own metabolism.  Whole cell oxidoreductases have been used 
for  both  laboratory  and  large  scale  syntheses  of  pharmacologically  valuable 
compounds,  many  of which  have  been  reviewed  (Zaks  and  Dodds,  1997).  The 
bakers’  yeast Saccharomyces cerevisiae is one of the favoured model organisms for 
basic biological  research  and  was  the  first  eukaryote  whose  genome  was  entirely 
sequenced  (Dujon,  1996).  As  a  consequence  of  this,  the  potential  for  this 
microorganism  as  a  valuable  biocatalyst  has  greatly  improved.  Saccharomyces 
cerevisiae has also been has been  successfully exploited to carry out a large-scale 
bioreductions (Kometani  et al.,  1993).  The difficulties associated with whole cell 
biocatalysis  include;  competing  reactions,  mass  transfer  limitations  and  difficult 
downstream  processing.  Some  competing  enzymes  may  be  eliminated  by  media 
optimisation,  which  can  alter  the  cells  metabolic  pathway  (Reddy  et  al.,  1996). 
Stereoselectivity  can  also  be  improved  by  genetic  engineering.  This  has  been 
observed  in  bakers’  yeast  where  reductases  were  either  knocked  out  or 
overexpressed (Rodriguez et al.,  1999).  Mass transfer limitations through the cell 
membranes mean that catalytic activities of many intracellular enzymes are not seen 
to be adequately exhibited by the whole cells. This may be due to the permeability 
barrier  of  the  cell  membrane  to  the  substrates  and  products.  Mass  transfer 
limitations can also occur because lipophilic substrates and products can incorporate 
themselves  into  the  cell  membranes  (Angelova  et  al.,  1999).  In  the  case  of the 
hydroxylation of steroids, the hydroxylated product exhibits a higher solubility than
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1999).  This, however, is only the case for steroids, and products with lower aqueous 
solubilities  may  accumulate  in  the  membrane  and  other  cell  surfaces  causing 
irreparable  cell  damage.  The  accumulated  lipophilic  products  can  only usually be 
removed  by the  addition  of a  solvent  therefore  preventing  the  reuse  of the  cells. 
Lipophilic  compounds  such  as  steroids  and  their  problems  have  been  reviewed 
(Angelova et al.,  1999).  Whole  cell  biocatalysis  in  organic  media has  also been 
reviewed (Leon et al.,  1998).  The objectives of this Chapter are to investigate the 
bioreduction  of  6-bromo-p-tetralone  by  the  whole  cells  of  a  soil  organism 
Tricosporon capitatum (MY 1890).  To determine the potential for using the cells in 
the  bioreduction  the  following  factors  will  be  investigated:  bioreduction 
methodology  (e.g.  growing  cells/  resting  cells),  the  effects  of  solvent  on  the 
bioreduction,  the  effects  of  substrate  on  the  bioreduction,  also  potential 
improvements to the whole cell biocatalytic system will be discussed.
5.2  Analytical Techniques
5.2.1  Extraction of Substrate and Product  from the Cell
The substrate and product were extracted from the cell suspension by addition of the
same  volume  of solvent  to  cells.  The  solutions  were  vortexed  to  mix  and  then 
centrifuged  for  lOmin  at  lOOOOrpm.  The  supernatant  was  used  to  determine  the 
quantities  of 6-bromo-P-tetralone  and  6-bromo-P-tetralol  using  the  HPLC  assay 
(Chapter 2.8.2).
5.3  Materials and Methods
5.3.1  Production ofTrichosporon capitatum (MY 1890)
lml of frozen Trichosporon capitatum (MY  1890) stock was used to inoculate 50ml
of media, the cells were incubated at 28°C for 48hr.  The final dry cell concentration 
was 18g/L.
1385.3.2  Whole Cell Bioconversion of 6-bromo-(3-tetralone
50ml of cells were grown to a dry cell weight of 18g/L in a 250ml Erlenmeyer flask.
5ml and 10ml of a lOg/L 6-bromo-p-tetralone in ethanol solution were added to the 
50ml  cell  solutions.  The  cells  were  agitated  on  an  orbital  shaker.  The 
bioconversions were monitored by assaying for 6-bromo-p-tetralone and 6-bromo-p- 
tetralol using the HPLC assay (Chapter 2.7.2).
5.3.3  Product Recovery Methods
Cells were grown to a dry cell weight of 18g/L; 9 x  10ml were aliquoted into 50ml 
reaction vessels.  1ml of a lOg/L 6-bromo-P-tetralone in ethanol solution was added 
to the cells (final substrate concentration  lg/L).  The bioconversion was allowed to 
proceed for 2hrs.  Nine methods of product (and unconverted substrate) extraction 
techniques were employed:
a.  The first method measured the amount of 6-bromo-p-tetralone and 6-bromo-P- 
tetralol in the supernatant after the reaction mix had progressed for 2hrs.
b.  The second method left the reaction to progress for 2hrs, sonicated the cells for 
5  passes  (lOsecs  on,  lOsecs  off  at  8MHz),  and  then  the  supernatant  was 
assayed for 6-bromo-P-tetralone and 6-bromo-p-tetralol.
c.  The  third  method  was  as  the  method  2,  but the  cells  were  sonicated  for  10 
passes.
d.  After the cells had been left to progress  for two hours,  1ml of the cells was 
aliquoted  into  an  Eppendorf  and  1ml  of  ethanol  added,  and  then  the 
supernatant was measured for 6-bromo-P-tetralone and 6-bromo-P-tetralol.
e.  The fifth method was  the  same  as  the  fourth  method  except  1ml  of acetone 
was used instead of ethanol.
f.  This method used sonication as 2 and then 1ml  of ethanol was added as 4.
g.  As 6, but acetone instead of ethanol was used.
h.  As 4, but 2ml of ethanol was used in 1ml of cells.
i.  As 8, but acetone was used instead of ethanol.
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of the  cells  for  lOmin  at  lOOOOrpm.  The  assay  for  6-bromo-p-tetralone  and  6- 
bromo-p-tetralol was completed by HPLC (Chapter 2.7.2).
5.3.4  Bioconversion with Substrate and Product Extraction
50ml of cells were grown to  18g/L (dew);  10ml of the cells were aliquoted into 4 x
50ml reaction vessels.  Volumes of 250pl, 500pl,  lml,  1.5ml of a lOg/L 6-bromo-p- 
tetralone  in  ethanol  were  added  to  the  cell  solutions.  The  reaction  vessels  were 
shaken on an orbital shaker.  The bioconversions were monitored by assaying for 6- 
bromo-p-tetralone and 6-bromo-p-tetralol using the HPLC assay (Chapter 2.7.2).
5.3.5  The Effects of  Removing the Growth Media
50ml of cells were grown to  18g/L (dew) and harvested by centrifugation (Beckman 
Coulter,  J2  Ml).  The  pellet  was  re-suspended  in  50ml  of  lOmM  Tris  pH7,  re­
centrifuged and re-suspended in 50ml  lOmM Tris pH7.  10ml of the washed cells 
were aliquoted into 4 x 50ml Sterelin™ tubes and then 250pl, 500pl,  lml, and 1.5ml 
of a  1  Og/L 6-bromo-p-tetralone in ethanol solution were added to the cell solutions. 
The Sterelin™ reaction vessels were shaken continuously on an orbital shaker.  The 
bioconversions were monitored by assaying for 6-bromo-p-tetralone and 6-bromo-p- 
tetralol using the HPLC assay (Chapter 2.7.2).
5.3.6  The Effects of  Ethanol and Methoxyethanol
50ml of cells were grown to  18g/L (dew);  10ml of the cells were aliquoted into 8 x 
50ml  reaction  vessels.  6-bromo-P-tetralone  in  ethanol  was  added  to  4  x  cell 
solutions to  give initial  substrate concentrations  of 0.5g/L,  lg/L,  1.5g/L and 2g/L; 
the respective volumes of solvent were 5%  10%  15% and 20%.  This was achieved 
using a stock solution of lOg/L.  6-bromo-P-tetralone in methoxyethanol was added 
to 4 x  cell solutions to give initial substrate concentrations of 0.5g/L,  lg/L,  1.5g/L
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was achieved using a stock solution of 120g/L.  The reaction was run for 7hr and the 
samples were taken and assayed by HPLC  (Chapter 2.7.2)  for 6-bromo-p-tetralone 
and 6-bromo-P-tetralol at defined time points.
5.5.7  The Effects of Solvent Volume
50ml  of  cells  were  grown  to  18g/L  (dew)  and  10ml  aliquoted  into  5  x  50ml 
Sterelin™ tubes.  Stock solutions of 50.5g/L, 25.5g/L,  13g/L, 6.75g/L and 4.7 g/L of 
6-bromo-p-tetralone in methoxyethanol  solution were  added to the cells in  lOOpl, 
200pl,  400pl,  800pl,  1200pl  volumes  respectively.  This  produced  an  initial 
substrate concentration of 0.5g/L in each tube.  The reaction was run for 6.5hr and 
the  samples  were  taken  and  assayed  by  HPLC  (Chapter  2.7.2)  for  6-bromo-p- 
tetralone and 6-bromo-p-tetralol at defined time points.
5.3.8  The Effects of  Initial Substrate Concentration
50ml  of  cells  were  grown  to  18g/L  (dew)  and  10ml  aliquoted  into  6  x  50ml 
Sterelin™  tubes.  6-bromo-p-tetralone  was  dissolved  in  lOOpl  of methoxyethanol 
and added to the cells to give final substrate concentrations of 0.5g/L,  lg/L,  1.5g/L, 
2g/L, 2.5g/L, 3g/L.  The reaction was run for 7.5hr and the samples were taken and 
assayed by HPLC (Chapter 2.7.2) for 6-bromo-P-tetralone and 6-bromo-p-tetralol at 
defined time points.
5.3.9  The Effects of  Exogenous Quantities of  NADH
50ml  of  cells  were  grown  to  18g/L  (dew)  and  10ml  aliquoted  into  4  x  50ml
Sterelin™ tubes.  NADH was added to the cells with lml of Og/L (control), 0.25g/L, 
0.5g/L,  0.75g/L NADH  in  lOmM  Tris  buffer pH7.  The  reactions were  initiated 
using  lOOpl  of a  lOOg/L  tetralone  in  methoxyethanol.  The  bioconversions  were
141monitored  by  assaying  for  6-bromo-(3-tetralone  and  6-bromo-p-tetralol  using  the 
HPLC assay (Chapter 2.7.2).
5.3.10  Growth ofE. coli
0.5ml  of frozen E.  coli  JM107  pQR711  stock was  used to  inoculate  50ml  of LB 
media (lOg/L bactotryptone,  lOg/L NaCl, 5g/L yeast extract).  The cells were left to 
grow at 37°C for 16hr on an orbital shaker.
5.3.11  The Effects of 6-brom o-p-tetralone on E. coli JM10 7pQR 711
Cells of is.  coli were aliquoted into 5 x  10ml samples, where  lml, 0.75ml, 0.5ml or
0.25ml of a  lOg/L 6-bromo-P-tetralone in ethanol  solution was added to the cells. 
The cells were mixed on an orbital shaker and the supernatant assayed after lhr and 
3hr.  The cells were vortexed in ethanol, centrifuged and the supernatant assayed by 
HPLC (Chapter 2.7.2) for 6-bromo-p-tetralone and 6-bromo-p-tetralol.
5.4  Results
5.4.1  Whole Cell Bioconversion of 6-bromo-p-tetralone
A whole  cell  bioconversion  was  carried  out  to  show that  Trichosporon  capitatum
(MY 1890) can convert 6-bromo-p-tetralone into 6-bromo-p-tetralol.  Analysis of the 
quantities of 6-bromo-p-tetralone and 6-bromo-P-tetralol in the reaction mix during 
the  course  of the  bioconversion  showed  that  (under  the  conditions  used  in  the 
bioreduction) a full mass balance of the reaction components was not obtained.  The 
results  showed  that  6-bromo-p-tetralone  was  removed  from  the  reaction  mixture 
within  lhr  of the  reaction  starting  but  a  concurrent  increase  of product  was  not 
visible (Figure 5.1).  After lhr when an initial 6-bromo-P-tetralone concentration of 
0.5g/L  was  used,  there  was  approximately  0.15g/L  of  6-bromo-P-tetralol  and 
0.02g/L  of 6-bromo-P-tetralone  in  solution.  Thus,  0.33g/L  of either  substrate  or 
product was not measured in the supernatant.  Similar results can also be observed at
142different substrate and solvent concentrations (Appendix B1.3  and B1.4). Under the 
conditions used for the bioreductions  and the associated methods  it currently does 
not prove that an efficient bioreduction  is possible.  One reason that the  substrate 
and  product  were  not  accounted  for  may  be  that  they  degraded  into  components 
which  did  not  show  up  during the  analysis.  Another reason  that the  components 
were not accounted may be because the substrate and product were not secreted into 
the cell environment and became associated within the cell membrane.  Diffusion of 
a  substrate  across  the  cell  membrane  is  strongly  correlated  with  the  molecule’s 
solubility in lipids (Bailey and Ollis,  1986), and the model substrate and product are 
lipophilic compounds.  It is hypothesized that the mass balance can be completed by 
analysing the cell debris.
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Figure 5.1 Whole Cell Bioconversion
A whole cell bioconversion of 6-bromo-P-tetralone (• ) to 6-bromo-(3-tetralol  (■). 
Initial  substrate  concentration  0.5g/L  (—)  with  a  solvent  concentration  5%  (v/v). 
The graph illustrates how the substrate is rapidly removed from the aqueous media 
but a concurrent increase in product is not observed.  Results using higher levels of
1436-bromo-p-tetralone  are  shown  in  Appendix  B  1.3  and  1.4.  (Reference  Section
5.3.2 for methodology)
5.4.2  Product Recovery Methods
The results from  Section  5.4.1  demonstrated that a high percentage of the product 
and unconverted substrate is not in the aqueous phase surrounding the cells, but was 
most likely associated with the cells.  Experiments were set up to show that a full 
mass balance  could be  achieved by  extracting  the  substrate  and product  from the 
centrifuged cell debris.  A number of different techniques were employed to try to 
discover which method would be the most effective.  Cells were incubated with lg/L 
of 6-bromo-P-tetralone for 2hr; the cells were then put through a number of different 
disruption techniques.  The results show (Figure 5.2) that when  lg/L of substrate is 
used the amount of product and substrate in the aqueous phase surrounding the cells 
after centrifugation  is  approximately 20%.  Sonication  (5-10 passes  at  8mH)  was 
used  a  method  to  break  open  the  cells,  however,  this  method  of extracting  the 
substrate and product only brought about a 40% recovery.  The low recovery of the 
substrate and product by sonication means that 6-bromo-p-tetralone and 6-bromo-P- 
tetralol most likely have  a high  affinity to  a component of the cell.  Therefore,  to 
remove the substrate and product from the cell a solvent with a high solubility of the 
reaction  components  may  be  required.  Ethanol  and  acetone  were  both  used  to 
extract and recover 6-bromo-p-tetralone and 6-bromo-p-tetralol from the cells.  This 
was the most efficient method of removing the substrate and product from the cells. 
This could have been caused by the hydrophobic tendencies of the solvent disrupting 
the cells by altering the hydrophobic structure of the cell membrane.  It is also likely 
that  there  is  a  favourable  partition  of 6-bromo-p-tetralone  and  6-bromo-P-tetralol 
into the solvents.  Extraction by the addition of a solvent was also the simplest and 
most effective method to obtain a mass balance.  These results show that a full mass 
balance can be achieved for the substrate and product,  but the extraction has to be 
done via a solvent (not sonication),  since it is likely that the substrate and product 
accumulate in the cell, probably on the cell membrane.
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Figure 5.2 Methods of Substrate and Product Recovery
Methods of substrate and product recovery:  (a)  Concentration  in  the supernatant, 
(b)  Concentration  in  supernatant  after  a  5 pass  sonication  (10  seconds  on,  10 
seconds off at 8 mH) and centrifugation,  (c) Concentration in supernatant after a 10 
pass  sonication  (10  seconds  on,  10  seconds  off at  8 mH)  and  centrifugation,  (d) 
Extraction with  lml ethanol,  (e) Extraction  with  lml acetone,  (f) Extraction as  (b) 
and then addition of lml ethanol then centrifugation,  (g) Extraction as (c) and then 
addition  of lml acetone  then  centrifugation,  (h)  Extraction  with  2ml  ethanol,  (i) 
Extraction with 2ml acetone.  (Reference Section 5.3.3 for methodology).
1455.4.3  Whole Cell Bioconversion of 6-bromo-P-tetralone with Recovery 
Four  bioconversions  were  run  using  substrates  at  different  concentrations  to
investigate the whole cell bioreduction.  Solvent extraction was used to remove the
product and unconverted substrate.  Ethanol was used to solubilise the substrate; this
in itself was a constraint since the low solubility of 6-bromo-p-tetralone in ethanol
meant that as the  substrate concentration was  increased,  the  solvent concentration
also needed to be increased.  The results show (Figure 5.3) that the bioconversion of
6-bromo-p-tetralone  to  6-bromo-p-tetralol  takes  between  approximately  2  and  6
hours.  This  is most  likely dependent upon the  initial  substrate concentration and
also the volume of solvent added to the reaction mix.  The results also show that
under the conditions used,  a product concentration of 0.8g/L could be obtained;  a
higher concentration could potentially been obtained by optimising the system.  The
system  which  had  a  low  initial  substrate  concentration  (0.2g/L)  neared  100%
conversion;  however,  increasing  the  initial  substrate  concentration  decreased  the
amount converted in the allotted time period.  The trend in the graph also shows that
running the reaction for an extended period of time would probably not bring about a
100%  conversion  in  the  other  systems.  This  reduction  in  conversion  is probably
caused by the inhibitory effects of high substrate and solvent concentrations causing
irreparable damage to the cell  metabolism.  At the higher substrate concentrations
there  may  also  be  effects  of product  inhibition  which  are  not  seen  at  the  lower
substrate concentrations.  The effects of substrate and solvent concentration on the
biocatalytic  reaction  rates  and  conversions  are  discussed  in  greater  detail  in  this
chapter.  In general, these results suggest that there are a number of components in
the  reaction  which  constrain  the  bioconversion  (even  at  low  levels  of substrate).
This could be the effects of solvent,  substrate or product on the enzyme.  It is also
probable that there is not one component which limits the bioreduction;  it is likely
that  there  is  a  combination  of  effects  which  limit  the  bioreduction.  Further
investigation  is  required  into  the  effects  on  the  biocatalyst  using  each  of  the
components  individually.  This  can  be  accomplished  by  maintaining  either  the
146substrate or solvent concentration  at a set value  and varying the other component; 
this is discussed later in this chapter.
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Figure 5.3 Whole cell Bioreduction of 6-bromo-[3-tetralone to 6-bromo-[3-tetralol
A  lOg/L solution  of 6 -bromo-p-tetralone in  ethanol was added to  10ml of cells  in 
volumes of 2.4%,  0.5%,  9.0%,  13.0% to give respective substrate concentrations of 
0.2g/L ( M ) ,  0.5g/L ( 0 ) , 0.9g/L (V), 1.3g/L (A).  6 -bromo-[3-tetralone and 6 -bromo- 
p-tetralol were extracted from the cells via the addition of a solvent,  centrifugation 
was  used to pellet  the  cell debris.  The supernatant  was  assayed for  6 -bromo-p- 
tetralone  and  6 -bromo-[3-tetralol.  The  graph  shows  that  the  bioreduction  of 6 - 
bromo-(3-tetralone  to  6 -bromo-[3-tetralol  can  be  achieved  by  the  addition  of  6 - 
bromo-(3-tetralone in ethanol, however, there are effects on the rates of reaction and 
the conversions by increasing either the substrate and/or the solvent concentration. 
(Reference Section 5.3.4 for methodology).
1475.4.4  Comparison of Growing and Resting Cells
A  comparison  of the  growing  cells  of  Trichosporon  capitatum  (MY  1890)  was 
investigated  to  determine  which  of the  reaction  systems  would  have  potentially 
higher  reaction  rates  and  conversions.  For  cell  isolation,  the  media  components 
from the growth of the cells of Trichosporon capitatum  (MY  1890) were removed 
by  pelleting  the  cells  by  centrifugation,  decanting  the  growth  media,  and  re- 
suspending  the  cells  in  Tris  buffer.  The  washed  cells  were  then  used  in  the 
bioconversion of 6-bromo-p-tetralone at the same concentration used in the growing 
cells.  Results  show  that  the reaction  rates  and  final  conversion  values  of the  re­
suspended cells were lower than compared to the cells in the growth media (Figure
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Figure 5.4 Comparison of  Resting and Growing Cell Biocatalytic Activity
The  bioreduction  of 6 -bromo-/3-tetralone  to  6 -bromo-(3-tetralol  using resting cells 
(MO) and growing cells (MO).  A lOmg/ml stock solution of  6 -bromo-/3-tetralone in 
ethanol  was  added to  the  cells  at  volumes  of lml  (OO)  and  0.5ml  (MM).  The
148results show that when  the cells are washed and re-suspended in  Tris buffer they 
exhibit lower initial activities and lower conversions than for the growing cells.  The 
results also show that the reaction rates at the higher substrate concentration (and 
higher solvent  concentrations)  are  lower for  both  the growing  and  resting  cells. 
(Reference Section 5.3.5 for methodology).
The results suggest that centrifugation of the cells and re-suspension in Tris buffer 
has a detrimental effect on the activity of the cells.  This may be due to disruption of 
the cell components during centrifugation or it may be due to the difficulty in the re­
suspension of the cells after pelleting.  The re-suspended cells may have had lower 
surface  areas  if the  cells  had  not  been re-suspended properly.  It was  difficult to 
resuspend the cells  since the centrifugation process produced  a pellet of high cell 
density.  A lower rotational speed in the centrifuge would not have created as high a 
density  pellet,  but  neither  would  it  have  been  possible  to  decant  all  the  growth 
medium.  However,  it  is  important  to  note  that  the  biocatalytic  activity  was  not 
increased by this re-suspension, and therefore using the cells in the growth media is 
acceptable and will be used in subsequent bioconversions.  The advantage of using 
growing cells is that there is one less process step than if washed cells are used.  This 
means  that  the process  time  is  reduced  and  the  stability of the  biocatalyst  is  not 
compromised.
5.4.5  The Effects of  Increasing Substrate Concentration by the Changing
Solvent Type
Methoxyethanol  was  previously  analysed  for  its  effects  on  the  isolated  enzyme, 
where tetralone reductase had previously shown comparable reaction rates in ethanol 
and  methoxyethanol  (Chapter  3).  The  following  experiment  was  carried  out  to 
determine  whether  the  addition  of  high  levels  of  ethanol  limits  the  whole  cell 
bioconversion,  and whether if methoxyethanol was employed (in lower amounts -  
with  a  higher  substrate  concentration)  the  whole  cell  would  benefit  by  showing 
increased reaction rates and higher conversions.  The main critical difference in the
149characteristics  of  the  solvents  is  their  solubility  of  6-bromo-p-tetralone; 
methoxyethanol dissolves 6-bromo-p-tetralone to a concentration of 250g/L, where 
ethanol dissolves 6-bromo-p-tetralone to a concentration of lOg/L.  The results show 
(Figure 5.5) that when methoxyethanol was used to dissolve 6-bromo-P-tetralone the 
initial  biocatalytic  activity  increases  with  increasing  concentration  of  solvent, 
however, at higher solvent concentrations there is a decrease in the rate of increase. 
The initial activity of the whole cell increases with a methoxyethanol content of up 
to 1.6% (it was not measured after this point) (Figure 5.5).  The effects of ethanol on 
the biocatalytic activity were significantly different to the effects of methoxyethanol. 
There was no dramatic increase in biocatalytic activity; however there was a small 
increase,  followed by a small decrease in activity at solvent concentrations greater 
than  10%.  The results  are comparable in that an increase in solvent increases the 
initial rate of reaction, although this increase was less so for ethanol.  A decrease in 
activity was not seen when using methoxyethanol, however it is expected that as the 
solvent volume  increases,  perhaps  up  to  10%  a  decrease  would be  seen.  To  get 
comparable  substrate  concentrations  in ethanol  a solvent  amount 25  times  greater 
than methoxyethanol needs to be used.  It is this high volume of solvent which most 
likely had an adverse effect on the biocatalytic activity.  The conversion of 6-bromo- 
p-tetralone  to  6-bromo-P-tetralol  using  the  whole  cell  biocatalyst  decreases  with 
increasing solvent concentration when either ethanol  or methoxyethanol  is used as 
the solvent, the decrease in substrate conversion is more pronounced when ethanol is 
used as the solvent (Figure 5.6).  At the substrate concentration of 0.5g/L (5%(v/v) 
ethanol,  0.4%(v/v)  methoxyethanol)  the  conversion  is  approximately 90%  at both 
the concentrations.  A decrease from  90% to  70% when the ethanol  concentration 
was doubled is observed,  whereas a doubling of the methoxyethanol  did not see a 
decrease within the limits of error.  At an ethanol concentration of 20% the cells did 
not convert any substrate; this is consistent with the biocatalytic activity which was 
negligible at this solvent level.  This is consistent with the hypothesis that a solvent 
with a higher solubility of substrate is less detrimental to the biocatalytic activity of
150the cells.  This is demonstrated via the higher reaction rates and conversions which 
were achieved when methoxyethanol (not ethanol) was used.
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Figure 5.5 The Effects of Type of Solvent on the Biocatalytic Activity
Initial activity of the whole cells when ethanol is used as the solvent (M).  Ethanol 
dissolves  6-bromo-f3-tetralone  to  a  concentration  of  lOg/L.  Methoxyethanol 
dissolves  6 -bromo-p-tetralone  to  a  concentration  of 250g/L,  but  used  here  at 
120g/L.  The solvent volumes for ethanol are 5%,  10%,  15% and 20%) respectively. 
Initial  activity  of the  whole  cell  biocatalyst  when  methoxyethanol  is  used as  the 
solvent ( 0 ) .   The solvent volumes for methoxyethanol are 0.4%,  0.8%,  1.25% and 
1.6% respectively.  The graph shows that the preferred solvent is methoxyethanol as 
the  initial activities  increase  with  increasing solvent.  (Reference  Section  5.3.6 for 
methodology).
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Figure 5.6 The Effects of Type of Solvent on the Conversion
Final  conversion  of 6 -bromo-fi-tetralone  to  6 -bromo-p-tetralol  using  whole  cells 
and  ethanol  as  the  solvent  w -   Ethanol  dissolves  6-bromo-/3-tetralone  to  a 
concentration  of lOg/L.  The solvent  volumes for ethanol are  5,  10,  15  and 20% 
respectively.  Final conversion  of 6 -bromo-p-tetralone to  6 -bromo-p-tetralol using 
whole  cells  and  methoxyethanol  as  the  solvent  ( 0 ) .  The  solvent  volumes for 
methoxyethanol are 0.4,  0.8,  1.25 and 1.6% respectively.  The results show that the 
final  conversions  are  detrimentally  affected  by  the  addition  of either  solvent, 
however,  the reduction  in  conversion  is more pronounced for ethanol.  (Reference 
Section 5.3.6 for methodology).
1525.4.6  The Effect of  Solvent Volume on the Whole Cells
The  effect  of the  amount  of solvent  on  the  biocatalytic  activity was  measured to
determine  the  levels  of solvent  in  solution  which  could  be  used  before  the  cells 
catalytic potential was affected.  Methoxyethanol was used to dissolve 6-bromo-p- 
tetralone.  The substrate concentration was kept constant at 0.5g/L.  The results show 
that the initial activity of the cell increases with solvent concentration.  The initial 
activity is more than doubled from an increase in solvent volume of 4% to 8% and 
this  trend  continues  up  to  12%  (v/v)  (Figure  5.7),  there  may  also  be  an increase 
above this level but it was not measured.  This demonstrates that at low substrate 
concentrations,  the addition of a solvent is  significant in increasing reaction rates. 
The increase in initial reaction rates is likely to be caused by the solvent facilitating 
an increase in mass transfer of the substrate across the cell membrane.  This can be 
achieved  because  the  membrane  bilayer  is  mainly  made  up  from  lipids,  and  the 
higher  the  solvent  concentration  the  more  likely  the  solvent  will  disturb  the  cell 
membrane.  If methoxyethanol was employed at  12% (v/v) to dissolve 6-bromo-p- 
tetralone  at  the  limit  of solubility  (250g/L)  in  a  reaction  solution  the  amount  of 
substrate  supplied  could  be  up  to  30g/L.  This  would  be  a  significant  increase 
compared to the isolated enzyme productivity.  In contrast to the reaction rates, the 
final  conversions  decreased  with  solvent  volume  (Figure  5.8).  At  high  levels  of 
solvent a decrease from 92% conversion in  1% solvent to 86% conversion in  12% 
solvent can be observed.  This reduction in conversion is most likely associated with 
the solvent since all the other components were kept constant.  It may be that the 
solvent brought  about  longer term  detrimental  effects  on  the cell,  possibly a slow 
degradation of the cell metabolism, which was not seen during the early stages of the 
reaction.  In  comparison to  the previous  experiments  (Chapter  5.5.4),  the rates of 
reaction  from  this  experiment  are  higher  at  the  same  solvent  volumes  used. 
However,  the substrate concentration tested in this experiment (0.5g/L) was lower 
than  the  concentrations  used  previously.  This  probably  means  that  the  substrate 
concentration  also has  a  significant  effect  on  the  cells  of Trichosporon  capitatum
153(MY  1890)  at  levels  above  0.5g/L.  Therefore,  it  is  likely  that  the  addition  of a 
solvent increases reaction rates, but only at low substrate concentrations.
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Figure 5.7 The Effects of  Methoxyethanol on Biocatalytic Activity
The effects of methoxyethanol concentration on the biocatalytic activity of the whole 
cells  of Trichosporon  capitatum  (MY  1890).  The  substrate  concentration  was 
maintained constant at  0.5g/L.  The solvent concentration  employed was  1%,  2%, 
4%,  8% and 12%.  The  results show  that at  low solvent  concentrations  the  cells 
exhibit low catalytic activity; however,  as the volume of  solvent increases the initial 
activity of the cells also increases.  (Reference Section  5.3.7 for methodology)  (See 
Appendix B1.5 for raw data).
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Figure 5.8 The Effects of  Methoxyethanol Concentration on Conversion
The  effects  of methoxyethanol  concentration  on  the  conversion  of 6-bromo-fT 
tetralone to  6-bromo-fi-tetralol by the whole cells of Trichosporon  capitatum  (MY 
1890).  The substrate concentration was maintained constant at 0.5g/L.  The solvent 
concentration employed was 1%,  2%,  4%,  8% and 12%.  The results show that final 
conversion  of  6-bromo-f3-tetralone  to  6-bromo-fd-tetralol  was  not  significantly 
affected by methoxyethanol up  to concentrations  of 12%o  (v/v).  (Reference Section
5.3.7  for methodology) (See Appendix B1.5 for raw data).
5.4.7  The Effect of  Initial Substrate Concentration on the Whole Cells
The  initial  substrate  concentration  was  investigated  to  determine  the  effects  of
substrate  concentration  on  the  biocatalytic  activity  of the  cells.  The  volume  of 
solvent was kept constant throughout  the  investigation  at  a concentration of 0.1%
155(v/v).  This constant volume of solvent was used to differentiate the effects of the 
solvent on the biocatalytic  activities  from the  effects of the substrate.  The results 
show  that  the  initial  biocatalytic  activity  increases  until  an  initial  substrate 
concentration  of  lg/L  (Figure  5.9),  after this  point  the  reaction  rates  remain  at  a 
constant level.  This is likely to be the concentration at which all of the active sites 
on the enzymes are used in the bioconversion.  The results also show that the final 
conversions are significantly affected by an increase in initial substrate concentration 
(Figure 5.10).  Up to lg/L there is a slow drop off in conversion, but as the substrate 
concentration  is  increased  to  2g/L  there  is  a  much  more  rapid  decrease  in 
conversion.  The  rate  of  decrease  then  slows  again  up  to  an  initial  substrate 
concentration of 3g/L, where the conversion after 7.5hr is approximately 38%.  The 
conversion at the initial  substrate concentration of 0.5g/L  at  7.5hr is  80%,  but by 
increasing  the  substrate  concentration  to  3g/L  the  conversion  decreases  to  38%. 
This reduction in the conversion was most likely caused by the substrate and product 
adhering either on or inside the lipid bilayer membrane,  and this may in turn have 
caused:  (1)  substrate  and/or product  inhibition.  It is likely that there was product 
inhibition since Figure 5.11  shows that the amount of substrate added increases but 
the amount of product produced maintains at a similar level.  Product inhibition was 
not  tested  to  confirm  this  since  there  was  not  enough  of the  product  to  run  the 
experiment.  (2) A disturbance to the cell metabolism and therefore the normal cell 
pathways were not maintained.  This could have meant that the enzyme could not 
reduce the substrate.  (3) Proteolysis of the cell, also causing detrimental effects to 
the metabolic pathway.  (4) Changes in enzyme conformation, thus the substrate is 
unable to bind to the active site.  The reason why there is a much quicker decrease in 
conversion  after  lg/L  may  be  down  the  combined  effects  of the  substrate  and 
solvent.  At low substrate concentrations, the solvent is helpful in increasing the rate 
of mass  transfer  across  the  cell  membrane,  thus  increasing  the  availability of the 
substrate to the enzyme.  As the substrate and solvent are increased a faster rate of 
degradation  is  potentially  caused  through  the  combined  effects  of  the  solvent, 
substrate, and product inhibition.  The results also show that the amount of substrate
156converted  into  product  is  between  lg/L  and  1.2g/L  for  all  initial  substrate 
concentrations above  1.5g/L (Figure 5.11) and in all cases the quantity of substrate 
available to the cell is significantly greater than the amount converted.
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Figure 5.9 The Effects of Initial Substrate Concentrations on Biocatalytic Activity
The  effects  of initial  concentrations  of 6-bromo-J3-tetralone  on  the  biocatalytic 
activity  of the  whole  cells  of Trichosporon  capitatum  (MY 1890).  The  solvent 
concentration was maintained constant at 0.1% methoxyethanol (v/v).  The substrate 
concentrations  employed  were  0.5g/L,  lg/L,  1.5g/L,  2g/L,  2.5g/L  and 3g/L.  The 
results show the  increase  in  initial activity of tetralone reductase up  to  an  initial 
substrate  concentration  of approximately  lg/L  after  this point  the  initial  activity 
levels  out.  (Reference Section  5.3.8 for methodology)  (See Appendix B1.6 for raw 
data).
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Figure 5.10 The Effects of  Initial Substrate Concentration on Conversion
The effect of initial concentrations of 6-bromo-p-tetralone on  the conversion  of 6- 
bromo-p-tetralone  to  6-bromo-p-tetralol  by  the  whole  cells  of  Trichosporon 
capitatum (MY 1890).  The solvent concentration was maintained constant at 0.1% 
methoxyethanol  (v/v).  The substrate  concentrations  employed were  0.5g/L,  lg/L, 
1.5g/L,  2g/L,  2.5g/L  and  3g/L.  The  results  show  that  the  initial  substrate 
concentration  has  a  significant  effect  on  the final  conversions  and has  a greater 
effect on the conversions than compared to the initial activities.  A decrease in the 
final  conversion  can  be  observed  after  lg/L  is  added  to  the  reaction  mixture. 
(Reference Section 5.3.8  for methodology) (See Appendix B1.6  for raw data).
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Figure 5.11 The Amount of  Substrate Converted in a Reaction
This graph  illustrates how the amount of  product  (0 ) formed remains constant at 
approximately  lg/L  at  concentrations  of substrate  added to  the  reaction  at levels 
much higher than this  (M).  The solvent concentration was maintained constant at
0.1%  methoxyethanol  (v/v).  The substrate  concentrations  employed were  0.5g/L, 
lg/L, 1.5g/L, 2g/L, 2.5g/L and 3g/L.  (Reference Section 5.3.8  for methodology).
5.4.8  The Effect of  Exogenous Quantities of  NADH
NADH is the cofactor which is required by tetralone reductase for the bioreduction 
of 6-bromo-(3-tetralone  to  6-bromo-(3-tetralol.  NADH  was  added  to  the  cells  to 
determine  whether  NADH  was  a  limiting  component  in  the  reaction  media  and 
whether additional  quantities of NADH  in the reaction solution could increase the 
amount converted and also potentially increase the reaction rates.  The results show
159that  there  is  no  increase  or  decrease  in  reaction  rates,  or  change  in  the  final 
conversion values (Figure 5.12).  This may mean that enzyme in the cell is already 
saturated with cofactor,  or it may mean that the NADH was not adsorbed into the 
cells and, therefore,  unavailable for the enzymes to use in a reaction.  The results 
show  that  adding  NADH  to  the  reaction  solution  does  not  affect  the  current 
bioconversion.
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Figure 5.12 The Effects of  Exogenous Quantities of NADH on the Bioreduction
The effect of adding exogenous quantities of  NADH on the conversion of  6 -bromo-p- 
tetralone to  6 -bromo-p-tetralol by the whole cells of Trichosporon  capitatum  (MY 
1890).  NADH  concentrations  employed  were  2.5mg/ml  ( M )  5mg/ml  ( 0 ) ,  and
0.75mg/ml (A). A  control of lml of buffer was also run with  no NADH (X).  The 
results show that there is no significant difference in the rates of reaction at different 
levels of  NADH. (Reference Section 5.3.9  for methodology).
1605.4.9  Effect of 6-bromo-J3-tetralone on E. coli JM107[pQR711]
In the previous sections it was demonstrated that the substrate, 6-bromo-(3-tetralone,
adheres to the cells of Trichosporon  capitatum  (MY  1890).  If tetralone reductase 
could be cloned into another type of cell, for example, E.  coli, the whole cell might 
exhibit  different  adherence  properties  towards  6-bromo-p-tetralone.  There  is  a 
possibility that different  substrate  and  solvent tolerance might  also be seen.  This 
hypothesis  was  tested  using  E.  coli  JM107  [pQR711].  This  microorganism  was 
selected  as  it  is  a  well-researched  microorganism  and  is  readily  available.  The 
results  show,  however,  that  6-bromo-p-tetralone  and  6-bromo-p-tetralol  adhere  to 
the cells of E.  coli (Figure 5.13).  Results also show that E.  coli JM107  [pQR711] 
reduces 6-bromo-p-tetralone to 6-bromo-p-tetralol with high activity (Figure 5.14). 
This  is  unexpected  as  this  microorganism  does  not  have  any  additional 
dehydrogenases  cloned  into  it  and,  therefore,  it  must  be  a  native  dehydrogenase 
which is reducing 6-bromo-p-tetralone.  The activities displayed by the E.coli were 
comparable  to  the  activities  displayed  by  Trichosporon  capitatum  (MY  1890), 
suggesting that the enzyme carrying out the conversion has the same affinity to the 
substrate as tetralone reductase.  Enantiomeric excess was not determined because 
(i?)-6-bromo-p-tetralol  was not available.  It is  likely,  however,  that E.coli JM107 
[pQR711] would not exhibit as high optical purity as  Trichosporon capitatum (MY 
1890) since this microorganism is not currently used for asymmetric bioreductions. 
The enzyme in E.coli is more likely to be a competing enzyme which would need to 
be removed or suppressed from the bioreduction (in the selection of Trichosporon 
capitatum (MY 1890) the competing enzymes were removed via media optimization 
(Reddy et al.,  1996)).  The  aim  of this  experiment using E.coli was to  determine 
whether the substrate and product had similar adherence to the E.coli cells; however, 
the  results  suggest  more  importantly,  that  if tetralone  reductase  was  cloned  into 
E.coli there would be a competing enzyme (from E.coli) which would have a similar 
catalytic  activity towards  6-bromo-P-tetralone,  therefore,  to  remove the  impact  of
161competing enzymes on the enantiomeric  selectivity of the product it may be more 
appropriate to use the native cells of Trichosporon capitatum (MY 1890) as the host 
microorganism.
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Figure 5.13 The Adherence of the Substrate and Product to E.coli
The adherence of 6-bromo-f3-tetralone and 6-bromo-f3-tetralol on the cells of  E.coli. 
Solutions  of 0.25ml,  0.5ml,  0.75ml  and  lml  of a  lOg/L  6-bromo-f-tetralone  in 
ethanol were added to 10ml of cells.  This gave an initial concentration of 6-bromo- 
(3-tetralone  of 0.24g/L,  0.48g/L,  0.70g/L  and  0.9lg/L.  The  results  show  that  6- 
bromo-j3-tetralone  and  6-bromo-/3-tetralol adhere  to  the  cells  of E.coli,  and at a 
initial substrate concentration of 9g/L,  less than half of the substrate is observed in 
the supernatant. (Reference Section 5.3.11 for methodology).
1620.25  0.5  0.75  1
Initial Substrate Concentration (g/L)
Figure 5.14 E.coli conversion of 6-bromo-p-tetralone
The conversion  of 6-bromo-/3-tetralone  to  6-bromo-/3-tetralol using the cells of E. 
coli JM107 [pQR711] after lhr (M) and 3 hr (M).  The graph shows that the cells of 
E.coli carry out the bioreduction effectively.  After 3hr and a substrate concentration 
of 0.25g/L  there is a  70% conversion.  This is comparable  to  the bioreduction  by 
Trichosporon capitatum (MY 1890).  (Reference Section 5.3.11 for methodology).
5.5  Discussion
Whole  cell  biocatalysis  is  a  more  established  technology  than  isolated 
oxidoreductase  biocatalysis  for  enantioselective  bioreductions  in  the  synthesis  of 
chiral alcohols.  There are two main reasons for this:
1631.  Whole  cells  used  in  enantioselective  bioreductions  do  not  require  the 
addition  of stoichiometric  quantities  of  cofactor,  nor  do  they  require  the 
addition of an expensive and complicated two-enzyme regeneration system, 
since  the  cells  complete  cofactor  regeneration  naturally  as  part  of  cell 
metabolism.
2.  Expensive  and  lengthy  purifications  of the  active  oxidoreductase  are  not 
required as the bioreduction can be completed using growing cells (without 
even removing the growth media).
These two advantages were observed in the whole cell bioreduction of 6-bromo-p- 
tetralone, since it was possible to perform the bioreduction after the growth stage of 
the cells (where there is no time-consuming purification procedure), and there was 
no  requirement  to  add  external  cofactors  or  an  enzyme  regeneration  system  for 
catalytic  activity.  Although  the  bioreduction  itself can  be  simplified by  using  a 
whole cell biocatalyst,  this  increases the number and the type of impurities in the 
solution compared to the isolated enzyme system.  This consequently increases the 
amount  of  downstream  processing  required.  Contamination  from  the  crude 
biocatalytic system can potentially arise from:
1.  The accumulation  of  by-products  produced  by  competing  enzymes,
particularly  problematical  are  competing  enzymes  which  produce  the 
opposite  enantiomer  to  the  active  compound.  This  causes  difficulties  in 
downstream processing  as  the by-product  and  the active  ingredient will be 
chemically similar.
2.  The media used for the growth of the cells.
3.  Cell debris including, other cell proteins.
4.  The position  on  the  growth  curve  may  also  produce  difficult  types  of
contamination.  For example, if the cells are not grown for enough time there 
may not be sufficient enzymes to produce an efficient system, if the cells are
164grown  for  too  long  then  there  may  be  more  impurities  through  the 
degradation of the cell components.
All  these  types  of contaminants  will  need  to  be  separated  from  the  product  via 
suitable methods.  The crude isolation of the product from the cell growth media and 
the cell debris could be made via solvent extraction.  However, it is the purification 
of  the  product  from  molecularly  similar  compounds  which  is  more  difficult  to 
achieve.  In  instances  where  there  are  chemically  similar  compounds  in  solution 
which are difficult to separate, it may be more practical to use a less crude form of 
biocatalyst;  for  example,  an  isolated  and  purified  oxidoreductase.  In  a  purified 
oxidoreductase  system there would be very few other enzymes (depending on the 
purity  of  the  oxidoreductase)  which  could  potentially  cause  the  build  up  of 
chemically similar compounds by competing with the active oxidoreductase.  The 
relative  purity  of  the  whole  cell  biocatalyst  could  potentially  be  improved  by 
overexpressing the active oxidoreductase, overexpression would likely increase the 
ratio  of  active  enzyme  to  competing  enzyme,  thus  also  increasing  the  ratio  of 
product to by-products; this is discussed in more detail later in this chapter.
The delivery of substrate and the removal of product from the cells of Trichosporon 
capitatum (MY 1890) was completed using a solvent.  The use of a solvent serves to 
increase the  solubility of the  substrate  to  enable  the bioreduction  to  advance  at  a 
faster  rate  than  if the  substrate  was  added  as  a  solid  of low  aqueous  solubility. 
Investigations  using  the  Trichosporon  capitatum  (MY  1890)  whole  cell  system 
demonstrated that there are issues associated with the delivery of the substrate to the 
cells and also the removal of the product from the cells.  One of the main problems 
was that the substrate and the product accumulated inside the cell and could only be 
removed  via  the  addition  of  a  solvent  (the  substrate  and  product  could  not  be 
disassociated  from  the  cell  components  through  sonication).  In  this  case,  the 
substrate and product are hydrophobic and it is this property which causes them to 
have  a higher affinity for the  cells  than the  aqueous  environment  surrounding the
165cells.  All cells have a membrane made up of a bilayer of lipids (Bailey and Ollis, 
1986), and the permeability of substances through the membrane can depend upon 
the  lipid  solubility  (partition  coefficient).  6-bromo-p-tetralone  is  a  lipophilic 
compound  and most  likely either diffuses  through the  cell  membrane or becomes 
incorporated into the lipid bilayer (Angelova et al.,  1999).  The varying amounts in 
the cell, in the bilayer, and in the aqueous environment may all depend upon one or a 
combination of:
•  The amount of solvent in the reaction.
•  The amount of substrate added to the reaction.
•  The ratio of substrate and product in the cell.
•  The solubility of the substrate and product in  the solution
The  acute  adherence  and  accumulation  of  substrate  and  product  in  the  cell  is 
disadvantageous in the whole cell biocatalytic system as it means that the substrate 
and product will not be homogenous throughout the solution (in the isolated enzyme 
system  the  solution  is  homogeneous  as  there  are  no  surfaces  for  substrate  and 
product  adherence).  This  means  that  there  is  a  high  risk  that  the  substrate  and 
product will be toxic to the cell even at low substrate concentrations, as the cell and 
consequently  the  enzyme  inside  the  cell,  will  be  subjected  to  higher  overall 
concentrations  of substrate than  exhibited  in  a homogenous  solution.  This  shows 
that  even  at  low  substrate  concentrations  there  is  the  potential  for  only  low 
productivities to be obtainable.  The adherence of the substrate and product to the 
cells also means that the product will have to be recovered from the cells through a 
method such  as  solvent extraction.  The  addition of large volumes of solvent will 
generally cause a detrimental effect on the cell by  disrupting the cell  membrane,  it
will also cause the enzyme to become deactivated.  This was observed in  the whole
cell  bioreduction  of 6-bromo-p-tetralone  where the  addition of equivalent parts  of 
solvent for extraction to the reaction solution destroyed the cells so they could not be 
recycled.  Solvent extraction has also been used in the extraction of the product from 
a benzylidene thiazolidinedione reduction (Heath et al,  1997).  In this paper (Heath
166et al,  1997) it was stated that such an extraction, although prevented the cells from 
reuse, was actually economically feasible and preferred.
The delivery of the substrate to the cells and removal of the product from the cells is 
not  the  only  constraint  in  the  application  of an  effective  whole  cell  biocatalytic 
bioreduction.  For  oxidoreductases,  it  is  necessary  to  ensure  that  the  cofactor 
required  for  the  reaction  is  not  limiting  the  conversion.  Cofactors  are  a  low 
molecular weight, non-protein species that are essential participants in most isolated 
enzyme catalysed reactions (Chenault et al,  1988), they are either oxidised, donating 
a hydrogen ion, or reduced, accepting a hydrogen ion.  In whole cell biocatalysis the 
cofactors are in a continuous loop of oxidation and reduction via the cells metabolic 
pathway.  One way to speed up the whole cell oxidoreductase reaction could be to 
increase the amount of cofactor available in the cell, thus if the regenerating enzyme 
is the limiting parameter in the cell, the addition of further quantities of cofactor may 
increase the reaction rates.  In  the  Trichosporon  capitatum  (MY1890)  whole  cell 
system, this theory was tested, where exogenous quantities of NADH were added to 
the whole cell reaction to determine whether these additional quantities of cofactor 
could increase the reaction rate.  The results showed that there was no increase or 
decrease  in  activity  and  it  was  assumed  that  either,  the  NADH,  which  is  highly 
soluble in aqueous environments was not taken up by the cells, and therefore could 
not be used in an enzymatic reduction by tetralone reductase; or tetralone reductase 
was  the  limiting  enzyme  and  was  already  saturated  in  NADH.  However,  in  the 
isolated enzyme  system  an  increase  above  a certain  level  of NADH proved to be 
detrimental  to the enzyme  (see  Figure  3.11).  This result was not observed in the 
whole cell bioconversion, and therefore it was more likely that the cells did not take 
up the NADH.  To increase the  amount of NADH  available to  the enzyme in the 
cell,  it may be necessary to permeabilise  the membrane to  enable the hydrophilic 
component to enter the cell.  Permeabilisation of the cell membrane could cause the 
creation of a synthetic pathway in the membrane which the cofactor could simply 
diffuse through.
167In the whole cell system it seems that there are two main parameters which control 
the rate of reaction.  These are (1) the amount of substrate/product in the reaction, 
and (2) the amount of solvent in the reaction.  It is evident from the results that the 
cells and their corresponding reaction rates are  adversely affected by an increased 
amount of substrate/product in the  reaction.  In  contrast,  however,  the  amount of 
solvent  used  to  deliver  the  substrate  was  significant  in  positively  increasing  the 
reaction  rates.  In  the  case  of  Trichosporon  capitatum  (MY1890)  the  results 
demonstrated that at low levels of substrate (0.5g/L) reaction rates were improved 
with  increasing  solvent  concentration  (up  to  12%).  This  increase  in  biocatalytic 
activity may have been caused by a permeabilisation of the cell membrane by the 
solvent,  thus  facilitating  transfer  of the  substrate  across  the  cell  membrane  more 
readily.  However, if the mass transfer rate of the substrate into the cell is increased, 
this increase in substrate is also likely to increase the rate of degradation of the cell 
membrane and most likely cause a reduction in the cell viability.  Therefore, there 
the amount of solvent used to deliver the substrate must be optimized with respect to 
the  amount of substrate  required  in  the reaction  and the  associated  effects on the 
biocatalytic  activity  and  stability.  The  effects  of  cell  permeabilisation  have 
previously been  reported  where  the  yeast  cells  of Saccharomyces  cerevisae  were 
permeabilised with alcohol (Liu et al.,  1999).  The treatment of cells with an alcohol 
significantly  enhanced  the  biocatalytic  activities  cells.  It  was  proposed  that  this 
method increased the membrane permeability to the substrate and product (Liu et al.,
1999).  This effect has also been previously reported, where it was demonstrated that 
by reducing the permeability barrier of the cell membrane (using a solvent) caused 
an increase in reaction rates but also caused a reduction in the cell viability (Gowda 
et  al.,  1991).  This  result  was  similar  to  behaviour  of  Trichosporon  capitatum 
(MY 1890)  where there  was  an  increase  in the  initial  rate  of reaction with higher 
solvent concentrations, but a decrease in  conversion.  This decrease in conversion 
was  probably  caused  by  a  reduction  in  cell  viability,  potentially  caused  by  an 
increased amount of solvent which had diffused through the cell membrane and had
168become in contact with the active enzymes.  This increase in solvent will most likely 
have caused the active site of the enzyme to become perturbed.  Therefore, using a 
solvent  to  increase  the  reaction  rates  by  facilitating  an  increase  in  mass  transfer 
across  the  cell  membrane  must  be  balanced  against  cell  viability,  biocatalytic 
reaction rates and conversions.  The correct choice of the type and amount of solvent 
is  therefore  critical  in  maintaining  the  biocatalytic  viability  and  ensuring  good 
reactions rates through appropriate levels of cell permeabilisation.
If the  volume  of solvent  is  trivial  in  a  whole  cell  bioreduction  at  low  substrate 
concentrations  then  it  is  the  amount  of  substrate  added  to  the  reaction  and  the 
amount  of product  removed  from  the  reaction  which  will  need  to  be  accurately 
monitored and controlled to maximize the biocatalytic activities of the cell.  Adding 
a  high  level  of substrate  in  batch  and  not  removing  the  product  will  have  two 
consequences.  Firstly,  in  a  whole  cell  system  with  a  substrate  of low  aqueous 
solubility there will be a tendency for the substrate and converted product to adhere 
and  accumulate  onto  the  cell  membrane.  Secondly,  the  uncontrolled  addition  of 
substrate  into  the  reaction  will  have  an  adverse  effect  on  the  cell  and  enzyme 
stability, as at high substrate/product concentrations they are likely to become toxic 
to  the  cell  and  corresponding  enzyme.  An  increase  in  the  initial  substrate 
concentration was investigated in the whole cell bioreduction of 6-bromo-p-tetralone 
to  determine  the  effects  on  the  biocatalytic  reaction  rates  and  conversions.  An 
increase  of  6-bromo-p-tetralone  caused  the  initial  activity  of  the  whole  cell  to 
increase up to approximately 1  g/L.  This is likely to be the concentration at which all 
the active sites of the enzyme are used; at substrate concentrations above this value 
the associated conversions were significantly affected.  To improve the whole cell 
system, it seems that the method by which the substrate is delivered to the cell and 
the method by which the product is removed from the cell must be enhanced if the 
system is to be capable of producing significant amounts of product.  In the isolated 
enzyme system it was suggested that the use of polymeric resins would be ideal, in 
that they could be employed instead of a solvent for the addition and removal of the
169substrate/product.  The use of resins in whole cell biocatalytic reactions for substrate 
delivery and product removal has been applied in a number of recent systems (these 
were  reviewed  in  Chapter  4.4).  Examples  of  the  successful  use  of  resins  for 
substrate  delivery  and  product  removal  include  a  ketone  reduction  using  XAD-7 
(Vicenzi,  et  al.,  1997),  and  the  Baeyer-Villiger  oxidation  using  Optipore  L493 
(Hilker  et  al.,  2004).  In  the  case  of  Trichosporon  capitatum  (MY1890)  and  6- 
bromo-p-tetralone, the use of resins alone to add the substrate to the reaction mix 
may  not be  appropriate  as  the  substrate  requires  the  permeabilisation  of the  cell 
membrane  to  increase  the  reaction  rates.  If  resins  were  employed,  it  may  be 
appropriate to  use them  in  conjunction  with  a  solvent.  In  such  a case,  the  resin 
would need to have the  appropriate  affinity  for the  substrate to  allow  the  correct 
equilibrium  of  substrate  on  the  resin  and  substrate  in  the  solution  to  ensure 
satisfactory reaction rates.  If resins were employed for delivery and removal of the 
substrate and product, it is optimisation of the properties of the substrate, product, 
and  resin,  which  would  be  critical  in  ensuring  the  correct  equilibrium  of  the 
components in the reaction solution.  This would need to be assessed before resins 
could  be  employed  in  a  bioreactor  (Straathof  et  al.,  2003).  Two-phase 
(aqueous/organic) solutions could also potentially be used to control the delivery of 
the substrate.  However,  as discussed  for the resins,  the use of a secondary phase 
(whether the secondary phase is liquid or solid) for the delivery of the substrate may 
not cause permeabilisation of the cell and it may be necessary to use the combination 
of  an  immiscible  solvent  to  control  the  substrate  and  a  miscible  solvent  to 
permeabilise the cell.
Generally, for the application of whole cell oxidoreductase biocatalysts, the enzymes 
are purified from their native cells with the intent of overexpressing and cloning the 
enzyme into a microorganism.  The selected microorganism is generally thoroughly 
characterized  and has well-defined  growth parameters.  As  a host microorganism, 
however, it must maintain the biocatalytic properties of the enzyme.  To improve the 
biocatalytic reduction of 6-bromo-p-tetralone with respect to substrate and product
170adsorbance  a  change  the  cell  type  was  investigated.  The  experiment  looked  at 
whether the bioconversion could be improved by changing the cell type to E.  coli 
JM107  [pQR711].  This  microorganism  (E.  coli  JM107  [pQR711])  expresses 
transketolase and is ampicillin resistant (however, it was only selected because it is a 
well-characterized microorganism).  The results from the experiment show that not 
only  does  the  substrate  have  a  high  affinity  for  the  cells,  but  also  and  more 
significantly, is the fact that E.coli converts the substrate 6-bromo-p-tetralone into 6- 
bromo-p-tetralol.  Cloning the active enzyme into a host cell which has a competing 
enzyme would be of little use if the native enzyme caused a reduction in the optical 
purity  of  the  product.  It  is  likely,  however  that  if  the  active  enzyme  was 
overexpressed  into  a microorganism  this  would  dramatically increase  the ratio  of 
overexpressed  enzymes  to  native  cell  enzymes;  it  may  also  mean  that  the 
biocatalytic  activity  of  the  enzymes  native  to  the  host  microorganism  are  not 
adequate to have an effect on the optical purity of the product.  This would have to 
be tested and depending on the results it may be more appropriate to overexpress the 
active enzyme back into its own cell.  Other options to improve the stereoselectivity 
of  the  whole  cells  could  include  knocking-out  competing  enzymes  by  genetic 
engineering,  this  has  been  accomplished  in  bakers’  yeast  where  reductases  were 
knocked out, the results demonstrated that it is possible to improve stereoselectivity 
of baker’s yeast via genetic modification (Rodriguez et al.,  1999).  The results from 
this  chapter  show  that  the  cells  of  Trichosporon  capitatum  (MY  1890)  can  be 
employed  for  the  bioreduction  of  6-bromo-p-tetralone  to  6-bromo-p-tetralol. 
However, the whole cells are limited by the accumulation of substrate and product 
inside  the  cell  membrane  causing  a  detrimental  effect  on  reaction  rates  and 
productivities.  A solvent is also required to extract the product from the cells and 
because  of this  the  cells  cannot  be  recycled.  The  bioconversion  could  not  be 
improved by increasing the amount of NADH available to the cell,  or by changing 
the cell type.
1715.6  Summary
The  whole  cells  of Trichosporon  capitatum  (MY  1890)  can  be  employed  for the 
bioreduction  of  6-bromo-p-tetralone  to  6-bromo-p-tetralol.  However,  a  high 
percentage of 6-bromo-P-tetralone and 6-bromo-p-tetralol  associates with the cell; 
either accumulating inside the cell or becoming  associated to the hydrophobic cell 
membrane.  To deliver the substrate and also to increase the substrate concentration 
in the reaction mix two options were analysed.  Firstly increasing the solubility of 
the substrate by changing the solvent type,  and secondly,  increasing the volume of 
solvent.  The results show that higher reaction rates and higher conversions can be 
achieved  by  changing  the  solvent  from  ethanol  to  methoxyethanol.  Results  also 
show  that  at  low  substrate  concentrations  (0.5g/L),  the  higher  the  solvent 
concentration (up to 12%) the higher the initial biocatalytic activities; the respective 
conversions  are  also  high  at  all  solvent  concentrations  investigated.  This  was 
attributed to  the  solvent  facilitating  an  increase  in the rate  of mass  transfer of 6- 
bromo-P-tetralone through the lipophilic membrane.  As there was little detrimental 
affect  on  the  cells  at  high  solvent  concentrations  the  effects  on  the  biocatalytic 
activity of the cells at different substrate concentrations were investigated.  Results 
show  that  the  initial  activity  increases  up  to  substrate  concentrations  of  lg/L. 
Conversions are significantly affected at substrate concentrations above  lg/L and a 
decrease of 50% is observed between an initial substrate concentration of 0.5g/L and 
3g/L,  the  results  indicate  that  the  amount  of substrate  is  more  detrimental  to  the 
biocatalytic  activity of the whole cells than the  concentration of the solvent.  It is 
hypothesised  that  the  substrate  due  to  its  hydrophobicity  adheres  to  the  cell 
membrane  and  somehow  causes  degradation  of the  cell  components,  whereas  the 
solvent  increases  the  reaction  rates  by  permeabilising  the  cell  membrane  and 
allowing  easier  transfer  of  the  substrate  into  the  cell  through  the  lipophilic 
membrane.  Further  investigation  in  the  rate-limiting  step  demonstrates  that 
exogenous  quantities  of  NADH  have  no  affect  on  the  whole  cell  biocatalytic 
activities.  Results also show that if Eschericha coli JM107  [pQR711] is used as a 
cell type to host tetralone reductase,  it is limited due to  a similar association of 6-
172bromo-p-tetralone with the cells, and it is also limited as there is a native enzyme in 
Zs.coli which reduces 6-bromo-p-tetralone to 6-bromo-p-tetralol.
The following chapter will be used to compare the whole cell biocatalytic system to 
the  isolated  oxidoreductase  system  for  comparison  of:  (1)  the  method  of 
bioconversion  of  6-bromo-P-tetralone,  including  the  type  and  purity  of  the 
oxidoreductase;  (2)  the  delivery of the  substrate  and the  consequences  of using  a 
solvent;  and  (3)  potential  improvements  to  the  biocatalytic  systems,  including 
improvements arising from recombinant technology.
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Enzyme and Whole Cell Catalysis
6.1  Introduction
NAD(P)H dependent oxidoreductases are one of the most important class of enzyme 
as they have the  ability to produce compounds of high optical purity (Anthonsen,
2000).  One way of achieving this  is via the  stereospecific  reduction of prochiral 
substrates,  in  this  case,  the  formation  of a  chiral  alcohol  ((S)-6-bromo-p-tetralol) 
from  a cyclic  ketone  (6-bromo-P-tetralone) by tetralone reductase.  The problems 
associated with implementing such oxidoreductases at large scale are dependent on 
whether  isolated  enzymes  or  whole  cell  biocatalysts  are  employed  for  the 
bioreduction.  The most documented advantage of using whole cell biocatalysts over 
isolated  enzymes  is  that  whole  cells  contain  all  the  necessary  cofactors  and 
metabolic  pathways  for  their  regeneration,  also  the  enzymes  and  cofactors  are 
protected in their natural  environments  (Faber,  1997).  Yet,  for whole  cells to be 
used at scale there are a number of significant drawbacks.  Firstly, their productivity 
is  generally  low  since  the  majority  of non-natural  substrates  are  toxic  to  living 
organisms.  Secondly, large amounts of biomass cause low overall yields and make 
product recovery hard, particularly when the product is stored inside the cell and not 
secreted into the medium.  Lastly, the formation of by-products causes difficulties in 
reaction monitoring  (Faber  1997).  The use of isolated  enzymes  for bioreductions 
can overcome the difficulty with respect to product recovery as the large amounts of 
biomass  have  already  been  removed  and  discarded  during  the  enzyme  isolation 
without  the  use  of large  volumes  of solvents.  The  use  of isolated  enzymes  also 
reduces  the  number  of  competing  enzymes  which  also  potentially  limits  the 
formation  of by-products.  However,  on  isolation  of oxidoreductases  from  their 
natural  cell  environment,  there  is  then  the  requirement  to  add  stoichiometric 
quantities  of  the  associated  cofactor.  Currently,  the  addition  of  stoichiometric 
quantities of cofactor is not suitable for large-scale processes due to the high costs
174which would be incurred, thus methods must be employed for the regeneration and 
retention of these cofactors (Chenault and Whitesides,  1987; Hummel,  1997).  There 
is  also  the  problem  of  enzyme  inhibition  by  the  cofactors,  as  demonstrated  in 
Chapter 3 (Figure 3.11).
There  are  currently  few  systematic  comparisons  of isolated  enzymes  and  whole 
cells,  examples include:  a comparison of pig liver esterase and Bacillus subtilis as 
catalysts for the hydrolysis of menthyl  acetate  in  stirred two-liquid phase reactors 
(Williams  et  al.,  1990).  In  this  system,  the  results  demonstrated  a  number  of 
differences between the isolated enzyme and the whole cell including, the whole cell 
requirement  for  much  higher  agitator  speeds  to  maximize  productivity  (approx 
4000rpm) whereas the esterase reaction was maximized at about  lOOOrpm.  Results 
also demonstrated that the optimized agitator speed was dependent on the phase ratio 
(defined as the volume fraction of reaction liquor occupied by organic phase), where 
the enzyme was much more susceptible to inactivation at the liquid/liquid interface. 
Lastly, the results showed that higher enzyme concentrations could increase reaction 
rates although this was probably due to the high concentration masking the decay of 
enzyme over time.  Pigs liver esterase for benzyl acetate hydrolysis and a whole cell 
(Pseudomonas putida)  for  toluene  oxidation  have  been  employed  in  Lewis  cell 
studies  to  determine  reactor  design  data  for  two-phase  bacterial  and  enzymatic 
reactions  (Woodley  et  al.,  1990);  however,  this  was  a  non-direet  comparison  as 
neither  the  enzyme  origin  or  the  reaction  was  the  same.  Cyclohexanone 
monooxygenase (CHMO) and E.coli overexpressing CHMO have also been used for 
the comparison of a biocatalytic reaction (Zambianchi et al., 2004), in this case the 
reaction was an enantiomeric oxidation.  Results from the comparison demonstrated 
that productivity was  similar in both  cases;  however,  the  optical purity was much 
higher with the isolated enzyme than the whole cell.  It was concluded that in this 
instance  the  isolated  enzyme  appeared  to  be preferable.  There  has  also  been  an 
assessment of the impact of biocatalyst selection on the design of aqueous-organic 
biphasic  biocatalytic  processes  (Woodley  et  al.,  1990).  There  are  currently,
175however,  no  systematic  comparisons  of oxidoreductases  and  whole  cells  used  for 
bioreductions,  and  neither  are  there  any  comparisons  of isolated  oxidoreductases 
which have not been overexpressed  and native whole cells.  The objective of this 
chapter is to compare tetralone reductase and Trichosporon capitatum (MY1890) for 
the  bioreduction  of 6-bromo-p-tetralone.  Initially,  it  was  hypothesized  that  the 
whole cell  would be robust  and  simple to  employ,  since  whole  cells  (in  general) 
have been previously used for bioreduction reactions.  Also, there is no requirement 
for the addition of cofactors.  In contrast, the isolated enzyme would be difficult to 
employ mainly due to the requirement for a cofactor recycling system to be set up. 
The  isolated  enzyme  would  also  need  to  be  purified;  and  the  enzyme  may  be 
difficult to use in a process due to instabilities caused by removing the enzyme from 
its natural cell environment.  In this Chapter, the findings from Chapters 3, 4 and 5 
will be used to compare the whole cell  and isolated enzyme against these general 
hypotheses.  This  will  include  comparisons  of  the  biocatalyst  type,  biocatalyst 
purity,  bioreduction methodology,  productivity,  methods  of substrate delivery and 
methods of extracting the product from the reaction solution.  Hypothetical potential 
improvements  to  the  isolated  enzyme  and  whole  cell  systems  via  recombinant 
technology will also be discussed.
6.2  General Considerations Required for Biocatalyst Comparisons
In the comparison of an isolated enzyme or whole cell biocatalyst for the application
of a particular bioreduction  there  should  be,  as  a minimum,  consideration  of the 
following parameters:
Biocatalyst Characteristics
1.  Biocatalyst  purity,  reaction  materials  and  related  downstream  processing 
(including the  separation  of compounds of similar chemical properties  and 
structures).
2.  The type of biocatalyst, biocatalyst stability, and their substrate specificities.
1763.  Cofactor regeneration to ensure that the maximum activity of the enzyme is 
achieved due to the associated cost implications.
4.  Biocatalyst  recycling  including  any  recycling  of  associated  regenerating 
enzymes.
5.  Potential  improvements  to  the  biocatalytic  systems  via  recombinant 
technology.
Substrate/Product Characteristics
6.  Delivery of the substrate to the biocatalyst.
7.  Recovery of the product from the biocatalytic reaction mix.
8.  The effect of the substrate and product on the biocatalyst (e.g. inhibition and 
stability).
Other
9.  Bioreduction  methodology  including  ease  of processing  and  robustness  of 
the process.
10. Equipment and materials.
11. Process costs.
All  these  listed parameters  were proven  to  be  important  issues  to  consider in  the 
production  of 6-bromo-tetralol  by  isolated  tetralone  reductase  and  Trichosporon 
capitatum  (MY 1890).  Also,  and just as  importantly,  was the consideration of the 
effects  these parameters  had  upon  each  other,  since  in  this  particular process  the 
characteristics of the biocatalyst were  driven by the composition/characteristics of 
the substrate(s), product(s) and the reaction medium which came into direct contact 
with the biocatalyst.  This is illustrated in Figure 6.1.
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Figure 6.1 Effects of  Reaction Components on Reactor Design
Figure  6.1a  shows  both  the  biocatalyst  and  the  substrates/products  must  be 
considered to enable the design of an efficient bioreactor.  For example,  in isolated 
enzyme  cofactor  requiring  reactions  the  configuration  of the  cofactor  must  be 
maintained and the enzyme activity must be retained,  so the reaction environment 
must  be such  that  it  is suitable for  both  components  (e.g.  conventional filtration 
cannot be used to retain the cofactor,  therefore there must be the adaptation of the 
cofactor or retention method).  Figure 6.1b is an adaptation of  Fig 6.1, it shows that 
the substrate/product and biocatalyst should not be investigated independently and 
the effects of one upon the other should be considered.  For example; in the isolated 
enzyme reaction the addition of the cofactor must be controlled or recycled and not 
added stoichiometrically in batch.  This is because high concentrations of cofactor 
cause enzyme inhibition (see Figure 3.11) (i.e. not only does the cofactor need to be 
retained, it also needs to be regenerated).
It is important to characterise the biocatalyst for a number of reasons; however, it is 
also  important  to  characterise  the  substrate  and  product.  An  example  of  the 
importance of this  is  described  in  Chapter 4  where the hydrophobic  nature of the 
substrate and product was only detected once immobilisation of the enzyme onto a 
support was  attempted.  Characterisation  of the  substrate  and  product  could have 
potentially detected this  inherent property at an  early stage.  This characterisation 
should  have  also  prevented  the  initial  confusion  on  running  a  whole  cell 
bioreduction, where the substrate and product seemed to degrade, but were actually
178accumulating in the cell.  This illustrates the importance of initial characterisation 
work,  where  the  reaction  components  and  surrounding  environments  should  be 
investigated individually first of all and then again once the reaction components are 
put together.  Only then should a satisfactory comparison of the reaction systems be 
considered.
6.3  Biocatalyst Purity
The purity of the biocatalyst employed in a reaction has a number of consequences 
on the purity and the enantiomeric excess of the final product and also the amount of 
downstream  processing  which  is  required.  To  achieve  a  high  conversion  in  a 
bioreduction it is generally considered important to have a high purity enzyme.
Whole Cell
Pelleted Cells
Broken Cells
Enzyme Solution
Re-Suspended Cells
Resuspension puts cells into a controlled environment
Homogenisation is used to break open the cells to release the 
active enzyme from the cell debris.
Centrifugation then decantation removes cell broth, extra cellular 
enzymes (e.g hydrolases) and other excreted cell components
Centrifugation to pellet the cell debris and leave the active enzyme 
in solution ready for further purification
Chromatography is generally used to remove intracellular cell 
proteins from the active enzyme, the earlier chromatography
enzyme.
Figure 6.2 Isolation Flow Diagram
This flow diagram shows a simplified isolation of tetralone reductase,  it is easy to 
see how many more impurities the whole cell system has ranging from biomass,  to 
reaction medium, to contaminating proteins.
179In whole cell bioreductions, there are significantly more contaminants in the initial 
stages of the reaction when compared to isolated enzymes including, growth media, 
competing  enzymes  and  proteolytic  enzymes.  These  contaminants  need  to  be 
removed from the active ingredient via extractive processes which could potentially 
also  separate  the  biocatalyst  for  reuse.  If the  contaminants  from  the  whole  cell 
system are easily extracted from the product then the whole cell process may be the 
optimal  choice for the type of biocatalyst.  However,  as the contaminants start to 
resemble the product itself (due to competing enzymes catalyzing  a change in the 
substrate) the purification of the active compound during the downstream processing 
becomes more difficult to achieve;  and depending on the ease of separation of the 
similar compounds it may be  more  appropriate to  use  a biocatalyst which is  in a 
more  pure  form.  Isolated  enzymes  which  have  undergone  a  number  of 
chromatography  purification  stages  should  contain  very  few  contaminants  either 
from the isolation (e.g. growth media) or from the cell (e.g. competing enzymes).  In 
such a scenario, the product of the reaction should be relatively pure as there should 
be  limited  competition  for  the  substrate,  and  the  amount  downstream  processing 
should be relatively simple.  The question of how pure the biocatalyst needs to be is 
really  dependent  of the  end  reaction  mixture  and  how  easy  it  is  to  separate  the 
product from the other reaction components.  If an isolated  enzyme is  employed, 
there is a choice in the level of enzyme purity since the number of chromatographic 
stages can be selected and optimized as appropriate, it may even be suitable to use a 
low purity enzyme, possibly the use an enzyme  from a one-stage chromatography 
purification.  This would decrease the associated costs with respect to fully purifying 
the enzyme.
6.4  Biocatalyst Substrate Specificity
Selection of the most appropriate type of biocatalyst for a particular process may be 
based  upon  its  ability  to  accept  a  diverse  number  of substrates.  The  substrates 
accepted by the active  site of an  enzyme  in  a reaction  are known  as the  enzymes 
substrate  specificity.  The  more  diverse  the  type  of  substrate  accepted  by  the
180biocatalyst the more potential the biocatalyst has for further application; and it is of 
particular  relevance  that  the  biocatalyst  accepts  compounds  of  pharmaceutical 
importance.  Horse  liver ADH  is  a  very  catholic  enzyme  with  a broad  substrate 
specificity (including aldehydes  and cyclic ketones)  and a narrow stereospecificity 
and  because  of  this  is  probably  the  most  widely  used  dehydrogenase  in 
biotransformations (Faber,  1997).  In contrast, yeast ADH (in general) only accepts 
aldehydes  and methyl  ketones  and  is  therefore  of limited use.  The  specificity of 
oxidoreductases has recently been reviewed (Hummel,  1999).  There have also been 
reports of mass transfer problems for whole cell systems; for example, large and/or 
hydrophilic  substrates  may  not  be  easily  transferred  through  the  lipophilic  cell 
membrane.  The cell membrane acts as a barrier to the substrate entering the cell, 
and therefore if the substrate cannot diffuse through the membrane the contact of the 
substrate with the enzymes active site is not made and the product cannot be formed. 
In examples such as this, it is expected that the isolated enzyme would have a higher 
substrate specificity than the whole cell  enzyme as there is no barrier surrounding 
the enzyme.  In the final experimental work, substrates were investigated to compare 
the isolated enzyme and whole cell substrate specificity.
The substrates examined were pharmaceutically important precursors ranging from 
cyclic  ketones  to  small  molecules  to  long  chain  molecules.  The  substrates  were 
either  solubilised  in  ethanol  or  were  themselves  organic  liquid  substrates.  The 
results show that the whole cell system and the respective isolated enzyme system 
can  both  carry  out  a  variety  of bioconversions  for  a  range  of pharmacologically 
important substrates  (Figure 6.3),  it also  shows that the substrate specificity is the 
same for the whole cell as for the isolated enzyme (the assays used for the substrates 
and  product  are  described  in  Appendix  C).  The  results  also  show  the  high 
biocatalytic potential of tetralone reductase, since its specificity is not just limited to 
a single bioreduction.
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Figure 6.3 Substrate Specificity
A comparison of the substrate specificity between the isolated enzyme and the whole 
cell biocatalyst shows that both types of catalyst carry out the same type of reaction.
Structurally,  tetralone reductase  seems to need space to the  right hand  side of the 
oxygen component, and therefore compounds which have rings on both sides of the 
reducing centre are not capable of being reduced.  The enzyme is also able to reduce 
the oxygens at the end of straight line chains, such as the chloroketone (chlorine is a 
relatively small  molecule)  and benzylacetoacetate.  Tetralone reductase could  also 
easily  reduce  (3-tetralones  with  or  without  a  bromine  molecule;  however,  the  a- 
tetralone molecule could not be reduced even though the only change was a small
182positional change of the oxygen.  The fact that the whole cell catalyst has the same 
specificity  as  the  isolated  enzyme  means  that  bioconversion  of a  substrate  to  its 
respective product by a whole cell may rely more upon the substrate hydrophobicity 
and  its  interaction  with  the  lipophilic  membrane,  than  the  relative  size  of  the 
substrate.
6.5  Methodology and Productivity
The effective use of isolated tetralone reductase requires the in-situ regeneration of 
NADH, this can be achieved by the addition of formate and formate dehydrogenase 
(FDH).  This additional cofactor regeneration system increases the complexity of the 
isolated  enzyme reaction  methodology  and  also  increases  the process  costs.  The 
cofactor  can  not be  added  stoichiometrically  to  the  reaction  mixture  as  tetralone 
reductase is inhibited at high levels of NADH, and therefore cofactor regeneration is 
essential to maintain enzyme activity (not just to decrease the cost of the process). 
The FDH cofactor regeneration system was selected for the regeneration of NADH 
on  the  basis  that  the  enzyme  and  its  associated  regeneration  components  have 
previously  been  employed  as  a  secondary  enzyme  and  substrate  for  cofactor 
regeneration;  they  are  also  reasonably  well-defined  (Chenault  and  Whitesides, 
1987).  This  is  particularly  true  in  comparison  to  other  synthetic  cofactor 
regeneration  systems  for  example,  chemical  and  electrochemical  cofactor 
regeneration  methods  produce  cofactors  which  exhibit  low  specificity  and  are 
inactive when applied to an enzyme reaction  (see Chapter  1.6).  In contrast to the 
isolated enzyme system,  the whole cell  regenerates NADH  as part of its own cell 
metabolism and thus there are no implications on the associated methodologies (by 
adding further components) and neither is there a change in the costs.
The  reaction  methodology  selected  for  the  biocatalytic  reaction  will  affect  the 
efficiency  of the  process;  this  can  be  measured  using  productivity.  Conversion 
should  be  considered  concurrently  with  productivity,  as  a  high  conversion  will 
ultimately affect the purity and the level of downstream processing required.  In the
183isolated  enzyme bioreduction of 6-bromo-p-tetralone to  6-bromo-p-tetralol,  3.9g/L 
(Figure  4.13)  could  be  produced,  in  the  whole  cell  bioreduction  of  6-bromo-P- 
tetralone,  1.2g/L (Figure 5.10) could be produced.  These results show that under the 
conditions applied, the isolated enzyme biocatalyst has a productivity 3 times greater 
than the whole cell biocatalyst (these results do not include any bioreactor recycling 
as developed in Chapter 4).
Table 6.1  Effect of Substrate Concentration on Reaction Parameters
This  table  shows  how much  of the  initial substrate  has  been  converted after  the 
allocated  time.  In  all  cases,  as  the  initial  amount  of substrate  is  increased,  the 
amount converted has decreased.
Substrate
Concentration
(g/L)
Isolated Enzyme at t = 420min Whole Cell at t = 450 min
g/L Product Conversion g/L Product Conversion
0.5 0.46 92 0.40 79
1 0.86 86 0.79 79
1.5 1.25 83 1.08 72
2.0 1.64 82 1.06 53
2.5 2.03 81 1.03 41
3.0 2.31 77 1.17 39
For an  initial  substrate concentration  of lg/L the  isolated  enzyme  also  achieves  a 
higher conversion of 86% after 420min, where the whole cell biocatalyst exhibits a 
final conversion of 79% after 450.  Neither the isolated enzyme nor the whole cell 
system  reached  100%  conversion  within  the  experimentation  time  at  any  of the 
substrate  concentrations  employed.  There  are  a  number  of reasons  which  could 
explain the cause of the low productivities and conversions.  One of which may be 
the effects of the method used for the delivery of the substrate and also the method 
used for the removal of the product; these are discussed later in this chapter (Chapter 
6.6).  Other  explanations  include  the  method  of  running  the  bioreduction,  for 
example, a number of the reaction parameters were not monitored and controlled.  In 
the isolated enzyme system, the quantity of regenerating enzyme, substrate, and the 
cofactor was calculated and added to the reaction mix in quantities which would not 
affect the isolated enzyme; however, the affect these substrates had on the pH was
184not  monitored.  The  mixing  of  the  reaction  was  not  optimised  (although  was 
maintained  constant  for  comparison)  neither  was  the  temperature  of the  reaction 
optimised.  The most  logical reason the whole  cell  productivity is  lower than the 
isolated enzyme productivity is probably due to the hydrophobicity of the substrate 
and  product.  This  hydrophobicity  was  discussed  in  Chapter  5.4  where  it  was 
hypothesized  that  as  the  substrate  and  product  accumulate  in  the  cell,  the 
components are no longer homogenous in solution, this then causes the cells to be at 
higher substrate/product concentrations then if the solution was homogeneous.  In 
the  isolated  enzyme  system,  the  enzymes,  substrates  and  the  products  are 
homogeneous throughout the reaction mixture, thus the effects of small intense areas 
of substrate/product were not an  issue;  however,  the isolated enzyme was directly 
impacted by  the  addition  of any  components  including  mediums  used  to  deliver 
substrates of low water solubility.
6.6  Substrate Delivery and Product Removal
It  is  not  unusual  for  synthetic  biocatalytic  substrates  to  be  highly  insoluble  in 
aqueous environments (Angelova et al.,  1999).  To increase the availability of low 
aqueous solubility substrates to the active site of the enzyme requires an increase in 
the availability of the substrates surface area.  If the substrate is added as a solid and 
is not soluble in aqueous environments then the molecule will not be able to bind to 
the active site of the enzyme.  One method to increase the availability of the surface 
area of the substrate to the enzyme is to increase the solubility of the substrate by 
dissolving the substrate in a solvent.  The substrate, which has been solubilised in a 
solvent,  can  then  be  delivered  homogenously  to  the  biocatalytic  solution.  The 
optimal method of delivering the substrate to the biocatalyst will depend mainly on 
the stability of the biocatalyst under the given conditions and also the properties of 
the substrate and product.  In an isolated enzyme system, the enzyme is homogenous 
in  solution  and  will  be  impacted  directly  by  the  addition  of  other 
compounds/solutions;  therefore  the  addition  of  a  substrate  must  be  carefully 
controlled  particularly  if the  compound  is  toxic  to  the  enzyme.  In  the  case  of
185tetralone  reductase,  the  effects  of  using  a  solvent  for  substrate  delivery  were 
observed  immediately by  a decrease  in  catalytic  activity as the  amount of solvent 
was increased.  In the isolated enzyme system, the enzyme comes into direct contact 
with  the  solvent  and  the  carefully  folded  structure  is  perturbed  by  the  solvent 
disturbing the interactive forces which maintain the enzyme in its folded state in an 
aqueous  solution  (Klysov  et  al.,  1975).  Therefore,  to  maintain  a  high  enzyme 
activity and stability the amount of solvent added to the reaction solution should be 
minimised to reduce the enzyme/solvent contact.  In the case of the whole cells of 
Trichosporon capitatum  (MY1890) the effects were somewhat different in that  an 
increase in solvent used to  deliver the  substrate  actually increased the biocatalytic 
reaction rates.  This was only true for low levels of substrate (0.5g/L), and substrate 
concentrations at levels higher than this had a much more detrimental effect.
Table 6.2 Effect of Solvent Concentration on Reaction Parameters
This table shows that the isolated enzyme reaction rate decreases with  increasing 
solvent concentrations.  The whole cell reaction rate increases with  reaction rate. 
The  data  was  taken  from  results  observed  after  90  minutes.  (Substrate 
concentration was 0.5g/L).
Isolated Enzyme at t = 90min Whole Cell at t = 90min
Solvent
Concentration
(%)
g/L
Product
Conversion
(%)
Solvent
Concentration
(%)
g/L
Product
Conversion
(%)
1 0.40 80 1 0.23 46
2 0.37 74 2 0.25 50
3.8 0.35 70 4 0.29 58
7.4 0.33 66 8 0.32 64
10.7 0.25 50 12 0.35 70
For the whole cell system, it is assumed that at high substrate levels,  and therefore 
high  solvent  levels  (as  substrate  concentration  increases,  the  volume  of  solvent 
required to  dissolve the  substrate  also  increases),  the  solvent  increases  the rate  of 
mass transfer of substrate across the cell membrane, which in turn increases the rate 
of accumulation of substrate and product in the cell.  This then increases the rate of 
enzyme activation until a point at which the enzyme becomes inactivated by the high
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are  used  there  is  less  interaction  with  the  membrane,  and  thus  the  rate  of mass 
transfer  across  the  membrane  is  reduced.  In  the  whole  cell  system,  whether  a 
solvent which exhibits a high solubility of the substrate is used or whether a solvent 
which  exhibits  a  lower  solubility  is  used  is  important  in  determining  the  rate  of 
transfer of substrate across the cell membrane.  However, it likely the interaction and 
accumulation of the substrate and product within the cell membrane which is most 
significant in determining conversions.  It is therefore important in the cell solution 
to  control  both  the  addition  and  the  removal  of  the  substrate  and  the  product 
respectively.  It  can  also  be  important  to  control  the  amount  of substrate  in  the 
reaction due to potential unwanted changes in the enantiomeric excess.  In a recent 
example,  the  enantiodivergent  oxidation  of  a  racemic  bicyclohept-2-en-6-one  by 
cyclohexanone  monooxygenase  from  Acinetobacter  calcoaceticu  showed  that 
substrate  concentration  and  the  degree  of  conversion  significantly  affected  the 
enantiomeric excess of one of the lactones (Zambianchi et al., 2000).
The main problem with the whole cell biocatalytic  system was not the biocatalyst 
itself but  the  interaction  of the  hydrophobic  substrate  and  product  with  the  cell 
membrane,  and for the isolated enzyme it was a combination of the substrate and 
product and the use of a solvent to deliver the components.  Therefore, to increase 
the  substrate  concentration  in  the  reaction  solution  for  both  systems  most  likely 
requires different process methodologies.  For the whole cell system, there needs to 
be  a  method  of  supplying  the  substrate  yet  avoiding  the  accumulation  of  the 
substrate and product in the cells.  For the isolated enzyme it is important that there 
is  controlled  substrate  addition  and  product  removal  in  an  environment  which  is 
aqueous rich.  One method to increase the substrate concentration may be to employ 
a  different  type  of medium  which  would  maintain  enzyme  activity  and  stability. 
Mediums could include two-phase systems (Leon et al.,  1998; Carrea et al., 1988) or 
new  types  of media  for  lipophilic  compounds  such  as  ionic  liquids  (Kragl  et al., 
2002) may be more appropriate to use.  The use of resins as described in Chapters 4
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However, for whole cell systems, two-phase systems, ionic liquids,  and resins may 
only be available as a delivery system if a high enough affinity is not available for 
the product to diffuse back into the medium.  The whole cell  system and also the 
isolated enzyme system could potentially both benefit from increasing the solubility 
of the substrate, perhaps even by chemically changing the structure of the substrate 
into a more soluble form.  However,  a less water soluble compound may decrease 
the  conversion  in  the  whole  cell  system  as  a  substrate  soluble  in  an  aqueous 
environment may have problems in diffusing across the cell membrane without the 
use of a solvent.
If the converted substrate causes  a detrimental  effect on the biocatalytic  activities 
and  conversions,  or the  build-up  of product  has  the  potential  to  have  a negative 
affect  on  the  enantiomeric  excess,  then  the  product  should  be  removed  from  the 
reaction  solution.  In  the bioreduction  of 6-bromo-p-tetralone  the  removal  of the 
product  from  the  two  biocatalytic  systems  was  achieved  using  two  different 
methods.  The product from the isolated enzyme system was removed by adsorbing 
the product onto a cheap hydrophobic resin,  this meant that the enzymes could be 
recycled.  The adsorbed product was then removed from the resin by a solvent wash. 
In the whole cell biocatalytic system, the product was removed by the addition of a 
volume of solvent equivalent to the reaction solution volume;  the addition of such 
high volumes of solvent destroyed the  cells  so they could not be reused/recycled. 
This product solution was then centrifuged to remove the cell  debris and finally a 
two-phase solvent would be employed to remove any media components found in 
the  supernatant.  The  amount  of downstream  processing  required  for both  of the 
biocatalytic  systems  is  hard  to  quantify,  although  it would be  fair to  say that the 
whole  cell  system  requires  much  more.  The  isolated  enzyme  system  is  a  much 
cleaner  system  as  much  of the  clean-up  work  is  completed  during  the  enzyme 
isolation and purification.
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An  enzyme  cloned  from  its  native  cell  and  overexpressed  into  a  well-defined 
microorganism can appear advantageous in comparison to the native cell biocatalyst. 
This is because the host cell will contain a higher ratio of overexpressed enzymes to 
host cell enzymes than the native cell, the host cell is also generally better defined 
than the native microorganism.  Therefore, overexpressing tetralone reductase into a 
well-defined  microorganism  gives  the  potential  for  producing  a  biocatalyst  with 
greater  reaction  rates  and  potentially  higher  tolerances  to  components  such  as 
hydrophobic substrates and solvents.  If tetralone reductase could be overexpressed 
to a level of about  10% of the total protein in the cell, this would potentially have 
significant effects on the productivity of the enzyme.  A higher level of about 40% 
overexpression could possibly be achieved but this could lead to the formulation of 
inclusion bodies, which are not an active form for biocatalysis (Violand, 2001), so a 
more  realistic  level  of  10%  will  be  used  to  predict  the  potential  of the  isolated 
enzyme and the whole cell biocatalyst.
The  results  from  Chapter  5.4.9  suggest  that  if an  oxidoreductase  is  cloned  and 
overexpressed  in  a new microorganism,  then there are  a number of complications 
which can arise.  One of which is that the enzymes which are naturally available in 
the host cell may compete with the cloned enzyme  for the synthetic  substrate and 
thus may cause a reduction in the amount of active product produced.  Competing 
enzymes may cause a reduction in the optical purity of the substrate,  or may even 
bind to a separate part of the molecule  to  create  an  altogether different molecule. 
For example, the compound may have two reducing centres in different locations on 
the  molecule;  a  competing  enzyme  may  reduce  the  incorrect  centre  creating  a 
molecule  which  may  be  difficult  to  separate  from  the  active  molecule.  This  is 
similar to the results  from  Chapter 5  (Figure  5.14),  where it was  observed that  6- 
bromo-p-tetralone  was  reduced  by  an  active  reductase  from E.coli,  this  reduction 
caused  by  a  competing  enzyme  could  contaminate  the  active  product  and  cause 
difficulties  in  downstream  separation.  The  productivity  of  the  cells  for  the
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unaffected  through  recombinant  technology.  This  is  because  although  the 
sequencing,  cloning,  and  overexpression  of the  gene  which  codes  for  tetralone 
reductase into another microorganism (or Trichosporon capitatum MY  1890) would 
theoretically increase the quantity of active protein in the cell, it would not guarantee 
a parallel  increase  in  the  amount  of product  produced.  There  are  two  principle 
reasons for this; firstly, the model substrate 6-bromo-p-tetralone adheres to the cells 
of Trichosporon  capitatum  (MY  1890),  (whether  this  was  inside  the  cell,  in  the 
membrane,  or elsewhere  is  unknown  and  more  research needs  to be  done on the 
transport  of  lipophilic  compounds  into  and  out  of  the  cell  before  this  can  be 
determined).  In Chapter 5, (Figure 5.13) the substrate and product were also shown 
to adhere to E.coli JM107 pQR711, even though this was a completely different type 
of cell.  The adherence of 6-bromo-p-tetralone to the whole cell was caused by its 
hydrophobicity,  and therefore the  substrate  is highly likely to  adhere to  any other 
type  of microorganism.  This  argument  is  obviously  only  valid  for  hydrophobic 
compounds,  however,  many  important  pharmaceutical  precursors  are  highly 
insoluble in aqueous environments (Angelova et al.,  1999).  The second reason an 
increase  in  enzyme  in  the  whole  cell  may  not  increase  the  amount  of product 
produced  is  because  the  enzyme  tetralone  reductase  is  an  oxidoreductase  which 
requires the nicotinamide cofactor,  NADH.  Overexpressing the  enzyme  in E.coli 
may  cause  NADH  limitation  as  the  overexpression  of  the  enzyme  may  not 
automatically cause an increase in the quantity of cofactor available or quantity of 
the regenerating enzyme.  The reaction would therefore become limited by the units 
of cofactor,  or  the  units  of regenerating  enzyme,  rather  then  as  at  present,  the 
enzyme.  It may,  however, be possible to overexpress another enzyme in the same 
microorganism  to  reduce  the  cofactor,  but  again,  would  not  increase  the  initial 
amounts  of cofactor,  and  low  cofactor  levels  could  still  limit  the  system.  This 
problem of cofactor depletion has previously been described (Boonstra et al., 2001), 
whereby the depletion was overcome by the  expression of a third enzyme  into E. 
coli,  a  soluble  pyridine  nucleotide  transhydrogenase.  The  transhydrogenase
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and  NADP  without  the  requirement  for  any  other  substrate.  This  increased  the 
productivity when  compared  to  the  system  lacking  the  soluble  transhydrogenase. 
This result did not, however, increase the amount of available cofactor.  It was the 
oxidised/reduced form of the cofactor, which had been altered.
Overexpressing and cloning tetralone reductase to level of 10% of the total protein 
in a well-defined cell (100 times greater than previous level) would most likely be 
more  advantageous  for the  isolated  enzyme.  The  same  size  fermentations  would 
create  significantly  more  active  enzyme,  the  amount  of  chromatography  resin 
required for purification would be  less  due to  the decreased binding  of other cell 
proteins.  However, although providing more enzyme, there would probably be the 
same number of purification steps to remove the residual cell debris and unwanted 
enzymes,  this  is  because  resins  of  differing  properties  are  used  to  separate  the 
diverse cell components and this would still be required albeit in smaller amounts. 
The  purification  steps  may  be  more  efficient  due  to  the  higher  concentration  of 
active  enzyme,  and  the  enzyme  may  be  more  stable  because  of this  high  active 
protein concentration, high protein content can maintain activity this has previously 
been  reported  (Johnson  et al.,  1978;  see  Chapter  1.11).  The  cloning  of tetralone 
reductase  into  a  well-defined  microorganism  would  potentially  increase  the 
fermentation efficiencies due to enhanced characterized fermentation methods, this 
would mean an improvement for both the isolated enzyme and whole cell systems. 
However, in the recombinant whole cell system, the competing enzymes would need 
to  be  identified  and  quantified  for  the  potential  detrimental  effects  on  the  active 
substrate.  The  affects  of substrate  and  product  hydrophobicity  of the  transfer  of 
these components across the cell membrane in the recombinant microorganism will 
also  need  to  be  determined.  The  ideal  scenario  would  be  the  overexpression  of 
tetralone reductase into a well-defined microorganism, in a system where there are 
the same number of units of enzyme  as there are units of cofactor,  and where the 
kinetic parameters of the regenerating enzyme are comparable (whether this was in
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and the product removed in a controlled manner.  In a system like this, although the 
use of whole cells seems appealing, the reality of co-overexpressing two enzymes, 
one from a filamentous yeast, into E.coli with correct refolding of the enzymes and 
concurrent increase in NADH may not currently be a viable option.
6.8  Discussion
NADH dependent isolated enzymes and whole cell biocatalysts can be used for the 
reduction  of carbonyl  groups  in  the  production  of various  chiral  compounds.  In 
general,  it  is  the  whole  cell  biocatalysts  which  are  selected  to  perform  such 
reactions.  The rationale for employing whole cells include:  the general consensus 
that  whole  cell  biocatalysts  are  easy  to  use,  expensive  isolation  of  the  desired 
enzyme  is  avoided,  and  cofactor  regeneration  is  completed  via  the  cells’  own 
metabolic pathway.  However, cells frequently contain enzymes which interfere with 
the desired reaction so that a low yield and low enantiomeric excess of the product 
can  result  (Hummel,  1997).  Isolated  enzymes,  in  contrast,  perform  with  higher 
selectivity,  have a higher space time  yields,  but require the addition  of a cofactor 
regeneration system.  They also require purification which is generally considered as 
a highly complex and time-consuming activity.  In this thesis, the comparison of an 
isolated  reductase  and  a  whole  cell  biocatalyst  demonstrated  that  the  common 
assumptions  regarding  the  employment  of  biocatalysts  were  generally  true. 
However,  there were  also  a number of other  significant differences between  each 
biocatalyst type,  and these differences were generally a consequence of the model 
reaction  system  which  was  employed.  The  model  reaction  system  that  was  used 
resulted  in  a number of operating  constraints  which  were  unavoidable  due to  the 
biocatalyst and reaction component characteristics.  The constraints for each of the 
operating systems are summarised below in Table 6.3
192Table 6.3 Operating Constraints
The physical state of a biocatalyst used in a bioreaction and the characteristics of the 
reaction components can influence the method by which the reaction needs to be run
due to the constraints of the system.
Isolated Enzyme Tetralone Reductase 
Operating Constraints
1 Tetralone reductase needed to be purified; this added extra time, complexity and 
expense to the overall  reaction.  Also,  the  fact that tetralone reductase  is  not 
over-expressed meant that only small quantities of the enzyme were produced at 
the end of the purification.
2 Tetralone reductase  and  its cofactor were  immediately affected by changes to 
the environment, this meant that good control of the reaction was required and 
minimal addition of other compounds was essential.
3 NADH  needed  to  be  recycled  for  two  reasons:  (1)  it  was  expensive;  (2)  it 
caused substrate/product inhibition.  Thus, the requirement to use a secondary 
enzyme made the reaction more complicated than if just a single enzyme was 
used.
4 Since NADH needed to be recycled this increased the processing costs as both 
NADH and FDH were expensive components, this also meant that much of the 
experimentation had to be completed in small volumes.
5 Immobilisation of Tetralone Reductase was not possible since the substrate and 
product  adhered  to  the  available  surfaces.  This  meant  that  removal  of the 
substrate and product from the enzyme required another method.
6 Tetralone  reductase  was  adversely  affected  by  relatively  large  amounts  of 
substrate.
7 Miscible solvents had a detrimental effect on tetralone reductase activity.  This 
reduction in activity drives towards the use of two-phase solvents or other types 
of medium.  Two-phase  solvents,  however  (in  general)  did  not  solubilise  6- 
bromo-|3-tetralone.
Whole Cell Biocatalyst Trichosporon capitatum (MY 1890) 
Operating Constraints
1 The  initial  growth  of the  cells  required  sterile  technology  and  the  reaction 
required  aseptic  techniques.  However,  such  methods  and  equipment  are well 
defined and readily available.
2 The  reaction  was  run  with  growing  cells,  this  meant  that  the  final  reaction 
solution  had  a  large  amount  of biomass  and  growth  medium.  This  caused 
difficulties in the handling and downstream processing.
3 The substrate and product adhered to the cell (probably the cell membrane); this 
meant  that  an  extraction  method  was  required  to  isolate  the  product  and 
unconverted substrate from the cells.
4 The accumulation of substrate and product in the cells caused a reduction in cell
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5 Trichosporon capitatum  (MY1890)  was  adversely  affected by relatively large 
amounts of substrate.
6 At  high  substrate  concentrations  the  addition  of miscible  solvents  caused  a 
reduction in the biocatalytic reaction rates.
The general assumption for the isolated enzyme system was that the isolated enzyme 
system would be difficult to employ (mainly due to the requirement for a cofactor 
recycling system to be set up).  It was also suggested that the isolated enzyme would 
be unstable (caused by removing the enzyme from its natural cell environment).  The 
methodologies  and  results  from  this  thesis  suggest  that  there  are  similarities  and 
differences between the  results  and  general  assumptions.  Contrary to  the  general 
assumptions,  the  isolated  enzyme  system  was  easy  to  employ  and  the  enzyme 
retained much  of its  activity  for  a long period  of time.  The  set up  of a cofactor 
regeneration system was reasonably complicated but easily repeated;  the only key 
problem would be the expense of the regenerating enzyme at large scale.  The main 
difficulty was the isolation and purification which were considerably complex and 
time-consuming to develop, although once developed were robust and reproducible. 
The enzyme was unstable when  removed  from  the cell  environment,  but this was 
due  to  the  isolation  buffer  containing  a  certain  protease  inhibitor  which  was  not 
necessary.  This problem was rectified by removing the protease inhibitor from the 
reaction buffer.  The enzyme also became unstable in the reaction solution due to the 
addition of solvents and substrates.  This means that the enzyme must be protected 
as  much  as  possible  from  the  reaction  components  without  causing  a  significant 
reduction on the reaction rates.  Based on the observations taken from this thesis, the 
main  consideration  when  employing  isolated  enzymes  currently  is  the  expense 
caused by using NAD(H) and FDH at large scale.
The general assumptions for the whole cell system suggested that whole cell systems 
are robust and simple to employ, since whole cells (in general) have been previously 
used for bioreduction reactions.  The results from this thesis agree that the whole cell 
system  was  relatively easy to  employ for the  bioreduction.  However,  there  were
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solubility.  The operating constraints caused by using a substrate and product which 
were hydrophobic meant that they adhered to the cell membrane and caused enzyme 
inhibition /cell toxicity at very low levels of substrate.  This meant the whole cell 
was difficult to employ and optimise as a biocatalyst in an efficient bioreactor, and 
only  low  levels  of product  could  be  obtained.  There  were  also  difficulties  in 
recovering  the  product  since  it  was  retained  by  the  cell.  The  only  method  for 
product extraction was via the addition of a solvent which in turn destroyed the cells 
for future use.
This  thesis  employed  Trichsporon  capitatum  (MY1890)  and  tetralone  reductase 
(isolated from this microorganism) for the bioreduction of 6-bromo-p-tetralone to 6- 
bromo-p-tetralol.  This  allowed  a  comparison  to  be made between  two  types  of 
biocatalyst.  The  results  from  this  thesis  give  good  direction  into  the  problems 
associated with using both types of systems.  However, the comparison only deals 
with the model reaction system (low aqueous soluble substrate and product);  and it 
is very likely that if a similar biocatalysts were employed with  substrates of high 
aqueous  solubility  the  results  would  be  significantly  different.  In  the  use  of 
biocatalysts  for a long term  applications,  the comparison  should look at  all  of the 
substrates  and  products  which  will  be  employed.  The  results  from  this  thesis 
demonstrate that the isolated enzyme is a preferable system (it is cleaner, has higher 
reaction  rates  and  higher  conversions,  the  isolation  is  also  easy  to  perform  and 
robust)  to  the  whole  cell  system.  But,  before  tetralone  reductase  is  used  at  an 
industrial  scale  it  is  essential  that  further  investigation  into  the  systematic 
regeneration and retention of cofactors is carried out.
6.9  Summary
The objective of the work described in this thesis was to compare the application of 
an isolated enzyme and a whole cell biocatalyst for the stereospecific bioreduction of 
a  poorly  soluble  ketone.  The  results  demonstrated  that  the  isolated  enzyme
195exhibited  higher  conversions  and  higher  reaction  rates  than  the  whole  cell 
biocatalyst.  Both of the biocatalytic systems were constrained by the substrate and 
product which  exhibited  low  solubility  in  aqueous  environments.  In  the  isolated 
enzyme system, the enzyme activity and related conversions were directly affected 
by the addition of a solvent (required to solubilise the substrate) which most likely 
perturbed the active site of the enzyme.  In the whole cell system, the substrate and 
product accumulated in the cell causing a decrease in the cell viability resulting in 
lower substrate conversions  and reaction rates.  Both  systems were similar in that 
their  substrate  specificities  were  comparable;  this  suggests  that  the  mass  transfer 
through the cell membrane may be more reliant upon substrate hydrophobicity than 
molecule  size.  Recombinant  technology  is  potentially  more  applicable  to  the 
isolated enzyme system.  This is because an increase in the amount of active enzyme 
in the whole cell will potentially increase the purification efficiency.  However, for 
the  whole  cell  there  would  still  be  the  problems  of  the  substrate  and  product 
accumulating  inside  the  cell.  The  application  of the  isolated  enzyme  system  is 
preferable to the use of whole cell system; however, further work is required into the 
efficient regeneration of cofactors to reduce process costs at large scale.
1967.  Conclusions
1.  A stable form of tetralone reductase (a novel NADH-requiring oxidoreductase) 
can  be  purified  from  the  cells  of  Trichosporon  capitatum  (MY  1890)  via 
homogenisation, centrifugation, and chromatography.
2.  The  stability  of tetralone  reductase  is  dependent  upon  the  buffer  conditions 
selected for isolation, purification and storage.
3.  Removal of the protease inhibitor cocktail containing EDTA from the isolation 
and purification buffers increased tetralone reductase stability from 7hr at 22°C 
to 92hr at 22°C.
4.  Tetralone  reductase  is  inhibited  by  EDTA  and  requires  a  metal  cation  in  its 
active site.  However, tetralone reductase has a high enough affinity for the metal 
cation that extra amounts are not required in the buffers, and tetralone reductase 
is actually inhibited by heavy metal cations at levels of greater than 5mM.
5.  Tetralone reductase exhibits its highest activity at the pH value of 6.5.  There is 
an essential arginine residue and an essential sulfhydryl group in the active site 
of tetralone reductase.  Tetralone reductase is also inhibited by levels of NADH 
greater than 0.4g/L.
6.  Tetralone  reductase  activity  is  dependent  on  the  type  of  solvent  used. 
Methoxyethanol  was  selected  as  the  most  appropriate  solvent  as  it  maintains 
tetralone reductase activity and solubilises 6-bromo-(3-tetralone to 250g/L.
7.  Tetralone  reductase  could  not  be  applied  as  an  immobilised  enzyme  using 
Eupergit  C™  because  the  substrate  and  product  have  a  high  affinity  to  this
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support could not be performed.
8.  The  maximum  productivity  achieved  by  tetralone  reductase  using  a  cofactor 
regeneration system was 3.9g of product per g of cell mass.
9.  An  alternative  bioreactor  was  developed  using  an  adsorbent  resin  for  in  situ 
removal of the product.  The bioreactor allows the free enzyme to be used and 
NADH to be recycled via the  oxidation  of formate by formate dehydrogenase 
and reused in at least a 2-pass reactor; tetralone reductase was the rate limiting 
factor in the reactions.
10. The  whole  cells  of  Trichsporon  capitatum  (MY  1890)  can  be  used  in  the 
bioreduction of 6-bromo-p-tetralone to 6-bromo-P-tetralol.
11. The  substrate  and  product  due  to  their  inherent  hydrophobicity  adhere  to  the 
whole cells and extraction of the substrate and product can only be achieved via 
solvent extraction
12. Increasing  the  quantity  of  substrate  serves  to  increase  this  accumulation  of 
substrate/product inside the cell, which in turn causes a detrimental affect on the 
biocatalytic potential of the cells.
13. Increasing the amount of solvent increases the rate of reaction (at low substrate 
concentrations)  in  the  whole  cell  system  due  to  the  interactions  between  the 
solvent  and  the  lipophilic  membrane;  this  facilitates  an  increase  in  the  rate  of 
mass  transfer  of  substrate  across  the  membrane.  The  maximum  product 
achieved in the whole cell system was 1.2g of product per g of cell mass.
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more  useful,  currently,  for  the  isolated  enzyme  due  to  the  issues  of 
substrate/product accumulation in the whole cell.
8.  Future Work
>  Fully purify, sequence, and overexpress tetralone reductase into a host cell.  The 
high level of overexpressed active enzyme in the cell will potentially enable a 
more  efficient isolation  and purification of tetralone reductase to be  achieved. 
Tetralone reductase can then be used to perform the bioreduction of 6-bromo-p- 
tetralone,  where tetralone reductase  is no  longer the rate-limiting factor.  This 
will enable an accurate determination of the TTN (total turnover number) of the 
cofactor, as the cofactor will not be added in excess.  This number can then be 
used to establish the cost of the process relative to the cost of the cofactor and 
the  enzymes  used.  The  host  microorganism  containing  the  overexpressed 
enzyme could also be used to determine whether there would be an increase in 
the  activities  and  conversions  of  the  whole  cell  biocatalyst  or  whether  the 
adherence  of the  substrate  to  the  cell  would  as  hypothesized  be  the  limiting 
factor.
>  The addition and removal of the substrate and product respectively via polymeric 
resins  is  currently  in  its  infancy  and  further  research  into  such  systems, 
particularly for oxidoreductases (whole cell and isolated enzyme) could provide 
answer  to  substrate  and  product  toxicity.  The  use  of  resins  to  deliver  the 
substrate and remove the product in the reaction solution could also eliminate the 
need for a solvent,  and therefore remove the detrimental  effects these  solvents 
have on the enzyme.  However,  future work should also  focus the transport of 
lipophilic compounds into and out of cells and the position of the compounds in
199the cell (Angelova,  1999).  The addition of a resin with the substrate adsorbed in 
a whole cell system, in some systems, may not desorb into solution and similarly 
may not adsorb back onto the resin,  and research is required to understand the 
transport of the substrate and product through the cell membrane using resins.  In 
the  event  that  resins  may  not  be  applicable  to  all  bioconversions  and 
microorganisms it would also be appropriate to investigate novel approaches to 
increase the bioavailability of the substrate;  for example, ionic liquids (Kragl et 
al., 2002).
>  Scale-up of a bioreactor with substrate delivery and product removal in a column 
reactor in  an optimised  and controlled environment with re-use of the enzyme 
and cofactor.  This would give a greater degree of assurance, in that not only can 
an oxidoreductase can be used in such a manner with cofactor recycling, but also 
that significant quantities of product are obtainable from such a system.  It would 
also  be  of  use  to  compare  the  isolated  enzyme  bioreactor  to  a  whole  cell 
bioreactor.  Substrate  delivery  and  product  removal  has  been  previously 
described for whole cells in batch reactors (Vicenzi et al.,  1997) and for column 
reactors  (Hilker  et  al.,  2004),  but  neither  has  been  described  for  isolated 
oxidoreductases.  Column reactors using whole cell biocatalysts would, however, 
have  to  be  fluidized  to  some  degree  to  prevent  the  column  from  blocking. 
Although,  the whole cells  do  not have  to be reused  (as they do not  suffer the 
problems of the high cost of cofactors), and therefore it may be more appropriate 
to run the whole cell reduction in a batch reactor.
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225APPENDIX A: Calibrations
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Figure A 1.1  Calibration Curve of 6-brom o-fi-tetralol
Analysis  of predetermined  quantities  o f  6-bromo-f-tetralol,  solubilised  in 
ethanol via  the HPLC method defined in  Chapter 2.8.2,  to  determine  the peak 
area  in  absorbance  units  (AU).  The AU of an  unknown sample  concentration 
can then be employed to determine the actual sample concentration.
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Figure A1.2 Calibration Curve of 6-bromo-p-tetralone
Analysis  of predetermined  quantities  of  6-bromo~P~tetralone,  solubilised  in 
ethanol via  the HPLC method defined in  Chapter 2.8.2,  to  determine  the peak 
area  in  absorbance  units  (A U).  The AU o f an  unknown sample  concentration 
can then be employed to determine the actual sample concentration.
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Figure A 1.3 Calibration Curve of Total Protein
Analysis of  predetermined quantities  of BSA  via  the spectrophotomeric method 
defined in Chapter 2.8.5 to determine the absorbance units.  The optical density 
of an  unknown protein  concentration  can  then  be  employed  to  determine  the 
actual protein concentration in mg/ml.
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Figure A 1.4 Calibration Curve of  NADH
Analysis ofpredetermined quantities of  NADH via the spectrophotomeric method 
defined in Chapter 2.8.3 to determine the absorbance units.  The optical density 
of an  unknown  NADH  concentration  can  then  be  employed  to  determine  the 
actual NADH concentration in mg/ml.
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Figure Al. 5 Calibration Curve of  NAD
Analysis of  predetermined quantities of NAD via the spectrophotomeric method 
defined in Chapter 2.8.3 to determine the absorbance units.  The optical density 
of an unknown NAD concentration can then be employed to determine the actual 
NAD concentration in mg/ml.
230APPENDIX B:  Raw Data
B l.l Raw Data Isolated Enzyme Bioconversion -  Change in Substrate
Concentration (see Figure 4.5)
Raw Data Isolated Enzym e B ioconversion
Substrate (g/L)
Time
(min) 10 30 60 90 120 180 240 360 420
0.5
0.46 0.36 0.25 0.11 0.05 0.04 0.04 0.04 0.04
0.47 0.39 0.27 0.14 0.08 0.05 0.05 0.05 0.05
0.48 0.38 0.26 0.12 0.07 0.04 0.04 0.03 0.03
1
0.92 0.78 0.57 0.37 0.20 0.18 0.17 0.16 0.14
0.95 0.79 0.58 0.41 0.22 0.19 0.21 0.20 0.18
0.98 0.81 0.59 0.40 0.25 0.23 0.19 0.18 0.17
1.5
1.42 1.29 1.10 0.91 0.65 0.53 0.42 0.29 0.26
1.43 1.30 1.09 0.91 0.64 0.51 0.40 0.26 0.24
1.44 1.31 1.08 0.89 0.67 0.55 0.46 0.34 0.29
2
1.93 1.78 1.58 1.37 0.16 0.73 0.64 0.44 0.36
1.94 1.80 1.61 1.40 1.18 0.76 0.68 0.46 0.41
1.95 1.82 1.60 1.39 1.20 0.81 0.72 0.52 0.46
2.5
2.44 2.29 2.08 1.65 1.36 1.00 0.76 0.52 0.48
2.44 2.28 2.10 1.70 1.39 1.04 0.83 0.57 0.58
2.45 2.31 2.09 1.67 1.33 0.93 0.67 0.50 0.47
3
2.93 2.80 2.59 2.09 1.75 1.26 1.05 0.75 0.70
2.95 2.80 2.57 2.08 1.74 1.21 1.02 0.69 0.59
2.94 2.80 2.59 2.03 1.69 1.18 1.14 0.98 0.82
Product (g/L)
Time
(min) 10 30 60 90 120 180 240 360 420
0.5
0.04 0.13 0.25 0.39 0.45 0.46 0.46 0.46 0.46
0.03 0.12 0.24 0.37 0.43 0.45 0.46 0.45 0.45
0.02 0.12 0.24 0.36 0.42 0.46 0.46 0.46 0.47
1
0.07 0.21 0.42 0.63 0.80 0.83 0.83 0.84 0.86
0.06 0.21 0.42 0.59 0.78 0.80 0.79 0.80 0.81
0.02 0.20 0.41 0.60 0.76 0.77 0.81 0.82 0.83
1.5
0.07 0.21 0.41 0.62 0.84 0.98 1.08 1.22 1.25
0.07 0.20 0.41 0.59 0.86 1.00 1.09 2.24 1.26
0.06 0.19 0.42 0.59 0.82 0.94 1.03 1.16 1.18
2
0.07 0.21 0.42 0.63 0.84 1.26 1.36 1.57 1.64
0.06 0.20 0.40 0.61 0.83 1.24 1.32 1.54 1.59
0.06 0.20 0.40 0.60 0.80 1.20 1.28 1.49 1.54
2.5
0.07 0.21 0.41 0.82 1.13 1.50 1.74 1.98 2.03
0.06 0.22 0.40 0.80 1.12 1.45 1.65 1.94 1.92
0.06 0.19 0.41 0.83 1.17 1.57 1.83 2.00 2.12
3
0.07 0.20 0.40 0.91 1.25 1.75 1.95 2.25 2.30
0.06 0.20 0.42 0.92 1.26 1.78 1.97 2.30 2.41
0.06 0.20 0.40 0.96 1.30 1.82 1.86 2.02 2.17
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Figure B l.l Isolated Enzyme - Reaction Profile
Isolated enzyme bioconversion reaction profile with substrate concentration as 
the experiment variable.  The substrate concentrations used were as follows:  ■ 
(0.5g/L) •  (lg/L) ▲ (1.5g/L) ▼ (2g/L) ♦  (2.5g/L)  < (3g/L) - See Figure 4.5 
for more detail.
B1.2 Raw Data Isolated Enzyme Bioconversion - Change in Solvent 
Concentration (see Figure 4.6)__________________________________
Raw Data Isolated Enzyme Bioconversion
Substrate Concentration (g/L)
Time
(min) 10 30 60 90 150 260 400
1 0.47 0.36 0.20 0.11 0.04 0.02 0.01
0.47 0.36 0.20 0.13 0.04 0.02 0.02
0.46 0.35 0.18 0.11 0.02 0.02 0.02
2 0.46 0.34 0.16 0.14 0.02 0.02 0.02
0.46 0.35 0.18 0.14 0.05 0.02 0.02
0.46 0.35 0.18 0.16 0.05 0.02 0.02
3.8 0.46 0.36 0.20 0.15 0.07 0.03 0.03
0.46 0.34 0.18 0.17 0.06 0.02 0.02
0.48 0.37 0.20 0.19 0.10 0.03 0.03
7.4 0.48 0.40 0.29 0.21 0.08 0.05 0.03
0.48 0.39 0.26 0.18 0.04 0.02 0.02
0.47 0.41 0.28 0.20 0.07 0.05 0.03
10.7 0.49 0.43 0.34 0.27 0.13 0.07 0.05
0.50 0.43 0.33 0.25 0.11 0.05 0.02
0.49 0.43 0.33 0.27 0.11 0.06 0.05
232Raw Data Isolated Enzyme Bioconversion
Product Concentration (g/L)
Time
(min) 10 30 60 90 150 260 400
1 0.05 0.16 0.32 0.40 0.48 0.50 0.50
0.06 0.17 0.34 0.41 0.50 0.53 0.53
0.05 0.16 0.32 0.39 0.48 0.50 0.50
2 0.06 0.17 0.34 0.38 0.48 0.50 0.50
0.06 0.18 0.36 0.38 0.50 0.53 0.53
0.06 0.17 0.34 0.36 0.47 0.50 0.50
3.8 0.05 0.16 0.32 0.36 0.44 0.49 0.50
0.06 0.17 0.34 0.35 0.46 0.51 0.52
0.05 0.16 0.32 0.33 0.43 0.49 0.49
7.4 0.04 0.12 0.24 0.32 0.45 0.48 0.49
0.04 0.13 0.25 0.34 0.47 0.50 0.51
0.04 0.12 0.24 0.32 0.45 0.47 0.49
10.7 0.03 0.09 0.18 0.25 0.40 0.45 0.48
0.03 0.09 0.19 0.26 0.41 0.47 0.50
0.03 0.09 0.18 0.25 0.39 0.45 0.47
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Figure B1.2 Isolated Enzyme - Reaction Profile
Isolated enzyme bioconversion reaction profile with solvent concentration as the 
experiment variable.  The solvent concentration used are as follows:  ■  (1%) •  
(2%) A  (3%) T (8%) ♦  (10.7%) solvent volume - See Figure 4.6 for more 
detail.
233B1.3 Whole Cell Bioconversion without Recovery
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Figure B1.3 Whole Cell Bioconversion at Substrate Concentration o f 0.5g/L
A  whole  cell  bioconversion  of 6-bromo-fi-tetralone  (0 ) to  6-bromo-p-tetralol
m -   Initial substrate concentration  is  0.9g/L with  a solvent concentration  9% 
(v/v).  The  graph  illustrates  how  the  substrate  is  rapidly  removed from  the 
aqueous  media  but  a  concurrent  increase  in  product  is  not  observed.  A 
graphical result using higher levels of 6-bromo-(3-tetralone is shown in Appendix 
B 1.2
234B1.4 Whole Cell Bioconversion without Recovery
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Figure B1.4 Whole Cell Bioconversion at Substrate Concentration o f 0.9g/L
A  whole  cell  bioconversion  of 6-bromo-p-tetralone  ( 0 ) to  6-bromo-(3-tetralol
(Ml).  Initial substrate concentration is  1.7g/L with a solvent concentration  17% 
(v/v).  The  graph  illustrates  how  the  substrate  is  rapidly  removed from  the 
aqueous media but a concurrent increase in product is not observed.
235BJ.5 Raw Data Whole Cell Bioconversion Change in Solvent Concentration 
(see Figure 5.7)  _____   ______ ____________ __
Raw Data Whole Cell Bioconversion
Substrate Concentration (g/L)
Time
(min) 20 45 90 150 270 390
1
0.43 0.34 0.27 0.09 0.05 0.04
0.42 0.34 0.29 0.12 0.06 0.06
0.42 0.32 0.25 0.09 0.01 0.03
2
0.41 0.31 0.23 0.10 0.04 0.02
0.41 0.33 0.26 0.11 0.09 0.05
0.41 0.32 0.25 0.10 0.07 0.03
4
0.38 0.29 0.21 0.12 0.07 0.05
0.39 0.27 0.20 0.12 0.07 0.05
0.41 0.31 0.22 0.13 0.09 0.05
8
0.37 0.26 0.18 0.11 0.07 0.06
0.37 0.27 0.18 0.11 0.06 0.06
0.36 0.27 0.17 0.10 0.07 0.06
12
0.33 0.23 0.15 0.12 0.09 0.07
0.33 0.22 0.14 0.11 0.09 0.07
0.34 0.24 0.16 0.12 0.08 0.08
Product Concentration (g/L)
Time
(min) 20 45 90 150 270 390
1
0.07 0.16 0.23 0.40 0.45 0.46
0.08 0.17 0.23 0.40 0.47 0.47
0.08 0.17 0.23 0.39 0.46 0.47
2
0.09 0.18 0.25 0.40 0.44 0.48
0.09 0.18 0.26 0.39 0.43 0.48
0.09 0.18 0.25 0.40 0.43 0.47
4
0.11 0.21 0.29 0.37 0.42 0.45
0.11 0.22 0.30 0.38 0.43 0.46
0.10 0.20 0.28 0.37 0.42 0.45
8
0.13 0.24 0.33 0.40 0.44 0.44
0.13 0.23 0.31 0.39 0.43 0.44
0.13 0.24 0.33 0.40 0.43 0.44
12
0.17 0.27 0.35 0.38 0.41 0.43
0.18 0.28 0.36 0.38 0.41 0.43
0.18 0.28 0.35 0.40 0.42 0.43
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Figure B1.5 Whole Cell Biocatalyst -  Reaction Profile
Whole cell bioconversion reaction profile with solvent concentration as the 
experiment variable.  The solvent concentrations used were as follows:  ■ (1%) 
•  (2%) ▲ (4%) T (8%) ♦  (12%) - See Figure 5.7 for more detail.
237B1.6 Raw Data Whole Cell Bioconversion - Change in Substrate 
Concentration
Raw Data W hole Cell Bioconversion
Substrate (g/L)
Time
(min) 20 45 90 150 270 390 450
0.5
0.335 0.315 0.225 0.18 0.13 0.1 0.105
0.33 0.30 0.23 0.19 0.13 0.09 0.09
0.33 0.31 0.24 0.21 0.19 0.13 0.13
1
0.8 0.71 0.58 0.43 0.24 0.21 0.21
0.82 0.73 0.61 0.44 0.24 0.21 0.20
0.85 0.73 0.62 0.48 0.26 0.27 0.26
1.5
1.305 1.185 1.065 0.87 0.645 0.45 0.42
1.29 1.17 1.05 0.85 0.63 0.43 0.40
1.32 1.21 1.10 0.91 0.67 0.49 0.47
2
1.78 1.66 1.5 1.34 1.14 0.96 0.94
1.82 1.73 1.53 1.49 1.09 0.97 0.97
1.80 1.67 1.50 1.35 1.19 1.00 1.00
2.5
2.275 2.175 1.975 1.975 1.6 1.45 1.475
2.28 2.19 1.99 1.95 1.55 1.43 1.43
2.28 2.19 1.98 1.96 1.56 1.46 1.46
3
2.82 2.64 2.49 2.25 2.13 1.91 1.9
2.86 2.68 2.53 2.29 2.17 1.95 1.94
2.80 2.62 2.40 2.23 2.11 1.92 1.91
Product (g/L)
0.5
0.17 0.19 0.28 0.32 0.37 0.40 0.40
0.16 0.19 0.26 0.30 0.36 0.40 0.40
0.17 0.19 0.26 0.29 0.31 0.38 0.38
1
0.20 0.29 0.42 0.57 0.76 0.79 0.79
0.19 0.28 0.40 0.57 0.77 0.80 0.81
0.16 0.28 0.40 0.54 0.75 0.74 0.75
1.5
0.20 0.32 0.44 0.63 0.86 1.05 1.08
0.19 0.30 0.41 0.59 0.81 0.99 1.03
0.19 0.30 0.41 0.60 0.84 1.02 1.04
2
0.22 0.34 0.50 0.66 0.86 1.04 1.06
0.22 0.32 0.48 0.63 0.84 1.00 1.02
0.21 0.34 0.51 0.66 0.82 1.01 1.01
2.5
0.23 0.33 0.53 0.53 0.90 1.05 1.03
0.21 0.30 0.50 0.54 0.94 1.06 1.06
0.23 0.32 0.53 0.55 0.95 1.05 1.05
3
0.18 0.36 0.51 0.75 0.87 1.14 1.10
0.16 0.33 0.51 0.72 0.80 1.07 1.09
0.19 0.37 0.59 0.76 0.88 1.16 1.08
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Figure B1.6 Whole Cell Biocatalyst Reaction Profile
Change in Substrate Concentration.  Initial substrate concentrations are as 
follows* (0.5g/L) •  (lg/L) ▲ (1.5g/L) ▼(2g/L) ♦  (2.5g/L)  ^  (3g/L) - See 
Figure 5.9 for more detail.
239APPENDIX C: Materials and Methods 
Reverse Phase HPLC for Substrate Specificity
Confirmation  of  the  bioconversions  was  determined  with  a  Gilson  Liquid 
Handler (Gilson, Middletown, WI, USA) and a Zorbax RX-C8 column (MacMod 
Analytical,  Chadds  Ford,  PA,  USA).  The  following  assays  were used  for the 
different substrates and products (Chapter 6.2.3).
6-Bromo-p-T  etralone
Separation was achieved using an isocratic elution using a 50% acetonitrile and 
50%  acidified  water  (0.1%  H3PO4)  mobile  phase,  delivered  at  a  flow  rate  of 
1.5ml/min.  Detection  was  performed  by  UV  at  220nm,  and  under  these 
conditions tetralone and tetralol  eluted  at 4.70  and  6.20 respectively (Reddy et 
al, 1996).
Benzyl Acetoacetate
Separation  was  achieved  using  a  gradient  of acetonitrile  and  acidified  water 
(0.1%  H3PO4)  at  a  flow  rate  of  lml/min.  The  gradient  was  20/80  (v/v) 
acetonitrile/water to 80/20 over 20min, held for 5min and the re-equilibrated for 
5min before the next injection.  Detection was performed at 220nm, the alcohol 
and ketone eluted at 10.7min and 12.8min respectively.
Cyclohexylphenyl Ketone
Separation was achieved using an isocratic elution of a 50% acetonitrile and 50% 
acidified  water  (0.1%  H3PO4)  mobile  phase,  delivered  at  a  flow  rate  of 
1.5ml/min.  Detection  was  performed  by  UV  at  210nm,  and  under  these 
conditions  the ketone  eluted  at  11.2min,  no peak was  observed  for the  alcohol 
(Chartrain et al., 1997).
240|3-Ketoester
Separation was achieved using a gradient of acidified acetonitrile (0.1 % H3PO4) 
and acidified water (0.1% H3PO4) at a flow rate of 1.5ml/min.  The gradient was 
20/80 (v/v) acetonitrile/water to 70/30 over lOmin, held for 20min.  The system 
the re-equilibrated to 20/80 (v/v) for 7min before the next injection.  Detection 
was  performed  at  2 0 0 nm,  and  under  these  conditions  the  ketone  eluted  at 
14.7min, no peak was observed for the alcohol (Chartrain et al., 1995).
Ketone
Separation  was  achieved  using  a  gradient  of  acetonitrile  and  acidified  water 
(0.1%  H3PO4)  at  a  flow  rate  of  lml/min.  The  gradient  was  20/80  (v/v) 
acetonitrile/water to 80/20 over 20min, held for 5min and the re-equilibrated for 
5min before the next injection.  Detection was performed at 220nm, the ketone 
eluted at 8 .2 min, no peak was observed for the alcohol
Separation was achieved using a gradient of acidified acetonitrile (0.1% H3PO4) 
and acidified water (0.1% H3PO4) at a flow rate of 1.5ml/min.  The gradient was 
10/90 (v/v) acetonitrile/water to 90/10 over 25min then re-equilibrated for 5min 
before the next injection.  Detection was performed  at 254nm.  (Roberge et al, 
1996)
1,2-Indanedione
Separation  was  achieved  using  a  gradient  of acetonitrile  and  acidified  water 
(0.1%  H3PO4)  at  a  flow  rate  of  lml/min.  The  gradient  was  10/90  (v/v) 
acetonitrile/water  to  90/10  over  20min,  held  for  3min  then  re-equilibrated  for 
2min before the next injection.  Detection was performed at 220nm, the ketone 
eluted at 9.8min, no peak was observed for the alcohol (Stahl et al.,  1999).
241Bisaryl Ketone
Separation was achieved using an isocratic elution using a 50% acetonitrile and 
50%  acidified  water  (0.1%  H3PO4)  mobile  phase,  delivered  at  a  flow  rate  of 
lml/min.  Detection was performed by UV at 210nm. (Chartrain et al., 2000).
Ketosulfone
Separation  was  achieved  using  a  gradient  of  acetonitrile  and  acidified  water 
(0.1%  H3PO4)  at  a  flow  rate  of  lml/min.  The  gradient  was  20/80  (v/v) 
acetonitrile/water  to  90/10  over  20min,  held  for  5min  then  re-equilibrated  for 
5min before the next injection.  Detection was performed at 220nm, the ketone 
eluted at  13.5min, no peak was observed for the alcohol, no peak was observed 
for the alcohol.
Chloroketone
Separation was achieved using a gradient of acetonitrile and water at a flow rate 
of  lml/min.  The  gradient  was  40/60  (v/v)  acetonitrile/water  to  90/10  over 
15min,  held  for  lOmin then re-equilibrated  for  5min before the next  injection. 
Detection  was  performed  at  220nm,  alcohol  and  ketone  eluted  at  5.9min  and 
8.2min respectively.
Ketoester
Separation was achieved using a gradient of acetonitrile and water at a flow rate 
of  lml/min.  The  gradient  was  40/60  (v/v)  acetonitrile/water  to  90/10  over 
15min,  held  for  lOmin  then  re-equilibrated  for  5min before the next  injection. 
Detection was performed at 220nm, the
1-indanone
Separation  was  achieved  using  a  gradient  of  acetonitrile  and  acidified  water 
(0.1%  H3PO4)  at  a  flow  rate  of  lml/min.  The  gradient  was  20/80  (v/v) 
acetonitrile/water to 80/20 over 20min, held for 5min and the re-equilibrated for 
5min before the next injection.  Detection was performed at 220nm, the ketone 
eluted at 10.9min no peak was visible for the alcohol
2422 -Indanone
Separation  was  achieved  using  a  gradient  of  acetonitrile  and  acidified  water 
(0.1%  H3PO4)  at  a  flow  rate  of  lml/min.  The  gradient  was  20/80  (v/v) 
acetonitrile/water to 80/20 over 20min, held for 5min and the re-equilibrated for 
5min  before  the  next  injection.  Detection  was  performed  at  220nm,  ketone 
eluted at 11.5min.
P-Tetralone
Separation  was  achieved  using  a  gradient  of  acetonitrile  and  acidified  water 
(0.1%  H3PO4)  at  a  flow  rate  of  lml/min.  The  gradient  was  20/80  (v/v) 
acetonitrile/water to 80/20 over 20min, held for 5min and the re-equilibrated for 
5min before the next injection.  Detection was performed at 220nm, the alcohol 
eluted at 10.3min.
a-Tetr  alone
Separation  was  achieved  using  a  gradient  of acetonitrile  and  acidified  water 
(0.1%  H3PO4)  at  a  flow  rate  of  lml/min.  The  gradient  was  20/80  (v/v) 
acetonitrile/water to 80/20 over 20min, held for 5min and the re-equilibrated for 
5min before the next injection.  Detection was performed at 220nm, the ketone 
eluted at 31.2min, no peak was visible for the alcohol.
243APPENDIX D: List of Suppliers
Amersham Pharmacia Biotech 
UK Ltd.,
Amersham Place 
Little Chalfont 
Bucks 
HP7 9NA
APV Eura 
23 Gatwick Road 
Crawley 
W Sussex 
RH10 2JB 
UK
Beckman Coulter, Inc
4300 N. Harbour Boulevard
PO Box 3100
Fullerton
CA 92634-3100
USA
Bio-Rad Laboratories Ltd 
Bio-Rad House 
Maylands Ave 
Hemel Hempstead 
Herts 
HP2 7TD
Amersham Pharmacia Biotech Inc.,
800 Centennial Ave
PO Box 1327
Piscataway
NJ
08855
USA
Bio-Rad Laboratories Ltd
1000 Alfred Nobel Drive
Hercules
CA 94547
USA
Roche Diagnostics 
F.Hoffmann -  La Roche Ltd 
Dianostics Division 
Grenzacherstrasses 
CH -  4070 Basel 
Switzerland
Dionex
4 Albany Court 
Camberley 
Surrey 
GU16 7QL 
UK
Eppendorf 
10 Signet Court 
Swanns Road 
Cambridgeshire 
CB58LA 
USA
Gilson, Inc., USA
3000 West Beltline Highway
PO Box 620027
Middleton
WI 53562
USA
Fisher Scientific 
2000 Park Land 
Pittsburg 
PA 15275 
USA
Mac-Mod Analytical, Inc. 
127 Commons Court 
Chadds Ford 
PA 19317 
USA
244Merck and Co., Inc. 
PO Box 2000 
Rahway 
NJ 07065 
USA
Millipore (UK) Ltd 
The Boulevard 
Blackmore Land 
Watford 
Hertfordshire 
WD1  8YW 
UK
Microfluidics Corp.
30 Ossipee Road 
Newton 
MA 02164 
USA
Phenomenex
2320 North 205th Street
Torrance
CA 90501-1456
USA
Rohm GmbH 
Chemische fabrik 
Kirschenalle 
64293 Darmstadt 
Germany
Sigma-Aldrich Company Ltd
Fancy Road
Poole
Dorset
BH12 4QH
UK
USA Scientific Inc. 
PO Box 3565 
Ocala
FL 24478-3565 
USA
Whatman Pic 
Whatman House 
St Leonard Street 
Maidstone 
Kent 
UK
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